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Abstract 
 
A series of novel (a)chiral substituted BINOLs and achiral biquinoline compounds were 
synthesised and characterised. Different substituents were incorporated within the 
structure of these molecules to enhance biodegradation. These substituents were selected 
according to Boethling’s ‘rules of thumb’ for designing biodegradable chemicals.  
 
Final novel compounds were screened for antimicrobial activity and tested for 
biodegradation. As well a number of known organocatalysts were also studied for 
antimicrobial activity, tested for biodegradation and cytotoxicity, apoptosis and cell 
viability studies were performed against three blood cell lines. Both enantiomers of 
amino acids (L and D) and BINOLs (S and R) were screened for anti-microbial activity to 
determine the affect of stereochemistry. Antimicrobial studies were performed using the 
minimum inhibitory concentration assay. Highest concentration was dependant on 
chemical solubility, however, for most compounds tested the highest concentration was 2 
mM. Test organisms used for this study included fungi, Gram positive and Gram negative 
bacteria. Growth inhibition of microbes was noted for some compounds within tested 
concentration range. (R)-3,3’-Dibromo-H8-BINOL was found to be a hit antimicrobial 
agent for Gram positive bacteria with an MIC value in the low micromolar range.    
 
Cytotoxicity, apoptosis and cell viability studies of organocatalysts were carried out 
against the blood cell lines human erythroid progenitors, HL-60 and K-562 using the 
promega protocols, respectively. A Maruoka phase-transfer catalyst was found to reduce 
cell viability and promote apoptosis for all three cell lines studied. 
 
Biodegradation studies of organocatalysts were performed using the CO2 headspace test 
(ISO 14593). BINOL and derivatives showed poor biodegradation under the parameters 
of the CO2 headspace test (ISO 14593). L-Prolinamide passed the CO2 headspace test 
(ISO 14593) and can be classified as a readily biodegradable catalyst. For the inhibitory 
control biodegradation assay, a Maruoka phase-transfer catalyst was found to have an 
inhibitory effect on the activity of the inoculum. All other organocatalysts studied, 
showed low inhibition for the inhibitory control biodegradation assay. 
iv 
Chiral substituted BINOLs were synthesised and evaluated as asymmetric catalysts for 
the Morita-Baylis-Hillman reaction. For this study, test substrates hydrocinnamaldehyde 
and 2-cyclohexen-1-one were reacted together in the presence of triethylphosphine in 
THF and BINOL derived catalysts (2 mol%) in THF at room temperature. However, 
preliminary results show catalysts performed poorly when compared to known optimal 
catalyst. 
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1.1 Introduction to organocatalysis 
                                                 
 
1.1.1 Asymmetric organocatalysis 
 
The synthesis of enantiomerically pure compounds is of fundamental importance for 
chemical and pharmaceutical industries today.1,2 One strategy that can be used for the 
generation of enantiopure compounds is asymmetric synthesis. This approach can involve 
the employment of asymmetric catalysts, which act as chiral promoters for the conversion 
of achiral substrates into chiral products.3 There are three branches of asymmetric    
catalysts reported in the literature, transition metal catalysis,4 biocatalysis5 and 
organocatalysis.6-13 Organocatalysis has re-emerged as an alternative asymmetric 
methodology and involves the use of small chiral organic molecules called 
organocatalysts in sub-stoichiometric amounts to catalyze a reaction enantioselectively.6  
After seminal reports made by List and Barbas14 and MacMillan,15 in 2000, 
organocatalysis as a synthetic methodology gained momentum. Since their initial reports 
the number of publications on organocatalysis has steadily risen.6-13  
 
1.1.2 Classes of organocatalysts 
 
Organocatalysts, a word coined by MacMillan is used to define organic molecules as 
catalysts for synthesis.12 These catalysts avoid the application of toxic metals (many 
compounds/complexes of which have undesirable toxicities) and is one of the main 
reasons this field as a whole has gained such prominence. Many classes of 
organocatalysts have been reported (Figure 1.1) and the field is ever expanding.6-13 
One of the first reports, for the use of an organocatalyst was made in the 1970s by the 
industrial groups of Eder, Sauer and Wiechert 16 and Hajos and Parrish.17 They reported 
the use of (S)-proline, a natural amino acid, for an intramolecular Aldol reaction of a 
triketone (1) (Scheme 1.1). 
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Fig. 1.1 A selection of the main classes of organocatalysts 
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  Scheme 1.1: The Hajos-Parrish-Eder-Sauer-Wiechert reaction16,17 
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Since the revival of organocatalysis in 2000,14, 15 many reports have been made for the 
application of (S)-proline in the Aldol,18 Mannich,19 Michael20 and Baylis-Hillman 
reactions.21 However, (S)-proline has proven to be inefficient for some reactions such as 
the Michael reaction (low ee obtained in some cases) and has also been found to require a 
higher catalyst loading compared to transition metal catalysts.20 These initial drawbacks 
have lead to numerous modifications being made to the structure of (S)-proline. The 
purpose of modifying (S)-proline and other chiral catalysts, can be for widening of 
reaction and substrate range, to improve solvent compatibility, to lower catalyst loading 
and for the attachment to solid support which allows for easier recyclability.22-24 Modified 
proline derivatives have demonstrated wide usage for a number of reactions.6-13 As well, 
acyclic amino acids have emerged as a class of organocatalysts, however, the reaction 
range has proven to be quite limited to date.25,26 For instance, (S)-tryptophan27 and (S)-
alanine28 have been demonstrated as asymmetric catalysts for the Aldol reaction. 
Cinchona alkaloids are another class of asymmetric catalysts and numerous modifications 
have been applied to their scaffold.29 The BINOL backbone which is the focus of this 
project, has found applications as a chiral unit for the design and development of 
organocatalysts such as chiral phosphoric acids30-32 and Maruoka phase-transfer 
catalysts.33   
 
1.1.3 Advantages of organocatalysts 
 
There are several advantages for using an organocatalyst compared to transition metal 
catalysts or biocatalysts.6 
• Both enantioseries are more readily available 
• Robust 
• Inexpensive 
• Inert towards moisture and oxygen 
• Absolute solvents generally not required 
• Metal-free  
 
5 
These advantages are the fundamental reason organocatalysis as a synthetic methodology 
has received so much attention. However, organocatalysts do have their drawbacks such 
as high catalyst loading which still need to be addressed before their wide adoption by 
industry.6 
 
1.2 Organocatalysis in synthetic reactions 
 
 
1.2.1 Aldol reaction 
 
The Aldol reaction is a useful carbon-carbon bonding forming reaction, also providing 
high “atom-economy”.34,35 It is a typical example of electrophilic substitution at the alpha 
carbon in enols or enolate anions. The fundamental transformation usually catalyzed by 
base or equivalent acid is a dimerization of an aldehyde or ketone to form a β-hydroxyl 
aldehyde or ketone by α-carbanionic addition of one reactant molecule to the carbonyl 
group of a second reactant molecule.36 
In 2000, with the inspiration of the action of class I aldolases, List et al. were first to 
demonstrate the ability of (S)-proline (5) to mediate intermolecular asymmetric Aldol 
reactions between unmodified acetone (3) and a variety of aldehydes with moderate to 
good enantioselectivities (Scheme 1.2).14 In this reaction, the ketones acted as source of 
nucleophile and aldehydes as electrophiles. Modest enantiomeric excess (60-77% ee) 
were obtained for the synthesis of aromatic Aldols (6a, 6b and 6c). Unbranched 
aldehydes (e.g. pentanal) did not yield any significant amount of the desired cross-Aldol 
product. However, the reaction of acetone (3) with isobutyraldehyde gave the Aldol 
product (6d) in 97% yield and 96% ee. 
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Scheme 1.2: Intermolecular Aldol reaction between acetone (3) and aldehydes catalyzed 
by (S)-proline (5) 14 
  
Carter and coworkers have designed and synthesised a novel (S)-proline-sulfonamide 
derivative (8) which is capable of catalyzing the Aldol reaction in non-polar solvents.37 
Catalysis of the Aldol reaction with (S)-proline (5) must be performed in polar solvents 
such as DMF and DMSO. Carter was able to expand the solvent scope for catalysis of the 
Aldol reaction with a proline derivative, by designing a more hydrophobic (S)-proline 
sulfonamide catalyst (8) (Scheme 1.3). The placement of a dodecyl hydrocarbon on the 
para position of the phenyl substituent generates a lipophilic (S)-proline sulfonamide 
catalyst (8) which can readily dissolve in non-polar solvents. For instance, 300 mg of (S)-
proline sulfonamide (8) is soluble in 1 mL of DCM while 300 mg of (S)-proline (5) is not 
readily soluble in the same volume of DCM.38 From an industrial perspective, non-polar 
solvents are easier to remove and recycle compared to polar solvents.37  
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Scheme 1.3: Intermolecular Aldol reaction catalyzed by (S)-proline sulfonamide (8) 37 
 
For their study, cyclohexanone (7) was reacted with various aldehydes using the (S)-
proline sulfonamide catalyst (8). Optimum conditions for their Aldol reaction were 20 
mol% of 8, DCE as solvent, 1 equivalent of water was found to enhance reaction rate and 
diastereoselectivity and the reactions were performed at 4 °C. Electron deficient 
aldehydes performed better than electron rich aldehydes in terms of product yield for the 
Aldol reaction (Scheme 1.3). The para-nitrobenzaldehyde substrate gave a yield of 95% 
with an ee of 99% and dr of >99:1 while para-methoxybenzaldehyde furnished a low 
yield of 16% with an ee of 98% and dr of 80:1. 
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1.2.2 Michael reaction 
 
The Michael reaction is a key C-C bond forming reaction that involves various Michael 
donor and acceptor molecules. Recent interest in the direct asymmetric organocatalyzed 
Michael reaction is due to the diverse array of products that can be obtained, such as γ-
nitrocarbonyl compounds, functionalised pyrrolidines and 1,4-Michael adducts.11 There 
are many modes of activation for the catalyzed Michael reaction, including catalysis via 
iminium ion-based activation of the Michael acceptor and enamine-based activation of 
Michael donor molecules. The potential usage of organocatalysts for the Michael reaction 
has been investigated using a wide range of Michael donors and acceptors. 
 
 A (S)-diphenylprolinol silyl ether catalyst (12) has been reported to be effective for 
addition of nitroalkanes to α,β-unsaturated aldehydes via chiral iminium ion catalysis 
(Scheme 1.4).39 Addition to α,β-unsaturated aldehydes is more challenging because of the 
competitive 1, 2-addition reaction.39 The (S)-diphenylprolinol silyl ether (12) generates 
Michael products using methanol as solvent in moderate yields and enantioselectivities 
greater than 90%. Aromatic α,β-unsaturated aldehydes generated products with higher 
yields compared to aliphatic analogs. Similar enantioselectivities were obtained using 
aliphatic and aromatic α,β-unsaturated aldehydes. However, longer reaction times were 
required for aliphatic α,β-unsaturated aldehydes (42-120 h) compared to aromatic α,β-
unsaturated aldehydes (16-48 h). 
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Scheme 1.4: Intermolecular Micheal reaction of α,β-unsaturated aldehydes with 
nitromethane (11) via iminium ion catalysis 39 
 
Jacobsen and coworkers have reported an enantioselective direct conjugate addition of 
acetone (3) to nitroalkenes using a chiral primary amine-thiourea catalyst (15) (Scheme 
1.5).40 Jacobsen catalyst (15) is a bifunctional catalyst, the primary amine activates the 
acetone (3) substrate to generate a nucleophilic enamine and the electrophilic nitroalkene 
substrates are further activated by the thiourea functional group. Thiourea catalyst (15) 
was applied at a loading of 10 mol% for the Michael reaction between acetone (3) and 
nitroalkenes (Scheme 1.5), furnishing the nitroalkane products in good yields (>70%) and 
with high ee (>94%).  
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Scheme 1.5: Enantioselective Michael addition of acetone (3) to nitroalkenes catalyzed 
by Jacobsen thiourea (15) 40 
 
Aromatic, heteroaromatic and aliphatic nitroalkenes were good substrates for this 
reaction. The addition of 10 mol% benzoic acid was required to avoid the formation of 
the bisalkylation product, therefore ensuring that higher yields of the monoalkylated 
product were obtained. Without the addition of benzoic acid, a bisalkylated byproduct for 
16a was obtained in 40 % yield. The acid suppressed this byproduct without erosion of 
enantioselectivity.  Non-polar solvents (DCM, toluene) were found to be optimum for this 
reaction with toluene giving the best results. 
11 
1.2.3 Diels-Alder reaction 
 
The Diels-Alder reaction occurs between a conjugated diene and an alkene, usually called 
the dienophile to form six-membered rings.41 Organocatalysts have been reported for the 
asymmetric Diels-Alder reaction. 
 
MacMillan and coworkers developed a chiral amine capable of activating α,β-unsaturated 
ketones as dienophiles for the asymmetric Diels-Alder reaction.42 The chiral 
imidazolidinone (19) was applied for the reaction of cyclopentadiene (18) with various 
acyclic enones (Scheme 1.6). Good yields (>78%) and ee (>90%) were obtained for most 
Diels-Alder products. Modification of the dienophile at R1 (Me, n-Pr, i-Pr) had little 
impact on yields and ee being obtained for the Diels-Alder products. However, 
substituents present at R2 had an influence on the yield and ee being obtained for the 
Diels-Alder adduct. A methyl group at R2 resulted in a lower ee (61%) for the Diels-Alder 
product when compared to the ee for ethyl group (90%). An iso-propyl substituent at R2 
yielded the Diels-Alder adduct as racemate with a low yield of 24%. This transformation 
was performed in water which is a green safe medium. 
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R2 O
N
N
HPh O
O
19 (20 mol%)
20 mol% HClO4, H2O, 0 oC
17 18 20
 
 
entry R1 R2 % yield endo:exo % ee 
20a Me Me 85 14:1 61 
20b Me Et 89 25:1 90 
20c Me n-Bu 83 22:1 92 
20d Me i-Pr 24 8:1 0 
20e n-Pr Et 84 15:1 92 
20f i-Pr Et 78 6:1 90 
 
Scheme 1.6: Organocatalyzed Diels-Alder reaction between cyclopentadiene (18) and 
acyclic enones (20a-f) 42 
 
 
The chiral amine (19) was further evaluated for the cycloaddition between ethyl vinyl 
ketone (21) and a range of dienes (Scheme 1.7). Good yields (>79%) and ee (>85%) were 
obtained for the alkyl-, alkoxy-, amino-, and aryl-substituted cyclohexenyl ketone 
products. This reaction was performed in the polar protic solvent ethanol. 
 
MacMillans imidazolidinone catalyst (19) has proven to be versatile for the catalysis of 
various dienes and dienophiles in the asymmetric Diels-Alder reaction.  
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COEt
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90 
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23e 
 
COEt
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79 
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Scheme 1.7: Organocatalyzed Diels-Alder reaction between ethyl vinyl ketone (21) and 
dienes (23a-e) 42 
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1.2.4 BINOL derivatives as organocatalysts 
1.2.4.1 BINOL overview 
 
1,1’-Bi-2-naphthol or commonly referred to as BINOL is an axial chiral biaryl molecule 
which can be obtained in two enantiomers (Figure 1.2).  
 
OH
OH
OH
OH
 
 
              (S)-(−)-BINOL                                                     (R)-(+)-BINOL 
 
 
Fig. 1.2 Enantiomers of BINOL 
 
  
 
BINOL was first synthesized in racemic form by Von Richter in 1873.43 Since then, the 
synthesis and application of BINOL in asymmetric synthesis has been widely reported.44 
Also modified versions of BINOL have been prepared to broaden their catalytic scope.45 
Most of these modifications occur at the 3,3’ or 6,6’ positions on the BINOL scaffold 
(Figure 1.3).  
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Fig. 1.3 Numbering of BINOL scaffold 
 
 
15 
There are some examples of polysubstituted BINOLs (where more than one position is 
modified).46-53 BINOL and its derivatives have been applied as ligands for transition 
metal catalysts44, 45 and more recently as a scaffold for organocatalysts.30-33 
 
1.2.4.2 Scaffold for organocatalysts 
 
 
In 2004, a new class of organocatalysts named the chiral phosphoric Brønsted acid 
catalysts were independently reported by the research groups of Akiyama and Terada.54,55 
Both groups reported on the phosphorylation of modified BINOL derivatives to yield a 
chiral phosphoric acid which functions as a Brønsted acid catalyst. Since then, the 
Brønsted acid activation of imine and carbonyl substrates using chiral phosphoric acids 
has received great attention especially for reactions like the Mannich, aza-Diels-Alder 
and aza-Baylis-Hillman.30-32 In general, reactions involving prochiral basic substrates 
(imines) that can be activated by general acid catalysis may potentially be activated by 
chiral phosphoric acids in an enantioselective manner. 
 
Terada and co-workers in their first report described an enantioselective direct Mannich 
reaction involving various N-Boc-protected arylimine derivatives and acetyl acetone 
catalyzed by phosphoric acid derivatives, a new family of chiral Brønsted acid catalysts.54   
Initially, a selection of catalysts (Scheme 1.8) were evaluated against N-Boc-protected 
arylimine 24 and acetyl acetone (acac) to furnish β-aminoketone 25 in high yields. The 
enantiomer excess (ee) of products varied depending on catalysts. Absence of bulky 
substituents at the 3,3’-position of the phosphoric acid catalyst proved detrimental for ee. 
For instance, using 26b as catalyst, the product was obtained with an ee of 12% while in 
the case of 27 an ee of 56% is achieved. The presence of 3,3’-bisaryl substituents for 
catalysts 28 and 29 increased the ee of product further (90% and 95% respectively).  
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Cat (2 mol%)
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Catalyst R2 Yield (%) 25 ee (%) 
26b 
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28 
29 
H 
Ph 
4-Biph 
4-(β-Naph)-C6H4 
92 
95 
88 
99 
12 
56 
90 
95 
 
 
Scheme 1.8: Optimization of chiral phosphoric acid catalysts for Mannich reaction.54 
 
 
 
 
The highest enantiomeric excess (95%) was obtained with catalyst 29 and was further 
evaluated against test substrates containing methoxy, methyl and bromo substituents at 
the para position of the phenyl ring to yield the products as in Scheme 1.9. Products 
(25a-25d) were generated with good yields (93-99%) and high ee (90-98%).     
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Scheme 1.9: Chiral products obtained using catalyst 29.54 
 
 
Akiyama et al. reported the enantioselective Mannich-type reaction of silyl enolates with 
aldimines catalyzed by a chiral Brønsted phosphoric acid.55 For their initial experiment, 
they screened aldimine 30 (1 equivalent) and ketene silyl acetal 31 (3 equivalents) with 
30 mol% of the chiral phosphoric acid catalysts (Scheme 1.10). 
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20 
27 
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Scheme 1.10: Optimization of chiral phosphoric acid catalysts 55 
 
 
Catalyst 26b gave a moderate yield albeit with no enantioselectivity. The presence of 
aromatic groups at the 3,3’-position induced good enantioselectivity. A nitro group at the 
para position of the aromatic ring exerted a significant increase in ee (87%) with high 
yields (96%) being obtained and the reaction time lowered to 4h. They found that 
aromatic solvents (e.g. toluene) produced high enantioselectivities, whereas protic 
solvents (e.g. ethanol) produced racemates. In further optimization reactions the catalyst 
loading was lowered to 10 mol% with high enantioselectivity being retained.  
 
The reaction scope was further extended with different aldimines and ketene silyl acetals 
using 35 as catalyst (10 mol%). Products were furnished with good yields, high syn 
selectivity and with excellent enantioselectivity being obtained (Scheme 1.11). 
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Scheme 1.11: Enantioselective Mannich-type reaction 55 
 
 
 
 
1.2.5 Alkylation reactions via chiral phase-transfer catalysis 
 
Chiral phase-transfer catalysis is a synthetic methodology that offers many advantages as 
it involves mild reaction conditions, simple reaction procedures and the possibility to 
conduct on large-scale.56,57 The preparation of optically active α-amino acid derivatives 
by chiral phase-transfer catalysis with a prochiral protected glycine derivative called N-
(diphenylmethylene)-glycine tert-butyl ester (36) (Scheme 1.12) has been achieved by 
various research groups using chiral organocatalysts.58 
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Et 
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Et 
Et 
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100 
100 
100 
79 
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92:8 
86:14 
93:7 
100:0 
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n-BuH
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42% ee (R)
61% yield,
52% ee (R)
36 37 39
39a 39b
39c 39d
N
N
HO Cl
Scheme 1.12: Asymmetric alkylation of 36 with alkyl halides using the phase-transfer 
catalyst N-benzylcinchoninium chloride (38b) 59 
 
The alkylation of the glycine Schiff base ester (36) by the N-benzylcinchoninium chloride 
phase-transfer catalyst (38b) has been demonstrated by the O’Donnell research group.59 
This transformation leads to the enantioselective synthesis of amino acid precursors, 
which can furnish enantiopure amino acids subsequent to recrystallisation and acid 
hydrolysis. O’Donnell cinchonine derived phase-transfer catalyst (38b) gave moderate 
yields (>42%) and ee (>60%) for the alkylated Schiff base ester products (Scheme 1.12). 
However, they found it possible to obtain enantiopure α-amino acid derivatives by 
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recrystallisation of the enriched alkylated Schiff base ester products. 
Phase-transfer catalysts developed by the Maruoka group have resulted in lower catalyst 
loadings being employed for the asymmetric alkylation of glycine Schiff base ester (36). 
Maruoka and coworkers have designed and developed a series of chiral phase-transfer 
catalysts based on the binaphthyl backbone.60 Quaternary ammonium salt (40) (Scheme 
1.13) is one example of a phase-transfer catalyst synthesised by the Maruoka research 
group. 
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Scheme 1.13: Enantioselective alkylation of 36 using Maruoka catalyst (40) 61 
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Maruoka catalyst (40) was applied for the enantioselective phase-transfer alkylation of 
prochiral protected glycine derivative (36) and was found to be highly effective at a 
catalyst loading of 0.05 mol%.61 A range of alkylating agents were evaluated for the 
alkylation of 36. High yields (>81%) and good enantioselectivities (>97%) were obtained 
for the alkylated products (Scheme 1.13). 
 
Organocatalysts have shown great versatility as catalysts for asymmetric synthesis. They 
have been employed as catalysts for many carbon-carbon, carbon-oxygen and carbon-
nitrogen bond forming reactions.6-13 Their reaction scope continues to expand, evident 
from the papers being published to date.6-13 Their inherent advantages over many (but not 
all) metal based catalysts continue to drive research within the organocatalysis field. 
 
 
 
 
1.3 Environmental Concerns 
 
1.3.1 Toxicity and biodegradation aspects 
 
Considering the number of structures which have been reported as organocatalysts,6-13 
very little information has been reported about their potential environmental impact. In 
early reports, it was mentioned that organocatalysts were at an advantage to transition 
metal catalysts on the basis they were non-toxic and environmental benign.16,25 This 
statement was made because organocatalysts do not contain a metal and the early 
examples came from natural molecules such as (S)-proline whose environmental impact 
would be considered negligible. However, as the structures of organocatalysts become 
more complex than there parent natural molecules due to structural modification for a 
more efficient catalyst, the environmental profile of the natural or synthetic molecule can 
not be assumed. For instance, a proline derivative will have a different environmental 
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impact and toxicological profile than (S)-proline. Currently, the design of new 
organocatalysts is from the perspective of expanding reaction and substrate scope, 
widening solvent compatibility, achieving recyclability and lowering the catalyst load, 
giving no consideration to the hazard posed by this new catalyst.22-24 Considering the 
importance of green chemistry for a more sustainable chemical industry,62 the design 
process for newer organocatalysts should take the 12 Principles of Green Chemistry into 
account when possible.63 The relevant principles that organocatalyst design should adhere 
to are underlined as follows, 
 
1.   Prevention: It is better to prevent waste than to treat or clean up waste after it has 
been created. 
2.   Atom Economy: Synthetic methods should be designed to maximize the 
incorporation of all materials used in the process into the final product.  
3.   Less Hazardous Chemical Syntheses: Wherever practicable,  synthetic methods 
should be designed to use and generate substances that possess little or no toxicity to 
human health and the environment. 
4.   Designing Safer Chemicals: Chemical products should be designed to effect 
their desired function while minimizing their toxicity. 
5.   Safer Solvents and Auxiliaries: The use of auxiliary substances (e.g., solvents, 
separation agents, etc.) should be made unnecessary wherever possible and innocuous 
when used. 
6.   Design for Energy Efficiency: Energy requirements of chemical processes 
should be recognized for their environmental and economic impacts and should be 
minimized. If possible, synthetic methods should be conducted at ambient 
temperature and pressure. 
7.   Use of Renewable Feedstocks: A raw material or feedstock should be renewable 
rather than depleting whenever technically and economically practicable. 
8.   Reduce Derivatives: Unnecessary derivatization (use of blocking groups, 
protection/deprotection, temporary modification of physical/chemical processes) 
should be minimized or avoided if possible, because such steps require additional 
reagents and can generate waste.   
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9.   Catalysis: Catalytic reagents (as selective as possible) are superior to 
stoichiometric reagents. 
10. Design for Degradation: Chemical products should be designed so that at the 
end of their function they break down into innocuous degradation products and do not 
persist in the environment. 
11. Real-time analysis for Pollution Prevention: Analytical methodologies need to 
be further developed to allow for real-time, in-process monitoring and control prior to 
the formation of hazardous substances. 
12. Inherently Safer Chemistry for Accident Prevention: Substances and the form 
of a substance used in a chemical process should be chosen to minimize the potential 
for chemical accidents, including releases, explosions, and fires.  
 
Clearly, being a catalyst these molecules satisfy principle 9. However, reports which 
satisfy principles 3, 4 and 10 are lacking for organocatalysts. Evidently, there is a need for 
these principles to be applied if organocatalysts are to be classified as truly green reagents 
and therefore satisfy principle 1. By making these compounds non-toxic and 
biodegradable a clear advantage will be gained among some of its competitors (transition 
metal catalysts) and the apparent drawbacks such as high catalyst loading might prove 
less prohibitive for their transition into industry.  
The focus of this project is to design a novel class of green organocatalysts by reducing 
toxicity and improving biodegradability. 
1.3.2 Environmental impact of organocatalysts 
 
At the outset of the project we set out to establish the toxicity, ecotoxicity and 
biodegradation data currently known in the literature for organocatalysts. A 
comprehensive literature search was performed on the proline-derived organocatalysts 
and BINOL organocatalysts and we found a lack of environmental impact data for these 
compounds. Representative catalysts presented and evaluated in chapter 2 showed no 
data regarding environmental impact. However, a number of reports were identified 
regarding the biological activity of some catalysts such as diphenylprolinol, BINOL and 
BINOL derivatives. These papers are presented in sections 1.3.2.1 and 1.3.2.2. 
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1.3.2.1 Biological activity of diphenylprolinol (41) 
 
Diphenylprolinol (D2PM) (41) has been used as a novel recreational drug and is sold as a 
legal high in street headshops.64 It is a phenethylamine analogue that acts as a stimulant 
with a mechanism of action that may involve inhibition of the dopamine reuptake 
transporter protein (DAT).65, 66 D2PM (41) has a structure similar to pipradrol which is 
known to possess a stimulant effect on the central nervous system (CNS) (Figure 1.4).67 
 
 
N
H OH OHNH
D2PM (41) Pipradrol (42)
 
 
Fig. 1.4 Structures of D2PM (41) and Pipradrol (42) 
 
A patent application reported that both enantiomers of diphenylprolinol (41a and 41b) 
have been shown to have activity at the cocaine binding site on the dopamine transporter 
protein and the patent also suggests that D2PM (41a and 41b)  may be useful in treating 
cocaine addition.68 In their study, four prolinol derivatives and a cocaine analogue (−)-2-
β-carbomethoxy-3β-(4-fluorophenyl)tropane (CFT) were screened for in vitro selectivity 
and binding potency to the cocaine binding site on the DAT protein (Table 1.1). 
Kibinding expresses the compounds ability to bind to the cocaine binding site on the DAT 
protein and Kiuptake expresses their ability to block dopamine re-uptake into neurons by 
the dopamine transporter. A lower Kibinding reflects the greater ability of the compound to 
antagonise cocaine’s binding to DAT. A higher Kiuptake reflects the compounds inability to 
inhibit the functioning of DAT. 
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In Vitro activity of CFT and prolinol derivatives 
Compound Affinity to the 
cocaine binding 
site (Kibinding) 
Effect on dopamine 
uptake 
(Kiuptake) 
Uptake to binding 
ratio 
(Kiuptake/Kibinding) 
 
   Cocaine analogue CFT 0.12 µM 0.20 µM 1.67 
    
N
H OH
 
(−)-(S)-41a 
 
 
0.40 
 
 
1.65 
 
 
4.12 
N
H OH
 
(+)-(R)-41b 
 
 
0.04 
 
 
0.17 
 
 
4.25 
N OH
 
(−)-(S)-43 
 
 
3.30 
 
 
10.3 
 
 
3.12 
N
H OH
F
F
 
(−)-(S)-44 
 
 
 
0.26 
 
 
 
0.44 
 
 
 
1.69 
Table 1.1: In Vitro activity of compounds for DAT 68 
 
Partial agonists and antagonists of the cocaine binding site on the DAT protein may show 
efficacy in treating cocaine addiction. Specifically, a cocaine antagonist must bind to the 
cocaine binding site and not inhibit dopamine re-uptake in order to have potential in the 
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treatment of cocaine addiction. Prolinol derivatives bind to the cocaine binding site with 
comparable Kibinding to the cocaine analogue CFT, however, the Kiuptake is higher, a uptake 
to binding ratio of at least 2 or greater suggests these compounds could antagonize 
cocaine’s binding to the DAT while having a minimal effect on transport function.  
 
Later reports on D2PM (41) suggest that it does exhibit biological activity for the CNS as 
D2PM (41) has found use as a legal high. A recent report has associated the recreational 
use of D2PM (41)  with cardiovascular toxicity.64 In their report they mention a case 
where an individual presents himself to the emergency department in a hospital, with 
high blood pressure and chest pain after ingesting a legal high called ‘head candy’ which 
contained the substance D2PM (41). Following toxicological analysis of the patient 
serum they detected the presence of D2PM (41) and glaucine at concentrations of 0.17 
mg/L and 0.10 mg/L, respectively. Since no reports of cardiovascular toxicity have been 
made regarding the usage of glaucine, they reasoned that D2PM (41) was the cause of the 
cardiovascular toxic effect. 
 
Recreational usage of D2PM (41b)  has been reported on a recreational drug website.69 A 
user of the drug reports ingesting 25 mg of (R)-diphenylprolinol (41b), followed by 20 
mg six hours later. The user describes a feeling of euphoria after 2 hours with symptoms 
similar to amphetamines such as jaw clenching, babbling speech and dilated pupils but 
does not mention any heart problems.   
 
Yoshida and coworkers have shown D2PM (41a and 41b) to produce inhibitory effects on 
nerve growth factor (NGF)-induced neurite outgrowth.70 Both enantiomers of D2PM (41a 
and 41b) induced a dose-dependent cell death in PC12 cells. The IC50 values of (R)-
diphenylprolinol (41b) and (S)-diphenylprolinol (41a) were 1.00 mM and 0.77 mM, 
respectively, after 24 hours. From their results they suggest that diphenylprolinol may act 
as a neurotoxin and cause impaired neuronal development. 
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1.3.2.2 Biological activity of BINOL and BINOL derivatives 
 
A literature search was done to establish current toxicity, ecotoxicity and biodegradation 
data reported for BINOL. No literature search was performed for metal complexes 
containing BINOL as a ligand. A few reports have been published regarding the 
biological activity of BINOL and BINOL derivatives. However, no reports were found 
for BINOL in relation to environmental impact in terms of ecotoxicity and 
biodegradation. 
 
A patent application filed in 2007 reported BINOL and BINOL derivatives as inhibitors 
for the Sir2 enzyme.71 Sir2 (Silent information regulator 2, Sirtuin) is a NAD+ dependant 
deacetylase enzyme which has been found to inhibit p53 and activate BCL6 proteins. The 
tumor suppressor protein p53 responds to DNA damage and when p53 becomes activated 
it induces the expression of pro-apoptotic genes which promote programmed cell death 
for cells that would otherwise go on to produce tumors.71 The activity of p53 depends on 
acetylation and such acetylation is reversed by Sir2 (inactivated via deacetylation on 
lysine 382). As well, a deacetylated BCL6 results in the inhibition of p53. Therefore, it is 
important to prevent the deacetylase activity of Sir2 in order to maintain BCL6 and p53 
in an acetylated state (Figure 1.5). A functioning p53 allows for apoptosis of damaged 
cells to occur, therefore preventing tumorigenesis. An effective Sir2 inhibitor maintains 
the activity of p53 therefore allowing for the apoptosis of damaged cells. The Sir2 
enzyme is believed to be implicated in biological conditions and disorders such as cancer 
(Specifically B-cell lymphomas), HIV/AIDS, silenced genes, metabolism, apoptosis, 
aging, malaria and infectious disease (e.g. Trypanosoma brucei (African sleeping 
sickness), Leishmaniasis (e.g. Leishmania infantum), Mycobacterium tuberculosis and 
Anthrax.71 
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Fig. 1.5 Sir2 activity with/without inhibitor 71 
 
 
 
The patent reported in 2007 describes the development of potent Sir2 inhibitors at the 
nanomolar concentration.71 A number of compounds (Figure 1.6) were screened at 
different concentrations for Sir2 activity. 
Initially, a series of naphthyl containing compounds (45a and 46a-46e) were screened at 
286 µM for Sir2 inhibition activity (Figure 1.7). Sir2 activity was measured using a 
HST2-based assay.71 BINOL (45a) was superior at inhibiting Sir2 compared to other 
naphthyl compounds (Figure 1.7). 
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Fig. 1.6 Compounds evaluated as Sir2 inhibitors.71 
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Fig. 1.7 Naphthyl derivatives screened for Sir2 inhibitory activity at 286 µM 71 
 
 
Further studies with modified BINOL derivatives (26a, 26b, 45a, 45b, 47a, 47b, 48a and 
49) at 143 µM helped to identify important determinants for Sir2 binding. For instance, 
the aromatic nature and the conformation of the binaphthyl ring system plus substituents 
at the 2,2’-position had an impact on Sir2 inhibition. The (S)-enantiomers of BINOL 
(45a) and the chiral phosphoric acid derivative (26a) were more active than the (R)-
enantiomers (26b and 45b). A primary amine substituent at the 2,2’-position was 
significantly less active when compared to BINOL. The presence of saturated rings on 
the BINOL scaffold resulted in lower inhibition for the Sir2 enzyme when compared to 
BINOL (Figure 1.8). 
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Fig. 1.8 BINOL and BINOL derivatives screened for Sir2 inhibitory activity at 143 µM 71 
 
 
Fig. 1.9 (S)-Chiral phosphoric acid (26a) and (S)-6,6’-dibromoBINOL (50a) screened for 
Sir2 inhibitory activity at 50 µM. 71 
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Subsequent to those findings they proceeded with the (S)-enantiomers of BINOL 
derivatives for further studies. The BINOL derivative containing electronegative bromine 
groups at the 6-position (50a) was screened at 50 µM and found to be a potent Sir2 
inhibitor (Figure 1.9). 
 
The electron deficient (S)-6,6’-dibromoBINOL derivative (50a) gave the best inhibition 
for the Sir2 enzyme. 
The authors evaluated (S)-6,6’-dibromoBINOL (50a) at 500 nM against Ramos cells (an 
in vitro cell line derived from an American Burkitt lymphoma). Ramos cells are a cell 
model of non-Hodgkins lymphoma (NHL). They found that the acetylation state of BCL6 
and p53 for Ramos cells treated with (S)-6,6’-dibromoBINOL (50a) had increased.71 
They suggest that (S)-6,6’-dibromoBINOL (50a) could promote apoptosis for Ramos 
cells. 
 
The structural features required for effective inhibition of the Sir2 enzyme with BINOL 
derivatives are an S-enantiomer, electron deficient unsaturated aromatic rings and the 
presence of hydroxyl substituents at the 2-position. (S)-6,6’-DibromoBINOL (50a) was 
found to be the best inhibitor of the Sir2 enzyme among the BINOL derivatives studied. 
 
 
Freccero and coworkers have synthesised and evaluated a series of specifically designed 
BINOL derivatives as photoprecursors for the generation of reactive BINOL quinone 
methides (BQMs) (Figure 1.10).72 BQMs are reactive intermediates capable of alkylating 
DNA which in turn inhibits both DNA replication and gene expression by preventing the 
melting of the two strands of DNA. Irradiation of BINOL derivatives (51a-51g) at 360 
nm can lead to the photogeneration of the BQMs. All water soluble BQM precursors 
(51a-51g) were studied for their ability to alkylate and cross link plasmid DNA and 
oligonucleotides by gel electrophoresis. Sequences analysis by gel electrophoresis, HPLC 
and MS determined that alkylation occurred for the purines, mainly for guanine. Further 
studies showed that the BQM was able to alkylate the N7 position of guanines.  
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Fig. 1.10 Phototriggerable BINOL derivatives (51a-51g) used for generating BQMs for 
the alkylation of DNA 72 
 
Photoprecursors (51a-51g) were tested for cytotoxic and photocytotoxic effects on two 
human cancer epithelial cell lines: A549 (human lung adenocarcinoma) and HT-29 
(human colorectal adenocarcinoma). Results from their study were defined in terms of 
EC50 values for the effective drug concentration able to kill 50 % of the cell population 
after photoirradiation and CC50 values for the cytotoxic concentration that killed 50% of 
cell population without photoirradiation. 51e and 51g were found to be the most active on 
both cell lines with EC50 values in the high nanomolar range. Compound 51e gave an 
EC50 value of 0.9 µM for the A549 cell line and 0.5 µM for the HT-29 cell line while 51g 
was reported with EC50 of 1.2 µM for A549 and 0.2 µM for HT-29. However, these 
compounds (51e and 51g) exhibited cytotoxicity prior to UV irradiation at low doses. 51e 
showed a CC50 value of 4.5 µM for A549 and 5 µM for HT-29 while 51g gave a CC50 
value of 6.5 µM for A549 and 1.4 µM for HT-29. Compounds 51c and 51d were less 
active for photocytotoxicity with reported EC50 values in the low micromolar range (1.5 - 
9 µM), however, 51c was less cytotoxic (CC50 value of 200 µM for both A549 and HT-
29) than 51d (CC50 value of 20 µM for A549 and 27 µM for HT-29). Remaining 
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derivatives 51a, 51b and 51f were less active for both photocytotoxicity and cytotoxicity 
for studied cell lines. Their study determined that the water soluble BINOL derivative 
(51c) was the most promising photocross-linking agent exhibiting purine selectivity and 
promising phototoxicity versus cytotoxicity.  
In an earlier report by Freccero, BINOL derivatives with substituents at the 3-position 
were reported as phototriggerable DNA alkylating agents. Similar substituents to those 
shown in Figure 1.10 were placed at the 3-position of BINOL. These compounds were 
capable of generating quinone methides upon irradiation at 360 nm and were studied for 
DNA alkylation.73, 74 
 
1.3.3 ‘Rules of thumb’: Guidelines for improving biodegradability 
 
The design of biodegradable chemicals is important and confers with the principles of 
green chemistry. Biodegradable chemicals will not bioaccumulate in the environment 
therefore reducing the potential toxic effects from the parent molecule and its 
metabolites.  
A chemical substance that proves to be non-biodegradable in the environment could be 
modified to allow for its degradation, this approach has been achieved for surfactants75 
and ionic liquids.76,77 Factors that were applied to improve biodegradation of surfactants 
and ionic liquids were based on the presence of certain structural motifs.   
Boethling et al. have reviewed and reported a list of structural features that have been 
observed to improve the biodegradability of chemicals.78 Structural motifs that have been 
found to have a positive effect on biodegradability are:  
 
• Benzene rings 
• Unsubstituted linear alkyl branches (generally ≥4 carbons) 
• Functional groups that are potential sites for enzymes (esters and amides) 
• Oxygenated molecules containing hydroxyl, aldehyde, ketone, ethoxylate and 
carboxylic acid groups 
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Structural motifs that can have a negative effect on biodegradability are: 
 
• Substituted alkyl branches (especially quaternary carbon)  
• Halogen groups (especially fluorine and chlorine) 
• Polycyclic residues with more than three fused rings 
• Tertiary amine, nitro, nitroso, azo and arylamino groups 
• Heterocyclic residues such as imidazole 
• Aliphatic ether bonds (except in ethoxylates) 
 
It must be emphasised that the presence of substituents that improve biodegradation will 
not guarantee biodegradability, as well, the presence of substituents that have a negative 
effect on biodegradability do not prohibit biodegradation in every case. By designing new 
compounds with structural motifs that improve biodegradation, it may be possible to 
minimize or eliminate their impact on the environment.  
1.3.4 CO2 headspace test (ISO 14593)  
 
 
The CO2 headspace test (ISO 14593) evaluates the ultimate biodegradation of organic 
chemicals.79 Biodegradation of an organic chemical involves metabolism of the parent 
compound either to a metabolite (referred to as primary biodegradation) or complete 
mineralisation to innocuous products such as CO2, water and biomass (referred to as 
ultimate biodegradation). Using the CO2 headspace test (ISO 14593) it is possible to 
assess water insoluble (hydrophobic) and water soluble organic chemicals. This assay is 
based on the Sturm test 80 and was formed by the amalgamation of independent studies by 
Struijis and Stoltenkamp 81 and by Birch and Fletcher 82 to give the current CO2 
headspace test (ISO 14593) which was ring tested in 1995.83 A similar procedure has been 
adopted as an OECD guideline (method 310) for assessing ready biodegradability of 
organic chemicals.84 
The CO2 headspace test (ISO 14593) is based on the principal that CO2 is evolved as the 
organic substance is being mineralised by a microbial community and if the percentage 
CO2 evolved is >60% ThIC (theoretical maximum inorganic carbon production) after 28 
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days, the organic chemical is deemed to be readily biodegradable. A readily 
biodegradable chemical should pose little impact on the environment due to it being 
rapidly removed in aquatic environments.  
 
The procedure for the CO2 headspace test (ISO 14593) involves the addition of the test 
substance as the sole source of carbon (20 mg C/L) and energy to a mineral salts medium 
containing a mixed microbial community. The assay is incubated for a period of 28 days 
in sealed bottles with a headspace of air to facilitate aerobic biodegradation.  
Measurements of evolved CO2 are taken at standard intervals (usually 7 days) over a 28 
day period (4 measurements). In order for a chemical to be deemed readily biodegradable 
it must evolve >60% CO2 after 28 days. The percentage biodegradation is expressed as a 
percentage of the theoretical maximum inorganic carbon (ThIC) that would be evolved, if 
100% mineralisation of the test substance to CO2 occurred.  
 
 
The percentage biodegradation is calculated from the following equation: 
 
% biodegradation = (TICt − TICb)/TOC x 100 
 
Where: 
• TICt = mg TIC (total inorganic carbon)  in bottle at time t 
• TICb = mean amount (mg) of TIC in blank bottles at time t 
• TOC (total organic carbon) = mg TOC initially added to bottle  (TOC = ThIC) 
 
The data obtained for % biodegradation is represented by a biodegradation curve as seen 
in Figure 1.11. 
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Fig. 1.11 An example of the biodegradation curve using the OECD CO2 headspace test 
(method 310). 84 
 
Time of incubation (days) is represented along the X-axis and % biodegradation along the 
Y-axis. The 10-day window is the ten days immediately following the attainment of 10% 
biodegradation.84 Plateau phase is the phase in which the maximal degradation has been 
reached and the biodegradation curve has levelled out. A readily biodegradable chemical 
should give a biodegradation curve similar to Figure 1.11.  
 
In conjunction with the test substance experiments, control experiments are also run. A 
reference substance (readily biodegradable) such as sodium n-dodecyl sulphate (SDS) is 
tested as a control experiment, this substance will give a pass value (>60% CO2) within 
the 28 day timescale and ensures that the inoculum is active. A blank control experiment 
is also performed, which contains no test substance. 
When the organic test substance fails the CO2 headspace test, this could imply that the 
sample is inhibitory to the inoculum or is poorly biodegradable. In order to determine if 
the test substance is inhibitory to the inoculum, an inhibitory control experiment is run 
whereby the test substance and reference substance (SDS) are added together to the 
inoculum. An inhibitory effect is apparent when CO2 evolution has decreased for SDS 
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biodegradation. The extent to which this occurs, determines whether or not the test 
substance is inhibiting the activity of the inoculum. However, if the test substance is not 
inhibiting the inoculum sufficiently (>25% inhibition) and fails the CO2 headspace test, it 
implys that the organic chemical is not readily biodegradable. 
Surfactants 85 and ionic liquids 77 are examples of chemicals that have been evaluated 
using the CO2 headspace test (ISO 14593). 
 
1.3.5 Pyridinium ionic liquids: Designed biodegradable chemicals 
 
Ionic liquids (ILs) are a class of organic chemicals whose environmental impact in terms 
of toxicity and biodegradation has been investigated.86 Early examples of ILs were found 
to be non-biodegradable.77 However, by applying the principles (‘rules of thumb’) that 
were employed for designing biodegradable surfactants, it was possible to design and 
synthesize biodegradable ionic liquids.  
 
Biodegradable pyridinium ionic liquids have been designed and synthesised by the 
Scammells research group.87 Scammells and coworkers were able to manipulate the 
pyridinium core with substituents that enhance biodegradation. Modification of the 
pyridinium core occurred at the nitrogen-position (N-position) and at the C3-position. 
They synthesised pyridinium ILs with n-butyl, methyl and ethoxycarbonylmethyl 
substituents at the N-position of pyridine while methyl, n-butylester and n-butylamide 
substituents were placed at the 3-position of pyridine (Figures 1.12 and 1.15). Pyridinium 
ILs with different anions such as OctOSO3−, NTf2− and PF6− were also prepared. 
Pyridinium ILs synthesised by Scammells were evaluated for ready biodegradability 
using the CO2 headspace test (ISO 14593).79 Under the guidelines of the CO2 headspace 
test (ISO 14593), compounds which reach a biodegradation level higher than 60% CO2 
evolution after 28 days are deemed readily biodegradable. 
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Fig. 1.12 Pyridinium ionic liquids with 1-alkyl and 1-alkylester side chains.87 
 
The 1-butylpyridinium salts containing Br−, NTf2− and PF6− showed low biodegradability 
(1-3%) over a 28 day period (Figure 1.13). Introduction of a methyl substituent at the 3-
position had little impact on biodegradation (Figure 1.13). However, the presence of the 
OctOSO3− anion for the 1-butylpyridinium salts gave increased levels of biodegradation 
(37-40%) This result can be attributed to the known biodegradable OctOSO3− anion and 
not to degradation of the pyridinium core. 1-Alkylpyridinium bromides with long alkyl 
chains C10 and C16 (58 and 59) exhibited poor biodegradability at 9% and 0%, 
respectively. The introduction of an ester group in the N-alkyl substituent leads to ready 
biodegradable pyridinium ILs (Figure 1.14). Both 60 and 61 showed biodegradability at 
87% and 89%, respectively. These compounds (60 and 61) also attained ready 
biodegradability after 7 days (71% and 74%, respectively). ILs 62 and 63 showed ready 
biodegradability at 64% and 86%, respectively.  
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Fig. 1.13 Biodegradation curves for 52 (○), 53 (□), 54 (+), 55 (∆), 56 (x), 57 (◊), 58 (■) 
and 59 (♦).87 
 
 
Fig. 1.14 Biodegradation curves for 60 (x), 61 (+), 62 (▲) and 63 (□).87 
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Fig. 1.15 Pyridinium ionic liquids derived from nicotinic acid.87 
 
 
 
 
 
 
 
Fig. 1.16 Biodegradation curves for 64 (∆), 65 (x), 66 (♦), 67 (+), 69 (■) and 71 (○).87 
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A series of pyridinium ILs were made from nicotinic acid which had ester and amide 
moiety’s present at the 3-position of the pyridine ring and alkyl substituents (n-butyl and 
methyl) present at the N-position (Figure 1.15). Pyridinium ILs containing ester groups 
showed high levels of biodegradability. ILs 64, 66 and 67 gave biodegradation values of 
72%, 68% and 75% respectively. (Figure 1.16) The OctOSO3− anion containing 
pyridinium ILs (65 and 69) showed biodegradation at 75% and 84% respectively. 
Pyridinium IL (71) containing the amide moiety showed poor biodegradation with a value 
of 30% being recorded after 28 days. 
From Scammells investigations with pyridinium ILs, it is clear that it is possible to 
enhance poorly biodegradable organic chemicals towards biodegradation by structural 
modifications that are in line with the ‘rules of thumb’. 
 
1.3.6 Similarity of BINOL to Polycyclic Aromatic Hydrocarbons 
 
 
The main reason for focusing on the BINOL scaffold as part of our study was due to their 
similarity with polycyclic aromatic hydrocarbons (PAHs) which are known pollutants and 
contaminants.88 Polycyclic aromatic hydrocarbons (PAHs) are a class of organic 
molecules that consist of two or more fused benzene rings in linear, angular or clustered 
arrangements such as anthracene (74) and benzo[a]pyrene (77) (Figure 1.17).89 
PAHs are lipophilic, hydrophobic and have low water solubility. For instance 
phenanthrene (73) has a water solubility of 1.30 mg/L and benzo[a]pyrene (77) 0.003 
mg/L.90 PAHs are natural constituents of fossil fuels and can be formed by the incomplete 
combustion of organic material such as wood and vegetation. Their poor biodegradability, 
potential carcinogenic, mutagenic and tertagenic properties means they are of high 
concern for human health and the environment.91 
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Naphthalene (72)
MW 128.2 g/mol
Solubility 31.70 mg/L
Phenanthrene (73)
MW 178.2 g/mol
Solubility 1.30 mg/L
Anthracene (74)
MW 178.2 g/mol
Solubility 0.07 mg/L
Chrysene (75)
MW 228.3 g/mol
Solubility 0.0015-0.0022 mg/L
Pyrene (76)
MW 202.3 g/mol
Solubility 0.14 mg/L
Benzo[a]pyrene (77)
MW 252.3 g/mol
Solubility 0.003 mg/L
 
 
Fig. 1.17 Selection of polycyclic aromatic hydrocarbons (PAHs) 
 
Benzo[a]pyrene (77) is a known carcinogen and has been classified as a high priority 
pollutant by the EPA.92, 93 The fate of PAHs in the environment can include photo-
oxidation, bioaccumulation, adsorption and microbial degradation.90, 94 Low water 
solubility and adsorption to the soil are the two major factors that limit PAH 
bioavailability for biodegradation. BINOL and its derivatives share many features to 
PAHs such as number of rings, hydrophobicity, poor water solubility and high molecular 
weight. These similar features will undoubtly impact upon the biodegradability for 
BINOL. The focus of our work is to determine the biodegradability of BINOL and 
improve the biodegradability for the biaryl scaffold of BINOL. 
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1.3.7 Designing non-toxic biodegradable polysubstituted BINOLs 
 
An aim of this project is to design and synthesise BINOL derivatives with substituents 
which may improve their biodegradation. Currently known BINOL and BINOL 
derivatives would be expected to have a poor biodegradation profile as many of these 
compounds have features such as fused rings, quaternary carbons, presence of carbon-
halogen bonds, high molecular weight and poor water solubility which would severely 
limit there biodegradability. For our study, we proposed to apply the ‘rules of thumb’ to 
the BINOL scaffold (see section 1.3.3).78 Structural features that have a positive effect for 
biodegradation like carboxylic acid and hydroxyl groups were selected for incorporation 
at position 6,6’ of the BINOL scaffold. Combined with a lack of information in the 
literature for polysubstituted BINOLs (3,3’, 6,6’ Substituted) a novel set of 
polysubstituted BINOLs were proposed. These compounds were synthesized in 1-3 steps 
from a known key intermediate. It is anticipated these compounds would have improved 
biodegradation properties in the environment.   
 
1.3.8 Historical development of organocatalysts: chiral phase-transfer catalysts and 
chiral phosphoric acids as a case study 
 
1.3.8.1 Chiral phase-transfer catalysts 
 
The achiral phase-transfer catalyst (78) was evaluated by Junggren and coworkers in 
1972 for the alkylation of benzylcyanide with various alkyl halides (Scheme 1.14).95 
Monoalkylated products were obtained in good yields (72-90%) within a reaction time of 
10-30 minutes by phase-transfer catalysis. Interestingly, the tetrabutylammonium cation 
has been found to have antimicrobial activity96, is toxic in aquatic organisms97, acts as a 
non-depolarizing muscle relaxant98 and a potassium channel antagonist.99 
In 1975, Fiaud reported N-benzyl-N-methyl ephedrinium bromide (79) as a chiral phase-
transfer catalyst (PTC) for the alkylation of β-keto esters with claimed ee’s of only 
15%.100 
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Fig. 1.18 Timeline for phase-transfer catalyst development, from achiral (78) to Maruoka 
catalyst (40) 
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Scheme 1.14: Alkylation of benzyl cyanide using achiral PTC (78).95 
 
 
The first efficient chiral phase-transfer catalyst, N-(p-(trifluoromethyl)-
benzyl)cinchonium bromide (80), was documented by the Merck group in 1984 for the 
asymmetric methylation of 6,7-dichloro-5-methoxy-2-phenyl-1-indanone to furnish the 
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(S)-α-methylated indanone in 95% yield and 92% ee.101 In 1997, a cinchona alkaloid-
derived quaternary ammonium phase-transfer catalyst bearing a N-anthracenylmethyl 
function was developed by Lygo and Corey independently.102,103 Lygo’s catalyst (81) was 
evaluated for the asymmetric alkylation of N-(diphenylmethylene)-glycine tert-butyl ester 
(36) and the corresponding alkylated products were formed with higher enantioselectivity 
when compared to results obtained with PTC (80).102 Maruoka designed and synthesised 
phase-transfer catalysts based on the binaphthyl backbone (40 and 82) and applied these 
catalysts for the asymmetric alkylation of N-(diphenylmethylene)-glycine tert-butyl ester 
(36).60, 61 For instance, PTC (40) was employed at a catalyst loading of 0.05 mol% for the 
alkylation of 36 with various alkyl halides and the alkylated products were obtained in 
good yields (81-98%) and high ee (97-98%) (Scheme 1.15). 
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Scheme 1.15: Alkylation of 36 with various alkyl halides using PTC (40) 61 
 
The advantage of the Maruoka catalysts are the low loadings (0.02 - 1 mol%) that can be 
employed for the alkylation reactions compared to the higher catalyst loadings (generally 
10 mol%) used for the cinchona alkaloid-derived phase-transfer catalysts. As can be seen 
from the timeline (Figure 1.18), the structures of the phase-transfer catalysts from achiral 
PTC (78) to the chiral Maruoka catalyst (40) have become more complex. Early 
examples of chiral phase-transfer catalysts were derived from the chiral pool and were 
made in one synthetic step. However, more recent examples are not based from the chiral 
pool and require many steps to be synthesised. The design and development of phase-
transfer catalysts has all been based on synthetic performance to date with little 
consideration for the environmental impact of the catalyst. 
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1.3.8.2 Chiral phosphoric acid 
 
Chiral phosphoric acids as a class of organocatalysts emerged in 2004 following the 
independent seminal reports of Terada and Akiyama.54,55 Terada applied the chiral 
phosphoric acids (26b and 27) for the Mannich reaction and obtained good yields (92-
95%) for products, however, ee was lower when the unsubstituted phosphoric acid 
catalyst (26b) was used. By placing bulky substituents ortho to the phosphoric acid 
moiety such as a phenyl group (27) the ee increased for products.54 Further modification 
of chiral phosphoric acid with bulkier groups leads to higher ee. 
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 Fig. 1.19 Timeline for development of chiral phosphoric acids 
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In 2005 a large number of diverse scaffolds were utilised for developing more efficient 
chiral phosphoric acids in terms of ee. Akiyama reported a chiral phosphoric acid (85) 
derived from TADDOL and applied it for the Mannich reaction with good yields and ee 
being obtained for the respective products.104 
TRIP catalyst (86) was synthesised by List for the asymmetric transfer hydrogenation of 
imines, the presence of iso-propyl substituents at the ortho and para positions on the 
phenyl group were important for obtaining high ee.105 The chiral VAPOL scaffold was 
used by Antilla in designing the chiral phosphoric acid (87) for a Brønsted acid catalyzed 
imine amidation with good yields and ee being reported for products.106 
Terada found the placement of anthracene as a bulky group ortho to the phosphoric acid 
moiety (88) beneficial for attaining high ee in the alkylation of α-Diazoester substrates.107 
As can be seen from the chiral phosphoric acid timeline (Figure 1.19) complexity for the 
chiral scaffolds has increased. Structural features such as CF3, substituted rings and 
polycyclic aromatic hydrocarbons (anthracene and phenanthrene) are not in line with the 
‘rules of thumb’ and may lead to undesirable toxicity and biodegradation. 
 
 
 
 
1.4 Conclusion 
 
  
Enantioselective organocatalysis, as an asymmetric catalytic methodology has had a 
major impact on organic synthesis over the past 12 years and has bridged the fields of 
stereochemistry and pharmaceutically active molecules. Organocatalysts have been found 
to catalyze a wide variety of carbon-carbon, carbon-nitrogen and carbon-oxygen bond 
forming reactions. New classes of organocatalysts are still being reported. In early 
publications one of the prominent advantages of organocatalysts over metal-catalyzed 
processes was their low toxicity and absence of heavy metal ions contaminating final 
products or accumulating in the environment. However, there has not been a detailed 
study of structure-toxicity relationships of organocatalysts. For naturally occurring (S)-
proline, a low toxicity and environmental impact would be expected, however, the 
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development of closely related proline derivatives raises question over the toxicity of 
novel catalysts. The potential toxicity of organocatalysts to humans and other organisms 
is significant, while ecotoxicity has the potential to limit biodegradation. Reports of 
diphenylprolinol as a recreational drug and the cytotoxicity data reported for some 
BINOL derivatives shows the potential hazards for organocatalysts. There is need to 
investigate the structure-toxicity relationship of organocatalysts. Also the 
biodegradability of organocatalysts needs to be assessed using biodegradation assays 
such as the CO2 headspace test (ISO 14593). Non-biodegradable catalysts could possibly 
be re-designed according to the ‘rules of thumb’ for the development of biodegradable 
alternatives. Toxicity and biodegradation data for organocatalysts will assist in the design 
of sustainable, efficient catalysts for synthesis and the pharmaceutical industry. 
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2 Antimicrobial, cytotoxicity, apoptosis, cell viability and 
biodegradation studies of known organocatalysts 
 
 
 
2.1 Aim 
 
The objective of this study was to determine the anti-microbial activity for known 
organocatalysts. The outcome of these results would establish the suitability of these 
compounds for further studies such as biodegradation. Chemicals that show potent anti-
microbial activity may have limited biodegradation in the environment. Therefore, a 
preliminary screen of organocatalysts to determine their anti-microbial activity is 
necessary before proceeding to a biodegradation assay. The effect of stereochemistry on 
anti-microbial activity is assessed using both enantiomers of amino acids and BINOLs. 
Cytotoxicity, apoptosis and cell viability studies are performed to determine the effect of 
organocatalysts on human blood cell lines. Biodegradability of organocatalysts will be 
determined using the CO2 headspace test (ISO 14593).1 
 
2.2 Introduction 
 
Data on the environmental impact of organocatalysts is lacking in the literature. In order 
to design and develop non-toxic, biodegradable organocatalysts that are sustainable, a 
structure toxicity relationship needs to be established. Our efforts are to determine which 
organocatalysts are biodegradable and exhibit low toxicity in microbial assays. 
A selection of organocatalysts were chosen for this study, amino acids (both L and D), 
proline derivatives, BINOLs, TADDOL, chiral phosphoric acids, Jacobsen thioureas, 
MacMillan imidazolidinones, cinchona alkaloid derivatives and a Maruoka phase-transfer 
catalyst. All catalysts were purchased from Sigma-Aldrich and Strem chemicals. 
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Fig. 2.1 Number of publications containing the concept organocatalysis from 2000-2011 
as entered in research topic in Scifinder. 
 
 
Both L and D enantiomers of amino acids were screened to determine the effect of 
stereochemistry on anti-microbial activity. Remaining organocatalysts were tested mainly 
as single enantiomers except for BINOL (45a and 45b), H8-BINOL (48a and 48b), 6,6’-
dibromoBINOL (50a and 50b), 3,3’-dibromo-H8-BINOL (105a and 105b) and chiral 
phosphoric acid (26a and 26b) which had both enantiomers screened for antimicrobial 
activity. A major benefit of organocatalysts is that both enantiomers are available. 
Enantiomers can exhibit different biological activities. Therefore one enantiomer of an 
organocatalyst could exhibit anti-microbial activity while the other enantiomer could be 
environmentally benign. To assess the different effects of enantiomers on anti-microbial 
activity, we screened both enantiomers of amino acids, BINOL and BINOL derivatives. 
 
Initially, the amino acids (both L and D), proline derivatives, BINOLs and a TADDOL 
were screened for antibacterial activity (section 2.3). While subsequent antimicrobial 
studies of a broader range of organocatalysts were performed by our collaborator Dr 
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Marcel Špulák of Charles University Czech Republic (section 2.4). Antimicrobial studies 
in our research group were performed using the microtiter broth dilution technique.2 This 
assay evaluates the minimum inhibitory concentration (MIC) for a chemical.  
2.3 Microtiter broth dilution technique (DCU study) 
 
Antibacterial screening of organocatalysts (amino acids, proline derivatives, BINOLs and 
TADDOL) for our study was performed using the microtiter broth dilution technique.2 A 
range of Gram positive and Gram negative bacteria were screened against to determine 
MIC values. Bacteria used for this screening were as follows  
 
                    Gram positive                                  Gram negative 
 
                    Micrococcus luteus 20030                Escherichia coli 498 
                    Bacillus subtilis 10                           Pseudomonas fluorescens 50090 
                                                                             Pseudomonas putida CP1 
 
Bacillus subtilis is common in soil samples while Pseudomonas putida CP1 is known to 
degrade organic compounds (toluene). These organisms were challenged at different 
concentrations and the MIC value was noted after 24 h incubation. 
2.3.1 Antibacterial screening of amino acids 
 
To study the effect of stereochemistry on antibacterial activity both L and D amino acids 
were screened. Tyrosine was excluded due to poor water solubility. The rationale behind 
this study was mainly to establish the effect of D-amino acids on our test set of bacteria. 
A set concentration of 20 mM was chosen to identify inhibitory amino acids. MIC values 
were determined for those amino acids showing inhibition. MIC values for the amino 
acid antibacterial study were defined as 100% inhibition of the growth of control. For this 
study, some amino acids proved non-inhibitory (Table 2.1) and others proved inhibitory 
for both enantiomers at 20 mM (Table 2.2). MIC values were determined for inhibitory 
amino acids and the results are presented in table 2.3. 
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L-alanine L-threonine 
 D-alanine 
 
D-threonine 
L-valine 
 
L-arginine 
 D-valine 
 
D-arginine 
 L-leucine 
 
L-lysine 
 D-leucine 
 
D-lysine 
L-isoleucine 
 
L-proline 
 D-isoleucine 
 
D-proline 
 L-methionine 
 
L-glutamine 
 D-methionine D-glutamine 
 L-serine 
 
L-asparagine 
 D-serine D-asparagine 
 4-trans-hydroxy-proline 
 
glycine 
 4-cis-hydroxy-proline 
 
 
 
Table 2.1: List of non-inhibitory amino acids 
 
 
 M.luteus B.subtilis E.coli P.fluorescens P.putida 
L-cysteine 20 mM 20 mM 20 mM 20 mM 20 mM 
D-cysteine 20 mM 20 mM 20 mM 20 mM 20 mM 
L-tryptophan 20 mM 20 mM 20 mM 20 mM 20 mM 
D-tryptophan 20 mM 20 mM 20 mM 20 mM 20 mM 
L-glutamic acid 20 mM 20 mM 20 mM 20 mM 20 mM 
D-glutamic acid 20 mM 20 mM 20 mM 20 mM 20 mM 
L-aspartic acid 20 mM 20 mM 20 mM 20 mM >20 mM 
D-aspartic acid 20 mM 20 mM 20 mM 20 mM >20 mM 
L-phenylalanine 20 mM >20 mM >20 mM >20 mM >20 mM 
D-phenylalanine 20 mM >20 mM >20 mM >20 mM >20 mM 
L-histidine 20 mM >20 mM >20 mM >20 mM >20 mM 
D-histidine 20 mM >20 mM >20 mM >20 mM >20 mM 
 
Table 2.2: List of both L and D inhibitory amino acids at 20 mM 
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 M.luteus B.subtilis E.coli P.fluorescens P.putida 
L-cysteine 5 mM 5 mM 10 mM 10 mM 10 mM 
D-cysteine 5 mM 5 mM 10 mM 10 mM 5 mM 
L-tryptophan 5 mM 5 mM 10 mM 5 mM 5 mM 
D-tryptophan 5 mM 5 mM 10 mM 5 mM 5 mM 
L-glutamic acid 2.5 mM 5 mM 5 mM 2.5 mM 2.5 mM 
D-glutamic acid 2.5 mM 5 mM 5 mM 2.5 mM 2.5 mM 
L-aspartic acid 2.5 mM 5 mM 5 mM 2.5 mM >20 mM 
D-aspartic acid 2.5 mM 5 mM 5 mM 2.5 mM >20 mM 
L-phenylalanine 20 mM >20 mM >20 mM >20 mM >20 mM 
D-phenylalanine 20 mM >20 mM >20 mM >20 mM >20 mM 
L-histidine 20 mM >20 mM >20 mM >20 mM >20 mM 
D-histidine 20 mM >20 mM >20 mM >20 mM >20 mM 
 
Table 2.3: MIC results for inhibitory amino acids 
 
During the course of this screen it became apparent that other research groups had 
reported in the literature cases for antimicrobial inhibition using amino acids and these 
papers are presented in section 2.3.2. 
 
2.3.2 Previous antimicrobial studies for amino acids 
 
Nature has selected natural amino acids (L configuration) as building blocks for peptides 
and proteins in living systems.3 However, unnatural amino acids (D configuration) have 
been found in living systems.4 The natural occurrence of D-amino acids, for example, 
include D-alanine and D-glutamic acid containing peptidoglycans of bacterial cell walls 
and D-amino acid containing antimicrobial peptides such as valinomycin (D-valine 
present).3,4  
 
 
Antimicrobial studies for natural and unnatural amino acids have been reported by 
various groups throughout the last hundred years. Early reports were confined for the 
inhibitory effects of a single amino acid towards a single microbe and the reversal of this 
inhibition by other amino acids. However, more recent reports give the inhibitory effects 
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for a complete set of D-amino acids against specific bacteria such as E.coli and discuss 
the possible modes of inhibition. 
 
Growth inhibition of a number of microorganisms in minimal medium containing amino 
acids has been reported by various groups, such inhibition can be reversed by other amino 
acids.5-8 Gladstone found that in Bacillus anthracis either valine or leucine alone inhibits 
growth at a concentration of 1 µg/ml but when both are present no inhibition occurred.5 
Tatum showed that E. coli K12 fails to grow in minimal medium containing valine and 
that isoleucine counters this inhibition.6 Beerstecher and Shive reported that the growth of 
E.coli is inhibited by tyrosine and phenylalanine reverses this inhibition in minimal 
medium.7 A comprehensive screen of various amino acids against 356 E.coli strains was 
reported by Rowley.8 
 
The effects for L-valine inhibition in E. coli K12 were reviewed by De felice and 
coworkers.9 Growth inhibition of E. coli K-12 by L-valine is due to the inhibition of the 
enzyme acetohydroxy acid synthase. This inhibition, in turn, leads to L-isoleucine 
starvation which results in the inhibition of growth for E.coli K12. 
 
For D-amino acids, early reports for inhibition of specific bacteria were shown using a 
single amino acid. Fox et al. reported the effects of D-leucine, an unnatural amino acid, 
on the growth of Lactobacillus arabinosus.10 Their experiments demonstrated that D-
leucine inhibited the growth of Lactobacillus arabinosus. D-Serine has been found to 
produce toxic effects in various groups of organisms. Among bacteria it prevents the 
growth of Streptococcus faecalis R,11 E.coli 12 and inhibits the production of tetanus toxin 
by Clostridium tetani.13 
 
Recent reports give a more comprehensive account for potential D-amino acid inhibition 
as a larger set of D-amino acids have been screened against specific bacteria. For cases 
where inhibition occurs with amino acids, the biochemical nature of this inhibition is 
discussed. Toxicity of D-amino acids could be due to the erroneous incorporation of D-
amino acids into the peptidoglycan layer disrupting its ability to withstand osmotic 
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pressure.14 It has been observed that at 20 mM concentration D-methionine, D-tryptophan 
and D-phenylalanine are incorporated into peptidoglycan layer. 
 
Another mode of inhibition postulated for D-amino acids is their interference for the 
biosynthesis of certain amino acids. Starvation of these amino acids inhibits the growth of 
the microorganism. The possibility of D-amino acids being incorporated into 
polypeptides or proteins is unlikely due to the high fidelity of protein translation.15  
 
De pedro and coworkers examined the effect various D-amino acids have on the structure 
and synthesis of peptidoglycan in E. coli.14 They investigated the accumulation of 
modified muropeptides in the peptidoglycan of cells grown in the presence of D-amino 
acids at 20 mM concentrations. This group found that the L-isomers had no effect on the 
structure of peptidoglycan. Under there conditions (20 mM), D-amino acids (D-
methionine, D-tryptophan and D-phenylalanine) had no apparent effect on growth or 
morphology for organism but caused a severe inhibition for peptidoglycan synthesis and 
cross-linking possibly leading to a reduction in the amount of peptidoglycan per cell. 
 
Blanquet and coworkers reported the effects D-amino acids have on strains of E.coli and 
Saccharomyces cerevisiae with and without deacylase activity.16 They discussed the role 
of D-Tyr-tRNA deacylase enzyme as a defence mechanism utilised by E.coli and 
Saccharomyces cerevisiae for combating the incorporation of D-amino acids into 
peptides thus preventing the development of faulty proteins that would lead to cell death. 
Tyrosyl-tRNA synthetase is known to esterify tRNA with tyrosine in E.coli. The resulting 
D-Tyr-tRNA can be hydrolyzed by a D-Tyr-tRNA deacylase enzyme thus preventing its 
incorporation into proteins.  
 
Blanquet studied other D-amino acids for toxicity which might be exacerbated by the 
inactivation of the gene encoding D-Tyr-tRNA deacylase. To determine whether the D-
Tyrosyl-tRNA deacylase enzyme protected E.coli cells from other amino acids, they 
studied the effect 18 D-amino acids had on the growth of E.coli strains K37 (dtd+= 
deacylase present) and K37∆TyrH (∆dtd= deacylase activity absent). Under there 
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conditions D-amino acid concentration ranged from 0-25 mM. For the two strains no 
inhibition of the bacterial growth was observed upon the addition of D-alanine, D-proline 
or D-arginine. With D-asparagine, D-histidine, D-isoleucine, D-leucine, D-methionine 
and D-phenylalanine the toxic effect was small and no difference could be noted between 
strains K37 and K37∆TyrH. Several D-amino acids such as D-glutamic acid, D-
threonine, D-lysine, D-valine and D-cysteine markedly inhibited E.coli growth for both 
strains. Inhibition caused by these amino acids is the result of another mode of action. 
They found a difference in the behaviours for the two strains in the presence of D-aspartic 
acid, D-serine, D-glutamine and D-tryptophan which implys that these amino acids attach 
to tRNA and with the loss of deacylase activity for E.coli K37∆TyrH can exert toxicity 
due to the creation of faulty proteins. 
 
For Saccharomyces cerevisiae (yeast) the toxicity of D-tyrosine also depends on the 
absence of deacylase activity. They explored the toxicity of 18 D-amino acids for 
Saccharomyces cerevisiae and it was found that only D-leucine toxicity was exacerbated 
by the inactivation of D-tyrosyl-tRNA deacylase activity. 
 
Dtd-like genes that encode for D-Tyr-tRNA deacylase enzymes are widely distributed in 
the living world and deacylase homologs are expected to occur in many bacteria as well 
as in yeasts, nematodes, higher plants, mouse and man. D-amino-acyl-tRNA deacylase 
activity is present in cells to counteract against the harmful effects of D-amino acid 
transfer onto tRNA. However, the set of incorporated D-amino acids may vary from one 
type of cell to another.  
 
Evidently from the papers presented above, there has been literature reported on the 
antimicrobial activity for amino acids. From the previous studies undertaken, it is clear 
that different microbes and their respective strains can be inhibited by specific amino 
acids in minimal medium. The causes for this activity can be due to the inhibition of 
biosynthesis for amino acids leading to the starvation for that respective amino acid or the 
erroneous incorporation of D-amino acids into the peptidoglycan layer may also result in 
antimicrobial toxicity. 
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In our study, a complete set of amino acids (both L and D enantiomers) were assessed 
against 5 strains of bacteria (M.luteus, B.subtilis, E.coli, P.putida and P.fluorescens). 
Microbial inhibitions observed in our study do not correlate with those reported in the 
literature. This lack of correlation could be due to different bacterial strains and medium 
(nutrient broth) being used for our respective assay. For instance, using a complex 
nutrient broth medium as opposed to a minimal medium may result in not observing 
antimicrobial activity resulting from the inhibition of amino acid biosynthesis. Inhibitory 
amino acids that are observed in our study may be the result of the erroneous 
incorporation of amino acids into the peptidoglycan layer resulting in the loss of cell 
viability or could be due to other modes of action not known. 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.3 Antibacterial screening of proline derivatives 
 
A series of proline derivatives (5, 89, 90, 91, 92, 93, 94, 95, 96 and 97) were screened as 
part of our study against the test set of bacteria. Different concentration ranges were used 
dependant on the chemicals solubility and molecular weight. MIC values for the proline 
derivative antibacterial study were defined as 100% inhibition of the growth of control. 
The results in table 2.4 represent MIC values obtained for proline derivatives.   
 
 
 
 
67 
 M.luteus B.subtilis E.coli P.putida P.fluorescens 
N
H
O
OH
5
 
 
>8.7 mM 
 
>8.7 mM 
 
>8.7 mM 
 
>8.7 mM 
 
>8.7 mM 
N
H
O
NH2
89
 
 
>8.8 mM 
 
>8.8 mM 
 
>8.8 mM 
 
>8.8 mM 
 
>8.8 mM 
N
H
O
OH
90
 
 
>7.7 mM 
 
>7.7 mM 
 
>7.7 mM 
 
>7.7 mM 
 
>7.7 mM 
N
H N N
N
N
H91
 
 
>7.2 mM 
 
>7.2 mM 
 
>7.2 mM 
 
>7.2 mM 
 
>7.2 mM 
N
H OH
92
 
 
>9.9 mM 
 
>9.9 mM 
 
>9.9 mM 
 
>9.9 mM 
 
>9.9 mM 
N
H N
93
 
 
 
>6.5 mM 
 
 
>6.5 mM 
 
 
>6.5 mM 
 
 
>6.5 mM 
 
 
>6.5 mM 
N
H
94
 
 
>3.9 mM 
 
>3.9 mM 
 
>3.9 mM 
 
>3.9 mM 
 
>3.9 mM 
         
N
Ph
Ph
OH
HH
Cl 95
 
 
 
3.45 mM 
 
 
3.45 mM 
 
 
3.45 mM 
 
 
>3.45 mM 
 
 
>3.45 mM 
N OH
HH
Cl
96
 
 
 
0.18 mM 
 
 
0.18 mM 
 
 
1.45 mM 
 
 
>2.89 mM 
 
 
>2.89 mM 
     
N
H
OH
F3C
CF3
CF3
F3C
97
 
 
 
 
>1.9 mM 
 
 
 
>1.9 mM 
 
 
 
>1.9 mM 
 
 
 
>1.9 mM 
 
 
 
>1.9 mM 
 
Table 2.4: Results from our antibacterial study of proline derivatives 
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Proline and derivatives (5, 89, 90, 91, 92, 93, 94 and 97) were found to be non-inhibitory 
towards bacteria. Proline derivative (96) was observed with the lowest MIC of 0.18 mM 
for Micrococcus luteus and Bacillus subtilis while an MIC of 1.45 mM was noted for 
E.coli. An MIC value of 3.45 mM was observed for 95 towards Micrococcus luteus, 
Bacillus subtilis and E.coli. The presence of methyl substituents at the meta position for 
the aromatic rings of proline derivative (96) are contributing to a more toxic compound. 
 
 
 
 
 
 
2.3.4 Antibacterial screening of BINOLs and TADDOL 
 
 
Racemic BINOL (45), chiral BINOL derivatives (98 and 99) and a TADDOL (100) were 
evaluated using the microtiter broth dilution technique against our panel of bacteria. 
These compounds have limited solubility in water and were screened at a low 
concentration. MIC values for the BINOLs and TADDOL antibacterial study were 
defined as 40% inhibition (IC40) of the growth of control. The results in table 2.5 
represent the MIC values obtained for BINOLs and TADDOL. In this study inhibition of 
bacteria was observed for racemic BINOL (45). Remaining chiral BINOL derivatives (98 
and 99) and TADDOL (100) were found to be non-inhibitory for bacteria within tested 
concentration range. For BINOL (45), an MIC value of 0.107 mmol was noted for 
Micrococcus luteus and Bacillus subtilis after 24 h while remaining bacteria were not 
inhibited by BINOL (45) within tested concentration range.  
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>0.7 mM 
 
 
 
 
 
>0.7 mM 
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O O
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>1.045 mM 
 
 
 
>1.045 mM 
 
 
 
>1.045 
mM 
 
 
 
>1.045 mM 
Table 2.5: Antibacterial results for BINOL (45), BINOL derivatives (98 and 99) and 
TADDOL (100) 
 
2.4 Antimicrobial studies of organocatalysts by our collaborator in Czech Republic 
 
In vitro antimicrobial activities of a broader range of organocatalysts (proline derivatives, 
chiral BINOLs, TADDOL, Jacobsen thioureas, cinchona alkaloid derived 
organocatalysts, MacMillan imidazolidinones, chiral phosphoric acids and a Maruoka 
phase-transfer catalyst) were evaluated by our collaborator Dr Marcel Špulák of Charles 
University Czech Republic. Organocatalysts were screened against the following bacteria 
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Staphylococcus aureus ATCC 6538, Staphylococcus aureus MRSA HK5996/08, 
Staphylococcus epidermidis HK6966/08, Enterococcus sp. HK14365/08, Escherichia coli 
ATCC 8739, Klebsiella pneumoniae HK11750/08, Klebsiella pneumoniae-ESBL positive 
HK14368/08 and Pseudomonas aeruginosa ATCC 9027. MIC values for the antibacterial 
study were defined as 95% inhibition (IC95) of the growth of control. The highest 
concentration tested for all organocatalysts was 2000 µM, however, poorly soluble 
catalysts in test medium were screened at a lower concentration. MIC values were 
recorded after 24 h and 48 h incubation. 
 
For the in vitro antifungal studies, all organocatalysts were screened against the following 
yeast strains (Candida albicans ATCC 44859, Candida albicans ATCC 90028, Candida 
parapsilosis ATCC 22019, Candida krusei ATCC 6258, Candida krusei E28, Candida 
tropicalis 156, Candida glabrata 20/I, Candida lusitaniae 2446/I, Trichosporan asahii 
1188) and filamentous fungi (Aspergillus fumigatus 231, Absidia corymbifera 272 and 
Trichophyton mentagrophytes 445). MIC values for antifungal study were defined as 
80% inhibition (IC80) of the growth of control for yeast and 50% inhibition (IC50) of the 
growth of control for filamentous fungi. The MIC values for most fungi were recorded 
after 24 h and 48 h except for the dermatophytic strain (T. mentagrophytes 445) which 
was determined after 72 h and 120 h.   
Results for antimicrobial study are presented in sections 2.4.1-2.4.12 according to the 
different categories of organocatalysts. 
 
2.4.1 Antibacterial study of proline derivatives (IC95) 
 
A series of proline derivatives (8, 41a, 89, 91, 92, 94, 97, 102, 103 and 104) were 
screened by our collaborator against the test set of bacteria for the determination of IC95 
values. All proline derivatives (Figure 2.2) for this study were tested at the highest 
concentration range of 2000 µM. The results in the appendix (Table 1) represent the MIC 
values obtained for proline derivatives (8, 41a, 89, 91, 92, 94 and 97). Table 2.6 
represents the MIC values for proline derivatives (101, 102, 103 and 104).   
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Fig. 2.2 Proline derivatives (8, 41a, 89, 91, 92, 94, 97, 101, 102, 103 and 104) screened 
for IC95 antibacterial activity and IC80/IC50 antifungal activity   
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Table 2.6: Antibacterial MIC/ IC95 (µM) results for proline derivatives (101, 102, 103 
and 104) with antibacterial activity < 2000 µM 
 
 
Proline derived catalysts 
 
Organism Time 
(h) 
101 102 103 104 
      
S.aureus 24 h 500 250 >2000 >2000 
  
  
  
 48 h 500 250 >2000 >2000 
  
  
  
MRSA 24 h 500 250 >2000 >2000 
  
  
  
 48 h 500 250 >2000 >2000 
  
 
   
S.epidermidis 24 h 500 125  2000 >2000 
  
   
 
 48 h 500 125  2000 >2000 
  
   
 
Enterococcus sp. 24 h 500 125  2000  2000 
  
    
 48 h 500 125  2000  2000 
  
 
   
E.coli 24 h 
 1000  1000 >2000 >2000 
  
  
  
 48 h 
 1000  1000 >2000 >2000 
  
  
  
K.pneumoniae 24 h 
 2000  1000 >2000 >2000 
  
  
  
 48 h 
 2000  1000 >2000 >2000 
  
  
  
K.pneumoniae 
ESBL positive 
24 h >2000 
 2000 >2000 >2000 
 48 h >2000 
 2000 >2000 >2000 
  
  
  
P.aeruginosa 24 h 
 2000  1000 >2000 >2000 
  
  
  
 48 h 
 2000  1000 >2000 >2000 
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Proline derivatives (8, 41a, 89, 91, 92, 94 and 97) were non-inhibitory for all bacteria 
(>2000 µM) within tested concentration range. 104 inhibited Enterococcus sp. with an 
MIC value of 2000 µM being observed after 24 h and at 48 h. All remaining bacteria 
showed low inhibition for 104. Staphylococcus epidermidis and Enterococcus sp. were 
inhibited by 103 with an MIC value of 2000 µM recorded after 24 h and at 48 h. No cases 
of MIC inhibition were seen for 103 against remaining bacteria. 
 
101 showed low inhibition for Klebsiella pneumoniae-ESBL positive (>2000 µM). An 
MIC value of 500 µM was observed for 101 towards Gram positive bacteria 
(Staphylococcus aureus, MRSA, Staphylococcus epidermidis and Enterococcus sp.) after 
24 h and at 48 h. E. coli was inhibited by 101 with an MIC value of 1000 µM being 
observed after 24 h and at 48 h. Klebsiella pneumoniae and Pseudomonas aeruginosa 
were observed with an MIC value of 2000 µM after 24 h and at 48 h for 101. Gram 
positive organisms were slightly more inhibited by 101 than the Gram negative bacteria. 
 
102 gave an MIC value of 125 µM after 24 h and at 48 h for Staphylococcus epidermidis 
and Enterococcus. The highest MIC recorded for 102 was against Klebsiella pneumoniae-
ESBL positive (2000 µM after 24 h and at 48 h). Staphylococcus aureus and MRSA were 
inhibited by 102 giving an MIC of 250 µM after 24 h and at 48 h. The remaining Gram 
negative organisms (E.coli, Klebsiella pneumoniae and Pseudomonas aeruginosa) were 
observed with an MIC value of 1000 µM after 24 h and at 48 h for 102. Lower MIC 
values were obtained for 102 against Gram positive bacteria than against Gram negative 
bacteria. 
2.4.2 Antifungal study of proline derivatives  
 
Proline derivatives (41a, 89, 91, 92, 94, 97, 101, 102, 103 and 104) were screened at 
2000 µM while 8 was screened at a lower concentration of 250 µM due to low solubility 
in test medium (RPMI 1640). The antifungal results in the appendix (Table 2) represent 
the MIC values obtained for proline derivatives (8, 41a, 89, 91, 92, 94 and 97). Table 2.7 
represents the MIC values for proline derivatives (101, 102, 103 and 104). 
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Proline derived catalysts 
 
Organism Time 
(h) 
101 102 103 104 
C.albicans 
(ATCC44859) 
24h 
 1000  2000 >2000 >2000 
 48h 
 1000  2000 >2000 >2000 
  
  
  C.albicans 
(ATCC90028) 
24h 
 500  2000 >2000 >2000 
 48h 
 1000  2000 >2000 >2000 
  
  
  C.parapsilosis 
(ATCC22019) 
24h 
 1000  1000 >2000 >2000 
 48h 
 1000  1000 >2000 >2000 
  
  
  C.krusei (ATCC6258) 24h 
 500  500 >2000 >2000 
  
  
 
 
 48h 
 500  500 >2000 >2000 
  
  
  C.krusei (E28) 24h 
 500  500 >2000 >2000 
  
  
  
 48h 
 500  500 >2000 >2000 
  
  
  C.tropicalis (156) 24h 
 1000  1000 >2000 >2000 
  
    
 48h 
 1000  1000 >2000 >2000 
  
  
  C.glabrata (20/I) 24h 
 1000  2000 >2000 >2000 
  
  
  
 48h 
 2000  2000 >2000 >2000 
  
  
  C.lusitaniae (2446/I) 24h 
 125  125 >2000 >2000 
  
  
  
 48h 
 250  125 >2000 >2000 
  
  
  Trichosporon asahii 
(1188) 
24h 500  500 >2000 >2000 
 48h 500  500 >2000 >2000 
  
  
  Aspergillus fumigatus 
(231) 
24h  >2000 
 2000 >2000 >2000 
 48h  >2000 
 2000 >2000 >2000 
  
  
  Absidia corymbifera 
(272) 
24h 
 2000  2000 >2000 >2000 
 48h 
 2000  2000 >2000 >2000 
  
  
  Trichophyton 
mentagrophytes (445) 
72h 250  2000 >2000   2000 
 120h 250  2000 >2000   2000 
 
Table 2.7: Antifungal IC80/IC50 (µM) values for proline derivatives (101, 102, 103 and 
104) 
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89, 91, 92, 97 and 103 were all non-inhibitory to the fungal strains within tested 
concentration range (>2000 µM in RPMI 1640 medium). As well, 8 proved to be non-
inhibitory towards test fungal organisms (>250 µM).  Candida albicans ATCC 90028 and 
Candida tropicalis were inhibited by 94 after 24 h (2000 µM) but recovered at 48 h 
(>2000 µM). Trichophyton mentagrophytes gave an MIC/IC50 value of 2000 µM after 72 
h for 94 but recovered at 120 h (>2000 µM). All remaining fungal strains were not 
inhibited by 94. An MIC value of 2000 µM was noted for 41a towards Candida krusei 
ATCC 6258 and Candida tropicalis after 24 h , however, a recovery was apparent after 48 
h (>2000 µM). 41a showed low inhibition towards remaining fungal strains (>2000 µM). 
101 gave the lowest MIC value of 125 µM after 24 h for Candida lusitaniae while a 
recovery was noted after 48 h (250 µM). Trichophyton mentagrophytes was inhibited by 
101 with an MIC/IC50 value of 250 µM being observed after 72 h and at 120 h. An MIC 
value of 500 µM was seen for 101 towards Candida krusei ATCC 6258, Candida krusei 
E28 and Trichosporon asahii after 24 h and at 48 h. Candida albicans ATCC 90028 and 
Candida glabrata were inhibited by 101 with MIC values of 500 µM and 1000 µM, 
respectively, after 24 h while at 48 h a recovery was seen as MIC values increased to 
1000 µM and 2000 µM, respectively. Candida albicans ATCC 44859, Candida 
parapsilosis and Candida tropicalis gave an MIC of 1000 µM for 101 after 24 h and at 48 
h. 101 inhibited Absidia corymbifera with MIC of 2000 µM after 24 h and at 48 h. 
Aspergillus fumigatus was the only fungal organism not to be inhibited by 101 (>2000 
µM). 
104 inhibited Trichophyton mentagrophytes with an MIC of 2000 µM being reported after 
72 h and 120 h. All remaining fungi showed low inhibition for 104 (>2000 µM). An MIC 
value of 2000 µM was noted for 102 towards Candida albicans ATCC 44859, Candida 
albicans ATCC 90028, Candida glabrata, Aspergillus fumigatus and Absidia corymbifera 
after 24 h and at 48 h Trichophyton mentagrophytes was inhibited by 102 with an MIC of 
2000 µM after 72 h and at 120 h. The lowest MIC value obtained for 102 was 125 µM 
against Candida lusitaniae after 24 h and at 48 h. Candida krusei ATCC 6258, Candida 
krusei E28 and Trichosporon asahii were inhibited by 102 with an MIC of 500 µM being 
observed after 24 h and at 48 h. An MIC value of 1000 µM was observed for 102 against 
Candida parapsilosis and Candida tropicalis after 24 h and at 48 h. 
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2.4.3 Antibacterial study of chiral BINOLs and TADDOL 
 
BINOL (45a and 45b) was screened at 500 µM, while BINOL derivatives (98 and 99) 
and TADDOL (100) were screened at a lower concentration of 125 µM due to low 
solubility in test medium (Mueller Hinton) (Figures 2.3 and 2.4). BINOL derivatives 
(48a, 48b, 50a, 50b, 105a and 105b) were screened at 2000 µM (Figures 2.3 and 2.4). 
Brominated BINOL derivatives were selected for this study as they are more lipophilic 
than unbrominated BINOL derivatives. MIC results for this antibacterial study are 
presented in tables 2.8 and 2.9. 
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Fig. 2.3 BINOL (45a and 45b) and BINOL derivatives (50a, 50b and 99) 
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Fig. 2.4 Saturated BINOL derivatives (48a, 48b, 98, 105a and 105b) and TADDOL (100) 
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Chiral BINOLs 
Organism Time 
(h) 
45a 45b 50a 50b 99 
S.aureus 24 h 31.25 31.25 7.81 3.9 >125 
  
    
 
 48 h 31.25 62.5 31.25 3.9 >125 
  
    
 
MRSA 24 h 31.25 31.25 7.81 3.9 >125 
  
    
 
 48 h 62.5 62.5 31.25 3.9 >125 
  
    
 
S.epidermidis 24 h 31.25 31.25 7.81 3.9 >125 
  
    
 
 48 h 31.25 31.25 31.25 3.9 >125 
  
    
 
Enterococcus 
sp. 
24 h 62.5 62.5 7.81 7.81 >125 
   
   
 
 48 h 62.5 62.5 31.25 7.81 >125 
    
  
 
E.coli 24 h >500 >500 >2000 >2000 >125 
     
 
 
 48 h >500 >500 >2000 >2000 >125 
     
 
 
K.pneumoniae 24 h >500 >500 >2000  >2000 >125 
     
 
 
 48 h >500 >500 >2000  >2000 >125 
       
K.pneumoniae  
ESBL positive 
24 h >500 >500 >2000 >2000 >125 
 48 h >500 >500 >2000 >2000 >125 
       
P.aeruginosa 24 h >500 >500 >2000  >2000 >125 
     
 
 
 48 h >500 >500 >2000  >2000 >125 
       
 
Table 2.8: Antibacterial MIC/IC95 (µM) results for BINOL (45a and 45b) and BINOL 
derivatives (50a, 50b and 99) 
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Chiral BINOLs and TADDOL 
Organism Time 
(h) 
48a 48b 105a 105b 98 100 
  
      
S.aureus 24 h 62.5 62.5 15.62 1.98 >125 >125 
  
  
 
 
  
 48 h 500 500 15.62 3.9 >125 >125 
  
    
  
MRSA 24 h 62.5 125 15.62 1.98 >125 >125 
  
    
  
 48 h 500 500 15.62 3.9 >125 >125 
  
    
  
S.epidermidis 24 h 31.25 62.5 15.62 1.98 >125 >125 
  
    
  
 48 h 62.5 62.5 15.62 3.9 >125 >125 
  
    
  
Enterococcus 
sp. 
24 h 31.25 125 1.98 1.98 >125 >125 
  
    
  
 48 h 500 1000 15.62 3.9 >125 >125 
  
 
  
 
  
E.coli 24 h >2000 >2000 >2000 >2000 >125 >125 
     
 
  
 48 h >2000 >2000 >2000 >2000 >125 >125 
     
 
  
K.pneumoniae 24 h >2000 >2000 >2000  >2000 >125 >125 
     
 
  
 48 h >2000 >2000 >2000  >2000 >125 >125 
        
K.pneumoniae  
ESBL positive 
24 h >2000 >2000 >2000 >2000 >125 >125 
 48 h >2000 >2000 >2000 >2000 >125 >125 
        
P.aeruginosa 24 h >2000 >2000 >2000  >2000 >125 >125 
     
 
  
 48 h >2000 >2000 >2000  >2000 >125 >125 
        
 
Table 2.9: Antibacterial MIC/IC95 (µM) results for saturated BINOL derivatives (48a, 
48b, 98, 105a and 105b) and TADDOL (100) 
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98, 99 and 100 were non-inhibitory for bacteria within tested concentration range (>125 
µM). (S)-BINOL (45a) and (R)-BINOL (45b) inhibited all Gram positive bacteria. 
Staphylococcus epidermidis was inhibited by (S)-BINOL (45a) and (R)-BINOL (45b) at 
31.25 µM after 24 h and at 48 h. An MIC value of 31.25 µM was noted for 45a towards 
Staphylococcus aureus after 24 h and at 48 h. 45b inhibited Staphylococcus aureus at 
31.25 µM after 24 h and at 62.5 µM after 48 h. Both 45a and 45b inhibited MRSA at 
31.25 µM after 24 h while an MIC value of 62.5 µM was noted after 48 h.  Enterococcus 
sp. was inhibited at 62.5 µM after 24 h and at 48 h for 45a and 45b. Gram negative 
bacteria showed low inhibition for (S)-BINOL (45a) and (R)-BINOL (45b) within studied 
concentration range (>500 µM).  
 
The brominated BINOL derivatives (50a and 50b) inhibited all Gram positive bacteria 
while Gram negative bacteria were noted with low inhibition (>2000 µM). (S)-6,6’-
DibromoBINOL (50a) inhibited all Gram-positive bacteria (Staphylococcus aureus, 
MRSA, Staphylococcus epidermidis and Enterococcus sp.) at 7.81 µM after 24 h but the 
MIC value increased to 31.25 µM after 48 h. Staphylococcus aureus, MRSA and 
Staphylococcus epidermidis were inhibited by (R)-6,6’-dibromoBINOL (50b) at 3.9 µM 
after 24 h and at 48 h. Enterococcus sp. was noted with an MIC value of 7.81 µM after 24 
h and at 48 h for 50b. The (R)-6,6’-dibromoBINOL (50b) enantiomer exhibited lower 
MIC values for Gram positive bacteria when compared to the (S)-6,6’-dibromoBINOL 
(50a) enantiomer. It is apparent that the placement of bromine substituents at the 6-
position of BINOL leads to a more toxic compound as MIC values for 50a and 50b are 
lower than those obtained for both enantiomers of BINOL (45a and 45b). 
 
Reduced BINOL derivatives (48a, 48b, 105a and 105b) exhibited inhibition for all Gram 
positive bacteria while Gram negative bacteria were observed with low inhibition (>2000 
µM). (S)-H8-BINOL (48a) gave an MIC value of 62.5 µM after 24 h for Staphylococcus 
aureus and MRSA while after 48 h the MIC values increased to 500 µM. Staphylococcus 
epidermidis was inhibited by (S)-H8-BINOL (48a) at 31.25 µM after 24 h and at 62.5 µM 
after 48 h. An MIC value of 31.25 µM was noted for (S)-H8-BINOL (48a) towards 
Enterococcus sp. after 24 h while an MIC value of 500 µM was observed after 48 h. 
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(R)-H8-BINOL (48b) gave an MIC value of 62.5 µM after 24 h for Staphylococcus aureus 
and an MIC value of 500 µM after 48 h. MRSA was inhibited by 48b at 125 µM after 24 h 
and at 500 µM after 48 h. An MIC value of 62.5 µM was noted for 48b towards 
Staphylococcus epidermidis after 24 h and at 48 h. 48b inhibited Enterococcus sp. at 125 
µM after 24 h and at 1000 µM after 48 h. Both enantiomers 48a and 48b did not show a 
clear trend with regard to inhibition of bacteria as similar MIC values were obtained for 
Gram positive bacteria.  
 
Brominated H8-BINOL derivatives (105a and 105b) were observed with lower MIC 
values for Gram positive bacteria when compared to the parent molecules (48a and 48b). 
(S)-3,3’-Dibromo-H8-BINOL (105a) inhibited Staphylococcus aureus, MRSA and 
Staphylococcus epidermidis at 15.62 µM after 24 h and at 48 h. An MIC value of 1.98 
µM after 24 h was observed for 105a towards Enterococcus sp. and after 48 h an MIC 
value of 15.62 µM was noted. 
 
(R)-3,3’-Dibromo-H8-BINOL (105b) gave an MIC value of 1.98 µM  for Staphylococcus 
aureus, MRSA, Staphylococcus epidermidis and Enterococcus sp. after 24 h and an MIC 
value of 3.9 µM after 48 h. The (R)-3,3’-dibromo-H8-BINOL (105b) enantiomer proved 
more toxic towards Gram positive bacteria when compared to the (S)-3,3’-dibromo-H8-
BINOL enantiomer as MIC values were lower. 
 
An overall trend can be seen for the antibacterial activity of BINOL and BINOL 
derivatives towards Gram positive bacteria (105b >50b >105a, 50a >45a, 45b, 48a, 48b 
>99, 98 and 100). 
 
The R enantiomers of BINOL derivatives are more active (lower MICs) than the S 
enantiomers. Brominated BINOL derivatives showed more antibacterial activity when 
compared to the unbrominated parent molecules (105b is more active than 48b). 
Saturated brominated BINOL derivative (105b) was found to be the most active 
antibacterial for Gram positive organisms in this study. 
 
82 
2.4.4 Antifungal study of chiral BINOLs and TADDOL 
 
 
BINOL (45a and 45b) was screened at 500 µM, while BINOL derivatives (48a, 48b, 50a, 
50b, 98, 99, 105a and 105b) and TADDOL (100) were screened at a lower concentration 
of 125 µM due to low solubility in test medium (RPMI 1640) (Figures 2.3 and 2.4). MIC 
results for this antifungal study are presented in tables 2.10 and 2.11. 
 
98, 99, 100 and 105a were non-inhibitory for fungi within tested concentration range 
(>125 µM). Trichophyton mentagrophytes was inhibited by 45b and 45a at 31.25 µM and 
15.62 µM, respectively, after 72 h and at 120 h. 45a inhibited Trichosporon asahii at 
31.25 µM after 24 h and at 125 µM after 48 h. Candida parapsilosis was inhibited by 45a 
at 250 µM after 24 h but recovered after 48 h (>500 µM). Candida albicans ATCC 44859 
was inhibited by 45b at 250 µM after 24 h and recovered after 48 h (>500 µM). An MIC 
value of 250 µM was noted for 45b towards Trichosporon asahii after 24 h and at 48 h. 
All remaining fungal strains showed low inhibition for 45a and 45b (>500 µM). 
 
50a inhibited Candida lusitaniae at 1.98 µM after 24 h and at 48 h. Candida parapsilosis, 
Candida tropicalis, Trichosporon asahii and Absidia corymbifera were noted with an 
MIC value of 1.98 µM after 24 h for 50a while the MIC increased to 3.9 µM after 48 h. 
An MIC value of 3.9 µM was observed for 50a towards both strains of Candida albicans 
after 24 h and increased to 7.81 µM after 48 h. Candida glabrata gave an MIC of 7.81 
µM after 24 h and an MIC of 15.62 µM after 48 h. Both strains of Candida krusei and 
Aspergillus fumigatus exhibited an MIC of 15.62 µM for 50a after 24 h and at 48 h. 
Trichophyton mentagrophytes was inhibited by 50a at 1.98 µM after 72 h and at 120 h.  
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Chiral BINOLs 
Organism Time 
(h) 
45a 45b 50a 50b 99 
  
     
C.albicans 
(ATCC44859) 
24h  >500 
  250 3.9  15.62 >125 
 48h >500 >500 7.81  15.62 >125 
    
  
 C.albicans 
(ATCC90028) 
24h >500  >500 3.9  15.62 >125 
 48h >500 >500 7.81  15.62 >125 
    
  
 C.parapsilosis 
(ATCC22019) 
24h 250 >500 1.98  7.81 >125 
 48h >500 >500 3.9  15.62 >125 
    
  
 C.krusei (ATCC6258) 24h >500 >500 
 15.62  7.81 >125 
    
  
 
 48h >500 >500 15.62  15.62 >125 
    
  
 C.krusei (E28) 24h >500 >500 15.62  7.81 >125 
    
  
 
 48h >500 >500 15.62  15.62 >125 
    
  
 C.tropicalis (156) 24h >500  >500 
 1.98  15.62 >125 
   
   
 
 48h >500 >500 3.9  15.62 >125 
    
  
 C.glabrata (20/I) 24h >500 >500 7.81  3.9 >125 
    
  
 
 48h >500 >500 15.62  7.81 >125 
    
  
 C.lusitaniae (2446/I) 24h >500 >500 1.98 7.81 >125 
    
  
 
 48h >500 >500 1.98 15.62 >125 
    
  
 Trichosporon asahii 
(1188) 
24h 31.25  250 1.98 3.9 >125 
 48h 125  250 3.9 7.81 >125 
    
  
 Aspergillus fumigatus 
(231) 
24h >500 >500 15.62 15.62 >125 
 48h >500 >500 15.62 15.62 >125 
    
  
 Absidia corymbifera 
(272) 
24h >500 >500 1.98  3.9 >125 
 48h >500 >500 3.9  3.9 >125 
    
  
 Trichophyton 
mentagrophytes (445) 
72h 15.62  31.25 1.98 1.98 >125 
 120h 15.62 31.25 1.98 1.98 >125 
Table 2.10: Antifungal IC80/IC50 (µM) results for BINOL (45a and 45b) and BINOL 
derivatives (50a, 50b and 99)  
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Chiral BINOLs and TADDOL 
Organism Time 
(h) 
48a 48b 105a 105b 98 100 
C.albicans 
(ATCC44859) 
24h >125 >125 >125  >125 >125 >125 
 48h >125 >125 >125  >125 >125 >125 
     
 
  C.albicans 
(ATCC90028) 
24h >125 >125 >125  >125 >125 >125 
 48h >125 >125 >125  >125 >125 >125 
     
 
  C.parapsilosis 
(ATCC22019) 
24h >125 >125 >125  >125 >125 >125 
 48h >125 >125 >125  >125 >125 >125 
     
 
  C.krusei (ATCC6258) 24h >125 >125 >125  >125 >125 >125 
    
  
  
 48h >125 >125 >125  >125 >125 >125 
     
 
  C.krusei (E28) 24h >125 >125 >125  >125 >125 >125 
     
 
  
 48h >125 >125 >125  >125 >125 >125 
     
 
  C.tropicalis (156) 24h >125 >125 >125  >125 >125 >125 
   
   
  
 48h >125 >125 >125  >125 >125 >125 
     
 
  C.glabrata (20/I) 24h >125 >125 >125  >125 >125 >125 
     
 
  
 48h >125 >125 >125  >125 >125 >125 
     
 
  C.lusitaniae (2446/I) 24h >125 >125 >125 >125 >125 >125 
     
 
  
 48h >125 >125 >125 >125 >125 >125 
     
 
  Trichosporon asahii 
(1188) 
24h >125 >125 >125 >125 >125 >125 
 48h >125 >125 >125 >125 >125 >125 
        Aspergillus fumigatus 
(231) 
24h >125 >125 >125 >125 >125 >125 
 48h >125 >125 >125 >125 >125 >125 
        Absidia corymbifera 
(272) 
24h >125 >125 >125  >125 >125 >125 
 48h >125 >125 >125  >125 >125 >125 
     
 
  Trichophyton 
mentagrophytes (445) 
72h 15.62  62.5 >125 1.98 >125 >125 
 120h 15.62 62.5 >125 1.98 >125 >125 
Table 2.11: Antifungal IC80/IC50 (µM) results for saturated BINOLs (48a, 48b, 98, 105a 
and 105b) and TADDOL (100)  
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50b inhibited Absidia corymbifera at 3.9 µM after 24 h and at 48 h. An MIC value of 3.9 
µM was noted for 50b towards Candida glabrata and Trichosporon asahii after 24 h and 
increased to 7.81 µM after 48 h. Both strains of Candida krusei, Candida parapsilosis 
and Candida lusitaniae exhibited an MIC of 7.81 µM for 50b after 24 h and an MIC of 
15.62 µM after 48 h. 50b inhibited both strains of Candida albicans, Candida tropicalis 
and Aspergillus fumigatus at 15.62 µM after 24 h and at 48 h. 
Trichophyton mentagrophytes was inhibited by 50b at 1.98 µM after 72 h and at 120 h.  
Brominated BINOL derivatives (50a and 50b) showed more growth inhibition towards 
fungal organisms than BINOL (45a and 45b).   
 
Trichophyton mentagrophytes was inhibited by 48a, 48b and 105b at 15.62 µM, 62.5 µM 
and 1.98 µM after 72 h and at 120 h, respectively. All remaining fungal organisms 
showed low inhibition for 48a, 48b and 105b (>125 µM).  
 
 
An overall trend can be seen for the antifungal activity of BINOL and BINOL derivatives 
(50a, 50b >45a, 45b >105b, 48a, 48b >98, 100, 105a and 99) 
 
Brominated BINOL derivatives (50a and 50b) were found to be the most active for 
antifungal activity (inhibited all test fungi) among the BINOLs studied. The S enantiomer 
50a was slightly more active than the R enantiomer 50b as lower MICs were obtained for 
fungi in most cases. BINOL (45a and 45b) were observed with 3 cases of antifungal 
activity each. BINOL derivatives (48a, 48b and 105b) were less active as they inhibited 
one fungal organism each. While BINOL derivatives (98, 99, 100 and 105a) showed no 
activity towards test fungal organisms. 
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2.4.5 Antibacterial study of Jacobsen thioureas (IC95) 
 
Jacobsen thioureas (15, 106 and 107) were screened against the test set of bacteria for the 
determination of IC95 values. Jacobsen thioureas (Figure 2.5) used for this study were 
tested at the highest concentration range of 2000 µM. The results in table 2.12 represent 
the MIC values obtained for Jacobsen thioureas (15, 106 and 107).   
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Fig 2.5 Jacobsen thioureas (15, 106 and 107) evaluated for antimicrobial activity 
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Organism Time 
(h) 
106 15 107 
  
   
S. aureus 24 >2000 1000 250 
     
 48 >2000 1000 250 
     
MRSA 24 1000 62.5 250 
     
 48 1000 62.5 250 
     
S. epidermidis 24 1000 15.62 250 
     
 48 1000 15.62 250 
     
Enterococcus sp. 24 1000 500 500 
  
 
  
 48 1000 500 500 
  
 
  
E. coli 24 >2000 1000 250 
  
 
  
 48 >2000 1000 250 
  
 
  
K. pneumoniae 24 >2000 1000 125 
  
 
  
 48 >2000 1000 125 
     
K. pneumoniae -
ESBL 
24 >2000 1000 >2000 
 48 >2000 1000 >2000 
     
P. aeruginosa 24 >2000 2000 >2000 
     
 48 >2000 2000 >2000 
   
 
 
 
 
Table 2.12: MIC/IC95 (µM) values of Jacobsens thioureas (15, 106 and 107) 
  
 
Jacobsens thioureas (15, 106 and 107) showed cases of inhibition towards bacteria. 15 
inhibited all bacteria. 106 was inhibitory for MRSA, Staphylococcus epidermidis and 
Enterococcus sp while 107 inhibited most bacteria except for Klebsiella pneumoniae-
ESBL positive (>2000 µM) and Pseudomonas aeruginosa (>2000 µM). 
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Low MIC values were obtained for 15 against MRSA (62.5 µM after 24 h and at 48 h) and 
Staphylococcus epidermidis (15.62 µM after 24 h and at 48 h). The highest MIC value 
obtained for 15 was against Pseudomonas aeruginosa (2000 µM after 24 h and at 48 h). 
Enterococcus sp gave an MIC value of 500 µM after 24 h and at 48 h for 15. All 
remaining bacteria (Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae and 
Klebsiella pneumoniae-ESBL positive) gave an MIC value of 1000 µM after 24 h and at 
48 h for 15. 
107 showed low inhibition for Klebsiella pneumoniae-ESBL positive (>2000 µM) and 
Pseudomonas aeruginosa (>2000 µM). The highest MIC value obtained for 107 was 
against Enterococcus sp (500 µM after 24 h and at 48 h). Klebsiella pneumoniae was 
observed with the lowest MIC value of 125 µM after 24 h and at 48 h for 107. Remaining 
bacteria (Staphylococcus aureus, MRSA, Staphylococcus epidermidis and Escherichia 
coli) were noted with an MIC value of 250 µM after 24 h and at 48 h for 107. 
106 exhibited an MIC value of 1000 µM after 24 h and at 48 h for MRSA, Staphylococcus 
epidermidis and Enterococcus sp. Remaining bacteria (Staphylococcus aureus, 
Escherichia coli, Klebsiella pneumoniae, Klebsiella pneumoniae-ESBL positive and 
Pseudomonas aeruginosa) were noted with low inhibition for catalyst 106 (>2000 µM). 
 
2.4.6 Antifungal study of Jacobsen thioureas 
 
Jacobsen thioureas (15, 106 and 107) were screened at a lower concentration for 
antifungal screening, this was due to there respective solubility in test medium (1000 µM 
for 15, 500 µM for 106 and 125 µM for 107). MIC results for this antifungal study are 
presented in the appendix (Table 3). 
 
Both 106 and 107 proved non-inhibitory for all fungal strains within studied 
concentration range. Some cases of antifungal inhibition were noted for 15. Candida 
parapsilosis, Candida tropicalis and Candida lusitaniae gave an MIC value of 1000 µM 
after 24 h and at 48 h for 15. The MIC value obtained for 15 against Trichophyton 
mentagrophytes was 1000 µM after 72 h and at 120 h. All remaining fungal strains gave 
low inhibition for 15. 
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2.4.7 Antibacterial study of Cinchona alkaloid derivatives 
 
Cinchona alkaloid derivatives 38a, 81a and 108 (Figure 2.6) were screened against the 
test set of bacteria for the determination of IC95 values. Both 38a and 108 were screened 
at the highest concentration of 2000 µM while 81a was tested at 500 µM. The results in 
the appendix (Table 4) represent the MIC values obtained for cinchona alkaloid 
derivatives (38a, 81a and 108). 
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Fig 2.6 Cinchona alkaloid derived catalysts (38a, 81a and 108) screened for antimicrobial 
activity 
 
 
All cinchona alkaloid derivatives (38a, 81a and 108) were observed with low inhibition 
against test bacteria within the tested concentration ranges. 
 
 
 
90 
2.4.8 Antifungal study of Cinchona alkaloid derivatives 
 
Both 38a and 108 were screened at the highest concentration of 2000 µM while 81a was 
tested at 500 µM. MIC results for this antifungal study are presented in the appendix 
(Table 5). 
 
Cinchona alkaloid derivatives 38a and 108 showed no inhibition towards fungal strains 
(>2000 µM). 81a was screened at 500 µM due to low solubility in the test medium. Some 
cases of inhibition were observed with 81a for fungal strains. Candida parapsilosis and 
Candida lusitaniae were noted with an MIC value of 125 µM after 24 h and at 48 h for 
81a. An MIC value of 500 µM was recorded for Candida albicans ATCC 44859, Candida 
albicans ATCC 90028, Candida krusei ATCC 6258, Candida krusei E28, Candida 
tropicalis and Candida glabrata after 24 h and at 48 h. Remaining fungal strains 
(Trichosporon asahii, Aspergillus fumigatus, Absidia corymbifera and Trichophyton 
mentagrophytes) were not inhibited by 81a within the tested concentration range. 
 
 
2.4.9 Antibacterial study of MacMillan imidazolidinones  
 
MacMillan imidazolidinones 19, 109 and 110 (Figure 2.7) were screened against the test 
set of bacteria for the determination of IC95 values. 19, 109 and 110 were screened at the 
highest concentration of 2000 µM. MIC results for the antibacterial study of 19, 109 and 
110 are presented in the appendix (Table 6). 
N
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Fig 2.7 MacMillan imidazolidinones (19, 109 and 110) screened for antimicrobial      
activity 
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109 was noted with an MIC value of 2000 µM for MRSA after 24 h and at 48 h. All 
remaining bacteria showed low inhibition for 109 (>2000 µM). Macmillan 
imidazolidinone 110 exhibited an MIC value of 2000 µM for Staphylococcus epidermidis 
after 24 h and at 48 h while remaining bacteria were not inhibited by 110 (>2000 µM). 19 
(>2000 µM) proved non-inhibitory for test bacteria within tested concentration range.    
2.4.10 Antifungal study of MacMillan imidazolidinones  
 
MacMillan imidazolidinones 19, 109 and 110 were screened against fungal organisms at 
2000 µM. MIC results for antifungal study of 19, 109 and 110 are presented in the 
appendix (Table 7). 
 
Both 19 and 109 proved non-inhibitory for fungal strains within tested concentration 
range. MacMillan imidazolidinone 110 inhibited Trichosporon asahii at 2000 µM after 24 
h while a recovery was noted after 48 h (>2000 µM). Trichophyton mentagrophytes was 
inhibited at 2000 µM by 110 after 72 h and at 120 h.  
 
2.4.11 Antibacterial study of chiral phosphoric acids and Maruoka phase-transfer 
catalyst 
 
Chiral phosphoric acids (26a and 26b) and Maruoka phase-transfer catalyst 40 (Figure 
2.8) were screened against the test set of bacteria for the determination of IC95 values. 
26a and 26b were screened at the highest concentration of 2000 µM while 40 was tested 
at a lower concentration of 125 µM. MIC results for the antibacterial study of 26a, 26b 
and 40 are presented in table 2.13. 
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Fig. 2.8 Chiral phosphoric acids (26a and 26b) and Maruoka phase-transfer catalyst (40) 
screened for antimicrobial activity 
 
 
 
 
26a proved inhibitory for Gram positive organisms Staphylococcus aureus, MRSA and 
Staphylococcus epidermidis with MIC values of 2000 µM, 1000 µM and 1000 µM noted 
respectively after 24 h and at 48 h.  Enterococcus sp. and remaining Gram negative 
bacteria (E.coli, Klebsiella pneumoniae, Klebsiella pneumoniae-ESBL positive and 
Pseudomonas aeruginosa) showed low inhibition for 26a (>2000 µM). 26b inhibited 
Staphylococcus aureus and MRSA at 2000 µM after 24 h and at 48 h. Staphylococcus 
epidermidis was inhibited by 26b at 1000 µM after 24 h and at 2000 µM after 48 h. 
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Organism Time 
(h) 
26a 26b 40 
  
   
S. aureus 24 
 2000 2000 125 
  
   
 48 
 2000 2000 125 
   
  
MRSA 24 
 1000 2000 31.25 
   
  
 48 
 1000 2000 31.25 
   
  
S. epidermidis 24 
 1000 1000 125 
  
   
 48 
 1000 2000 125 
   
  
Enterococcus sp. 24 >2000 >2000 62.5 
  
   
 48 >2000 >2000 62.5 
  
   
E. coli 24 >2000 >2000 >125 
  
   
 48 >2000 >2000 >125 
  
   
K. pneumoniae 24 >2000 >2000 >125 
  
   
 48 >2000 >2000 >125 
     
K. pneumoniae -
ESBL 
24 >2000 >2000 >125 
 48 >2000 >2000 >125 
     
P. aeruginosa 24 >2000 >2000 >125 
     
 48 >2000 >2000 
 
>125 
 
 
Table 2.13: MIC/IC95 (µM) values of 26a, 26b and 40 
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All 4 Gram positive organisms were inhibited by 40. MRSA exhibited the lowest MIC 
value of 31.25 µM for 40 after 24 h and at 48 h. Both Staphylococcus aureus and 
Staphylococcus epidermidis gave the highest MIC value of 125 µM after 24 h and at 48 h 
for 40. Enterococcus sp. was observed with an MIC value of 62.5 µM after 24 h and at 48 
h for 40. All Gram negative bacteria (E.coli, Klebsiella pneumoniae, Klebsiella 
pneumoniae-ESBL positive and Pseudomonas aeruginosa) showed low inhibition for 40 
(>125 µM). 
 
 
 
2.4.12 Antifungal study of chiral phosphoric acids and Maruoka phase-transfer 
catalyst 
 
Chiral phosphoric acids (26a and 26b) and Maruoka phase-transfer catalyst 40 (Figure 
2.8) were screened against the test set of fungi. 26a and 26b were screened at the highest 
concentration of 2000 µM while 40 was tested at a lower concentration of 125 µM. MIC 
results for the antifungal study of 26a, 26b and 40 are presented in table 2.14. 26a 
showed low antifungal activity (>2000 µM) for all fungal strains. Trichophyton 
mentagrophytes was inhibited by 26b at 500 µM after 72 h and at 2000 µM after 120 h. 
An MIC value of 2000 µM was observed for 26b towards Absidia corymbifera after 24 h 
and at 48 h. 40 was screened at 125 µM. Candida lusitaniae exhibited the lowest MIC 
value of 3.9 µM after 24 h and at 48 h for 40. An MIC value of 7.81 µM was obtained for 
40 towards Candida albicans ATCC 44859 after 24 h and at 48 h. Candida albicans 
ATCC 90028 and Candida parapsilosis were inhibited by 40 with an MIC value of 15.62 
µM after 24 h and at 48 h. An MIC value of 31.25 µM for 40 was noted for Candida 
krusei ATCC 6258 and Candida tropicalis after 24 h and at 48 h. Trichosporon asahii 
gave an MIC value of 62.5 µM for 40 after 24 h and at 48 h. All remaining fungi 
(Candida krusei E28, Candida glabrata, Aspergillus fumigatus, Absidia corymbifera and 
Trichophyton mentagrophytes) were observed with low inhibition (>125 µM). 
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Organism Time (h) 26a 26b 40 
  
   C. albicans (ATCC44859) 24 >2000 >2000 7.81 
   
  
 48 >2000 >2000 7.81 
   
  C. albicans (ATCC90028) 24 >2000 >2000 15.62 
   
  
 48 >2000 >2000 15.62 
   
  C. parapsilosis (ATCC22019) 24 >2000 >2000 15.62 
   
  
 48 >2000 >2000 15.62 
   
  C. krusei (ATCC6258) 24 >2000 >2000 31.25 
   
  
 48 >2000 >2000 31.25 
     C. krusei (E28) 24 >2000 >2000 >125 
     
 48 >2000 >2000 >125 
     C. tropicalis (156) 24 >2000 >2000 31.25 
   
  
 48 >2000 >2000 31.25 
     C. glabrata (20/I)  24 >2000 >2000 >125 
     
 48 >2000 >2000 >125 
     C. lusitaniae (2446/I) 24 >2000 >2000 3.9 
   
  
 48 >2000 >2000 3.9 
   
  T. asahii (1188) 24 >2000 >2000 62.5 
   
  
 48 >2000 >2000 62.5 
     A. fumigatus (231) 24 >2000 >2000 >125 
     
 48 >2000 >2000 >125 
     A. corymbifera (272) 24 >2000 2000 >125 
     
 48 >2000 2000 >125 
     T. mentagrophytes (445) 72 >2000 500 >125 
     
 120 >2000 2000 >125 
  
Table 2.14: Antifungal IC80/IC50 (µM) values for 26a, 26b and 40 
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2.5 Cytotoxicity, apoptosis and cell viability studies of organocatalysts 
 
Cytotoxicity, apoptosis and cell viability studies of organocatalysts were performed by 
our collaborator Dr. Petr Bartunek in the Czech Republic. These studies were carried out 
on human erythroid progenitors, HL-60 and K-562 blood cell lines in the presence of 
various concentrations of organocatalysts (0-10 µM). Human erythroid progenitors are 
normal blood cells while HL-60 (ATCC CCL-240) is a human promyelocytic leukemia 
cell line and K-562 (ATCC CCL-243) is a human myelogenous leukemia cell line.  
 
2.5.1 Cytotoxicity of organocatalysts 
 
Cytotoxic effects on all cell lines were determined using the CytoTox-ONE homogeneous 
membrane integrity assay (G7892, promega).17 This assay is a homogeneous, 
fluorometric method for estimating the number of non-viable cells present in multiwell 
plates.17 Non-viable cells generate a fluorescent signal for this assay and the emitted 
fluorescence is proportional to the number of non-viable cells present. The principle for 
this assay is that non-viable cells have a damaged plasma membrane that allows cellular 
contents to leak out which results in cell death. Viable cells will not emit a fluorescent 
signal for this assay. The cytotoxicity results for 8, 15, 26a, 38a, 40, 81a, 102, 103, 104, 
106, 107, 108 and 109 against human erythroid progenitors, HL-60 and K-562 cell lines 
are presented in Figures 2.9, 2.10 and 2.11 respectively. Fold induction for the 
cytotoxicity assay is the ratio between experimental fluorescence (cells + test substance) 
and control fluorescence (cells without test substance). An increase in fold induction for 
test compound indicates the presence of non-viable cells (cytotoxicity). 
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Fig. 2.9 Cytotoxicity results for erythroid progenitors 
 
 
 
 
 
 
 
 
 
 
Fig. 2.10 Cytotoxicity results for HL-60 
 
 
 
 
 
 
 
 
 
Fig. 2.11 Cytotoxicity results for K-562 
 
Cytotoxicity
(Erythroid progenitors)
0.1 1 10
0.0
0.5
1.0
1.5
2.0
109
106
15
26a
40
103
102
104
108
38a
81a
107
8µM
Fo
ld
 
in
du
c
tio
n
Cytotoxicity (HL60)
0.1 1 10
0.0
0.5
1.0
1.5
2.0
109
106
15
26a
40
103
102
104
108
38a
81a
107
8µM
Fo
ld
 
in
du
c
tio
n
Cytotoxicity (K562)
0.1 1 10
0.0
0.5
1.0
1.5
2.0
109
106
15
26a
40
103
102
104
108
38a
81a
107
8µM
Fo
ld
 
in
du
c
tio
n
98 
Organocatalysts (8, 15, 26a, 38a, 40, 81a, 102, 103, 104, 106, 107, 108 and 109) 
exhibited no cytotoxicity towards test cell lines under the parameters of the CytoTox-
ONE homogeneous membrane integrity assay within the studied concentration range 
(0.1-10 µM). These compounds failed to disrupt the plasma membranes which would lead 
to non-viable cells. 
 
2.5.2 Apoptosis induced by organocatalysts 
 
Apoptosis for cell lines was monitored using the Caspase-Glo 3/7 assay (G8091, 
promega).18 The Caspase-Glo 3/7 assay is a homogeneous, luminescent assay that 
measures caspase-3 and -7 activities.18 Caspases are proteases that are implicated in 
apoptosis.19 Apoptosis is a process of programmed cell death that is accomplished by 
specialized cellular machinery. In apoptosis, caspases function in both cell disassembly 
and the initiation of cell disassembly in response to pro-apoptotic signals.19 This assay 
determines cell death induced by apoptosis by measuring caspase-3 and -7 activities. The 
luminescent signal readout for this assay only occurs when caspase-3 and -7 become 
activated, therefore luminescence is proportional to caspase-3 and -7 activities. Viable 
cells that contain inactive caspase-3 and -7 enzymes will not give a luminescent signal. 
 
The apoptosis results for 8, 15, 26a, 38a, 40, 81a, 102, 103, 104, 106, 107, 108 and 109 
against human erythroid progenitors, HL-60 and K-562 cell lines are presented in Figures 
2.12, 2.13 and 2.14 respectively. Fold induction for the apoptosis assay is the ratio 
between experimental luminescence (cells + test substance) and control luminescence 
(cells without test substance). An increase in fold induction for test compounds indicates 
the activation of caspase-3 and -7. 
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Fig. 2.12 Apoptosis results for erythroid progenitors 
 
 
 
 
 
 
 
 
 
 
Fig. 2.13 Apoptosis results for HL-60 
 
 
 
 
 
 
 
 
 
Fig. 2.14 Apoptosis results for K-562 
Apoptosis
(Erythroid progenitors)
0.1 1 10
0
1
2
3
4
109
106
15
26a
40
103
102
104
108
38a
81a
107
8µM
Fo
ld
 
in
du
c
tio
n
Apoptosis (HL60)
0.1 1 10
0
5
10
15
109
106
15
26a
40
103
102
104
108
38a
81a
107
8µM
Fo
ld
 
in
du
c
tio
n
Apoptosis (K562)
0.1 1 10
0
2
4
6
8
109
106
15
26a
40
103
102
104
108
38a
81a
107
8µM
Fo
ld
 
in
du
c
tio
n
100 
Organocatalysts (8, 15, 26a, 38a, 81a, 102, 103, 104, 106, 107, 108 and 109) did not 
induce apoptosis for test cell lines under the parameters of the Caspase-Glo 3/7 assay 
within the concentration range (0.1-10 µM). These compounds failed to damage the cells 
which would in turn activate caspase-3 and -7 activities. However, 40 did produce 
apoptosis for all 3 cell lines within the concentration range (0.1-10µM). An increase in 
fold induction was noted for 40 against all 3 cell lines (Figures 2.12, 2.13 and 2.14).  
 
2.5.3 Cell viability study with organocatalysts 
 
Cell viability was measured using the CellTiter-Blue cell viability assay (G8082, 
promega).20 This assay is a homogeneous, fluorometric method for estimating the number 
of viable cells present in multiwell plates.20 Viable cells are metabolically active and will 
emit a fluorescent signal for this assay. The number of viable cells is proportional to the 
fluorescence signal. Non-viable cells are not metabolically active therefore these cells 
will not emit a fluorescent signal for this assay. A decrease in fold induction indicates a 
loss in cell viability. 
The cell viability results for 8, 15, 26a, 38a, 40, 81a, 102, 103, 104, 106, 107, 108 and 
109 against erythroid progenitors, HL-60 and K-562 cell lines are presented in Figures 
2.15, 2.16 and 2.17 respectively. Fold induction for the cell viability assay is the ratio 
between experimental fluorescence (cells + test substance) and control fluorescence (cells 
without test substance). 
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Fig. 2.15 Cell viability results for erythroid progenitors 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.16 Cell viability results for HL-60 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.17 Cell viability results for K-562 
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Organocatalysts (8, 15, 26a, 38a, 81a, 103, 104, 106, 108 and 109) did not result in loss 
of cell viability for test cell lines. 102 and 107 reduced cell viability by less than 50% for 
all 3 cell lines at 10 µM. 
40 resulted in a loss of cell viability for all 3 cell lines within the studied concentration 
range (0.1-10 µM). A decrease in fold induction was noted for 40 against all 3 cell lines 
(Figures 2.15, 2.16 and 2.17).  
 
2.5.4 EC50 and IC50 values for Maruoka phase-transfer catalyst (40) 
 
EC50 values were determined for the affect 40 has on apoptosis (Figure 2.18). An EC50 
value of 6.0 µM was observed for 40 against erythroid progenitors. Both HL-60 and K-
562 gave an EC50 value of 2.1 µM and 5.5 µM, respectively.  
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Fig. 2.18 Apoptosis results for 40 against all 3 cell lines (erythroid progenitors, HL-60 
and K-562) 
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IC50 values were determined for the affect 40 has on cell viability (Figure 2.19). An IC50 
value of 1.2 µM was observed for 40 against erythroid progenitors. Both HL-60 and K-
562 gave an IC50 value of 0.8 µM and 1.7 µM, respectively.  
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Fig. 2.19 Cell viability results for 40 against all 3 cell lines (erythroid progenitors, HL-60 
and K-562) 
 
From the apoptosis and cell viability studies it is apparent that 40 is toxic to erythroid 
progenitors, HL-60 and K-562 cell lines for those test parameters. 
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2.6 Biodegradation study of known organocatalysts 
 
Jacobsen thioureas, cinchona alkaloid derivatives, proline derivatives, MacMillan 
imidazolidinones, Maruoka phase-transfer catalyst and chiral phosphoric acids (Figures 
2.20 and 2.22) were evaluated for biodegradation using the CO2 headspace test (ISO 
14593).1 This study was performed by our collaborator Dr Teresa Garcia at the 
department of surfactant technology in Barcelona, Spain. General procedure for this assay 
was discussed in section 1.3.4. Results from this study are presented in Tables 2.15 and 
2.17. 
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Table 2.15: Biodegradation results for organocatalysts (8, 15, 26a, 38a, 40, 81a, 106, 
107, 108 and 109) 
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Fig 2.20 Organocatalysts (8, 15, 26a, 38a, 40, 81a, 106, 107, 108 and 109) evaluated for 
biodegradation using the CO2 headspace test (ISO 14593) 
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Fig 2.21 Biodegradation curves for organocatalysts (8, 15, 26a, 38a, 40, 81a, 106, 107, 
108 and 109) 
The readily biodegradable reference substance SDS was evaluated as the control 
experiment and exhibited 76% biodegradation after 6 days. Days 14, 21 and 28 gave 
biodegradation values of 93%, 93% and 94%, respectively. These data points verify that 
the inoculum is active and capable of mineralising biodegradable organic chemicals. 
Organocatalysts (8, 15, 26a, 38a, 40, 81a, 106, 107, 108 and 109) were non-
biodegradable as less than 7% CO2 output was measured for these molecules (Table 
2.15). In order for a chemical to be deemed readily biodegradable it must evolve >60% 
CO2 over a period of 28 days. Therefore, organocatalysts (8, 15, 26a, 38a, 40, 81a, 106, 
107, 108 and 109) failed the CO2 headspace test (ISO 14593) and can be classified as 
being non-biodegradable as negligible CO2 output occurred (Figure 2.21). As no 
biodegradation was apparent for organocatalysts (8, 15, 26a, 38a, 40, 81a, 106, 107, 108 
and 109), a control experiment was run to determine if compounds were having an 
inhibitory effect on the activity of the inoculum. For this experiment reference substance 
(SDS) and test substance (organocatalysts) were added together to the inoculum and if 
inhibition of SDS biodegradation occurred (>25% inhibition is required for a positive 
107 
result), this implied that the test substance is inhibiting the inoculum. Results from this 
experiment are presented in Table 2.16. Maruoka phase-transfer catalyst (40) gave the 
largest % inhibition (30%) for the inhibitory control assay at a concentration of 40 µM. 
Cinchona alkaloid derived phase-transfer catalyst (81a) gave a % inhibition value of 19% 
at 49 µM. Compounds 40 and 81a showed cases of inhibition for the antimicrobial 
screening.  Proline derived organocatalyst (8) was noted with an inhibition of 8% for the 
inhibitory control biodegradation assay at a concentration of 72 µM. Remaining 
organocatalysts (15, 26a, 38a, 106, 107, 108 and 109) were observed with low inhibition 
to the inoculum (Table 2.16).  
Compound Concentration 
(mgC/L) 
Molar 
concentration of 
test sample 
Inhibition (%) 
    8 + SDS 20 + 20 72 µM 8 
 
   15 + SDS 20 + 20 79 µM 3 
    26a + SDS 20 + 20 83 µM 0 
    38a + SDS 20 + 20 64 µM 3 
    40 + SDS 20 + 20 40 µM 30 
    81a + SDS 20 + 20 49 µM 19 
    106 + SDS 20 + 20 76 µM 0 
    107 + SDS 20 + 20 72 µM 0 
    108 + SDS 20 + 20 83 µM 1 
 
   109 +SDS 20 + 20 128 µM 0 
Table 2.16: Inhibition of SDS biodegradation by 8, 15, 26a, 38a, 40, 81a, 106, 107, 108 
and 109 
The % inhibition values for organocatalysts (8, 15, 26a, 38a, 81a, 106, 107, 108 and 109) 
are lower than the limit (>25% inhibition) generally accepted to consider an inhibitory 
effect on the activity of the inoculum. However, Maruoka phase-transfer catalyst (40) 
gave a % inhibition value of 30%, as a result this compound has an inhibitory effect on 
the activity of the inoculum. 
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Organocatalysts 19, 89, 103, 104 and 110 (Figure 2.22) gave biodegradation values >10 
% (Table 2.17).  
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 Fig 2.22 Organocatalysts (19, 89, 103, 104 and 110) giving >10% biodegradation 
 
% Biodegradation Compound 
6 d 14 d 21 d 28 d 
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38 
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Table 2.17: Organocatalysts (19, 89, 103, 104 and 110) showing >10% biodegradation 
after 28 days 
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Fig 2.23 Biodegradation curves for organocatalysts (19, 89, 103, 104 and 110) showing 
>10% biodegradation after 28 days 
L-Prolinamide (89) passed the CO2 headspace test (ISO 14593) as it gave a 
biodegradation value of 77% after 28 days (Figure 2.23). Compound 89 is readily 
biodegradable under the parameters of the CO2 headspace test (ISO 14593). Proline 
derivatives 103 and 104 showed biodegradation values of 11 % and 38%, respectively, 
after 28 days. Both MacMillan imidazolidinones 19 and 110 gave a biodegradation value 
of 30% after 28 days. Compounds 19, 103, 104 and 110 are not readily biodegradable 
under the parameters of the CO2 headspace test (ISO 14593).  
Organocatalysts (19, 89, 103, 104 and 110) showed no inhibitory effect on the activity of 
the inoculum (Table 2.18). 
 
 
 
110 
Compound Concentration 
(mgC/L) 
Molar 
concentration of 
test sample 
Inhibition (%) 
19 + SDS 20 + 20 104 µM 0 
    
89 + SDS 20 + 20 333 µM 0 
    
103 + SDS 20 + 20 88 µM 0 
    
104 + SDS 20 + 20 88 µM 0 
 
   
110 + SDS 20 + 20 111 µM 0 
    
Table 2.18: Inhibition of SDS biodegradation by organocatalysts (19, 89, 103, 104 and 
110) 
Biodegradation data for other organocatalysts (26b, 41a, 45a, 45b, 48a, 48b, 50a, 50b, 
92, 97, 100, 101, 102, 105a and 105b) studied, showed negligible CO2 output (see 
appendix table 8 and figure 1), these catalysts are non-biodegradable under the 
parameters of the CO2 headspace test (ISO 14593). 
 
 
2.7 Conclusions  
A range of known organocatalysts including amino acids, proline derivatives, BINOL, 
BINOL derivatives, TADDOL, Jacobsen thioureas, Cinchona alkaloid derivatives, 
MacMillan imidazolidinones, chiral phosphoric acids and a Maruoka phase-transfer 
catalyst were studied for antimicrobial activity. Studies performed in DCU showed a 
number of amino acids inhibiting test bacteria. MIC values for inhibitory amino acids 
were found to be high (>2.5 mM). Proline derivatives (95 and 96) inhibited Gram 
positive M.luteus, B.subtilis and Gram negative E.coli. Remaining proline derivatives 
proved non-inhibitory within tested concentration range (3.45 mM-0.007 mM). BINOL 
(45) exhibited inhibition towards M.luteus and B.subtilis (0.107 mM) while BINOL 
derivatives and TADDOL proved to be non-inhibitory for test organisms within studied 
concentration range.  
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Antimicrobial studies performed by our collaborator Dr Marcel Špulák showed a number 
of organocatalysts inhibiting test microorganisms. A number of cases of inhibition were 
found with proline derivatives (101 and 102) for both bacterial and fungal organisms. 
Jacobsen thioureas inhibited different bacteria with 15 being the most active. 15 was the 
only Jacobsen thiourea found to inhibit fungal strains (4 in total). Cinchona alkaloid 
derivatives were observed with low inhibition for bacteria, with only 81a exhibiting 
antifungal activity in some cases. MacMillan imidazolidinones were found to be mostly 
non-inhibitory towards both bacterial and fungal strains (>2000 µM). The only 
exceptions were 109 which inhibited MRSA at 2000 µM after 24 h and at 48 h and 110 
was found to inhibit Staphylococcus epidermidis at 2000 µM after 24 h and at 48 h. 110 
inhibited 2 fungal strains. Chiral phosphoric acids (26a and 26b) and Maruoka phase-
transfer catalyst (40) proved inhibitory for most Gram positive bacteria while Gram 
negative bacteria showed low inhibition. 26b was observed with two cases of inhibition 
for fungal organisms while 40 inhibited a number of fungal organisms. TADDOL (100) 
and BINOL derivatives (98 and 99) showed low inhibition towards all bacterial and 
fungal organisms. (S)-BINOL (45a) and (R)-BINOL (45b) inhibited all Gram positive 
bacteria while Gram negative bacteria showed low inhibition. 45a and 45b showed a few 
cases of anti-fungal activity. Brominated BINOL derivatives (50a and 50b) were found to 
be more toxic than BINOL (45a and 45b) as lower MIC values were obtained for Gram 
positive bacteria. 50a and 50b inhibited all Gram positive bacteria while Gram negative 
bacteria showed low inhibition (>2000 µM). A trend noted was that the R enantiomer 
(50b) was more active than the S enantiomer (50a). H8-BINOLs (48a and 48b) inhibited 
all Gram positive bacteria while Gram negative bacteria were not inhibited (>2000 µM). 
Brominated H8-BINOL derivatives (105a and 105b) were found to be more toxic towards 
Gram positive bacteria than the non-brominated H8-BINOLs (48a and 48b). (R)-3,3’-
Dibromo-H8-BINOL (105b) was observed with lower MIC values when compared to (S)-
3,3’-dibromo-H8-BINOL (105a). Cytotoxicity, apoptosis and cell viability studies 
showed most organocatalysts to be non-toxic towards erythroid progenitors, HL-60 and 
K-562 blood cell lines. However, 102 and 107 were found to reduce cell viability by less 
than 50% for all 3 cell lines at 10 µM. 40 proved toxic for all 3 blood cell lines as it was 
found to induce cell death by apoptosis and resulted in a loss of cell viability. 
112 
Organocatalysts (8, 15, 19, 26a, 26b, 38a, 40, 41a, 45a, 45b, 48a, 48b, 50a, 50b, 81a, 92, 
97, 100, 101, 102, 103, 104, 105a, 105b, 106, 107, 108, 109 and 110) were found to be 
non-biodegradable under the parameters of the CO2 headspace test (ISO 14593). L-
Prolinamide (89) passed the CO2 headspace test (ISO 14593) with a biodegradation value 
of 77% after 28 days. Compounds (8, 15, 19, 26a, 26b, 38a, 41a, 45a, 45b, 48a, 48b, 
50a, 50b, 81a, 89, 92, 97, 100, 101, 102, 103, 104, 105a, 105b, 106, 107, 108, 109 and 
110) did not have a significant inhibitory effect on the activity of the inoculum. Maruoka 
phase-transfer catalyst (40) had an inhibitory effect on the activity of the inoculum as a % 
inhibition value of 30% was noted. Persistence in the environment for organocatalysts (8, 
15, 19, 26a, 26b, 38a, 40, 41a, 45a, 45b, 48a, 48b, 50a, 50b, 81a, 92, 97, 100, 101, 102, 
103, 104, 105a, 105b, 106, 107, 108, 109 and 110) is a concern. 
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Chapter 3: Results and Discussion 
 
3 Polysubstituted BINOL derivatives 
 
3.1 Aim 
 
The aim for this part of the project was to design and synthesise a library of novel 
polysubstituted BINOLs which contained structural features that are known to improve 
biodegradability of a chemical (‘rules of thumb’). We anticipated poor biodegradability 
for BINOL due to the presence of quaternary carbons, fused rings and poor water 
solubility. Initially, the biodegradability of (+/−)-BINOL (45) and (+/−)-3,3’-diphenyl-
2,2’-dihydroxy-1,1’-binaphthyl (122) were determined using the CO2 headspace test (ISO 
14593). Subsequent to those findings the synthesis of polysubstituted BINOLs was 
initiated. 
 
3.2 Introduction 
 
For our design of polysubstituted BINOLs, the placement of bulky substituents at the 
3,3’-position of the BINOL scaffold was necessary, as bulky groups have been found as a 
requirement for effective asymmetric induction.1 As a result, a phenyl group was placed 
at the 3,3’-position of the BINOL scaffold which should have a lesser effect on 
biodegradability compared to more bulkier groups e.g. anthracene, naphthalene, 
triphenylsilyl and phenanthrene. The 6,6’-position was selected for the attachment of 
molecular features with a positive effect for biodegradability. Substituents to be placed at 
the 6,6’-position were n-butyl, hydroxyl, methoxy, ethoxy, carboxylic acid and an 
alkylcarbonyl group (Figure 3.1). Our hypothesis is these functionalities will provide a 
site for microbial attack, allow for ring cleavage which could result in the biodegradation 
of the compound. 
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Fig. 3.1 Target compounds 
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3.3 Synthesis of achiral polysubstituted BINOL derivatives 
 
 
In order to make these polysubstituted BINOLs (Figure 3.1), a key intermediate (123) had 
to be prepared from BINOL (45) in 5 steps following a literature procedure (Scheme 
3.1).2 
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O O
 
        NaH (2.2 eq)
        MOM-Cl (2.2 eq)
   dry THF
   0oC - RT
O O
O O
Br
Br
1. n-BuLi (3 eq)
   dry Et2O
   RT, 3 h
2. BrCCl2CCl2Br (3 eq)
    dry THF
    0oC - RT, 4 h
O O
O O
Pd(PPh3)4  (10 mol%)
DME
Phenylboronic acid (3.5 eq)
2M Na2CO3 (5.2 eq)
Refluxed for 18 h
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50oC, 2 h
Br2 (3.88 eq), DCM
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Scheme 3.1: Synthesis of key intermediate (+/−)-6,6’-dibromo-3,3’-diphenyl-2,2’-
dihydroxy-1,1’-binaphthyl (123) 
 
First step in the synthesis of key intermediate (123) involved the protection of (+/−)-
BINOL (45) hydroxyl groups with chloromethyl methyl ether to yield (+/−)-2,2’-
bis(methoxymethoxy)-1,1’-binaphthyl (119) as a white solid in 80% yield after column 
chromatography. Next step was to introduce Br atoms at the 3,3’-position of compound 
(119). These bromine atoms were introduced by a directed ortho-lithiation reaction 
followed by bromination. Firstly, the dilithiated (+/−)-2,2’-bis(methoxymethoxy)-1,1’-
118 
binaphthyl intermediate was formed by the addition of an excess (3 equivalents) of 1.6 M 
n-butyllithium in hexanes to a solution of (119) in dry diethyl ether. The MOM-protecting 
group acts as a directing metalating group thereby facilitating the deprotonation of the 
ortho C-H bond by co-ordinating n-butyllithium.3 This functionality also facilitates in the 
break up of lithium aggregates thus eliminating the need for TMEDA in this reaction. 
After the dilithiated intermediate was allowed to form, it was quenched with the 
appropriate electrophile 1,2-dibromo-tetrachloroethane to yield (+/−)-3,3’-dibromo-2,2’-
bis(methoxymethoxy-1,1’-binaphthyl (120).    
                                                                                      
At first, the dibrominated intermediate (120) was obtained in a range of yields (25-86%), 
dependant on the addition step of the electrophile. It was found that the method that the 
electrophile 1,2-dibromo-tetrachloroethane was added had an impact on the yield being 
obtained for the dibrominated product (120). Initially, 1,2-dibromo-tetrachloroethane was 
pre-dissolved in THF and was then added slowly to the dilithiated intermediate. A 
mixture of mono- and dibrominated products were obtained when the brominating 
reagent was added this way, the monobrominated product (124) was obtained in 48% 
yield and dibrominated product (120) was obtained in a lower yield of 25% (Figure 3.2).  
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Fig. 3.2 Mono and dibrominated products (124 and 120) 
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Further compounding this result was the fact that both products (120 and 124) eluted as 
very close spots on the TLC (Rf = 0.39 for 120, Rf = 0.34 for 124 in Hex/EA 10/1) which 
gave poor separation by column chromatography. In addition a mix fraction of the two 
compounds (27% yield) was also obtained after column chromatography. By changing 
the method of addition for the electrophile as reported by Chong and coworkers,4 it was 
found that no monobrominated product (124) resulted when THF was added directly to 
the dilithiated intermediate and allowed to stir for 1 h followed by the addition of 1,2-
dibromo-tetrachloroethane, only the dibrominated product (120) was formed and 
obtained in 86% yield after column chromatography. 
 
Following the synthesis of (120), phenyl groups were attached to the 3,3’-position of the 
BINOL scaffold via Suzuki coupling. For this step, (120) was reacted with phenylboronic 
acid using 2M sodium carbonate and tetrakis(triphenylphosphine)palladium(0) as catalyst 
to yield (+/−)-3,3’-diphenyl-2,2’-bis(methoxymethoxy)-1,1’-binaphthyl (121) in 72% 
yield. The MOM protecting group was removed by acidic hydrolysis using concentrated 
HCl to yield (+/−)-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (122) in 68% yield.  
 
The final step towards the key intermediate (123) involved the bromination of (122) with 
molecular bromine to yield (+/−)-6,6’-dibromo-3,3’-diphenyl-2,2’-dihydroxy-1,1’-
binaphthyl (123).  However, it was not possible to obtain (123) pure when 2.09 
equivalents of bromine was used for this reaction as reported in the literature.2 Additional 
signals relating to an impurity were apparent in the proton NMR spectrum (Figure 3.3) 
that did not correlate with the reported proton data for compound (123). 
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Fig. 3.3 Proton spectrum of key intermediate (123) after 2.09 equivalents of bromine 
 
Unfortunately, the impurity was overlapping with the product (123) on TLC and it was 
not possible to achieve separation with different mobile phases (Hex/EA, Hex/DCM, 
Tol). The addition of extra equivalents of bromine did help to improve the bromination 
reaction, for instance, 3.08 and 3.88 equivalents of bromine were all tried for this step. 
Best results were obtained with 3.88 equivalents of bromine, however, some impurity still 
remained and following recrystallisation it was possible to obtain (123) in 97 % purity 
(by 1H NMR) in 69% yield. As can be seen from the proton spectra, the impurity was 
more prevalent for 3.08 equivalents (Figure 3.4) than for 3.88 equivalents (Figure 3.5). 
As the addition of extra equivalents of bromine reduced the impurity, this suggests that 
underbromination of 122 occurred when 2.09 equivalents of bromine was used. The 
postulated structure of the impurity is the monobrominated product. 
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Fig. 3.4 Proton spectrum of key intermediate (123) after 3.08 equivalents of bromine 
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Fig. 3.5 Proton spectrum of key intermediate (123) after 3.88 equivalents of bromine 
DCM 
123 
122 
Bromination of (121) was also attempted, but due to the generation of HBr during the 
reaction, the deprotection of the MOM groups occurred. 
 
Following the preparation of key intermediate (123) the synthesis of target compounds 
(Figure 3.1) was started. Initially, (+/−)-6,6’-dimethoxy-3,3’-diphenyl-2,2’-dihydroxy-
1,1’-binaphthyl (111) and (+/−)-6,6’-diethoxy-3,3’-diphenyl-2,2’-dihydroxy-1,1’-
binaphthyl (112) were synthesised from (123) by a copper coupling reaction (Ullmann-
type condensation).5,6 By refluxing the key intermediate (123) in DMF with 4.4 M 
sodium methoxide in methanol and copper(І) iodide as catalyst, it was possible to obtain 
compound (111) in 65% yield after work-up and column chromatography. Substituting 
the sodium methoxide base for this reaction with 2.2 M sodium ethoxide allowed for the 
synthesis of (112) in 55% yield after work-up and column chromatography. 
 
For the synthesis of (+/−)-6,6’-dihydroxy-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl 
(113), a demethylation of (111) using 1 M boron tribromide in DCM was necessary to 
produce free hydroxyl groups in position 6.6  A yield of 49% was obtained for this 
reaction, however, degradation of the compound was apparent during column 
chromatography as a purple band was observed on silica and tailing fractions showed 
signs of an impurity in 1H NMR spectrum. Future studies should optimise the isolation 
method. 
 
The route selected for introducing a carboxylic acid group at the 6,6’-position, was to 
perform a halogen metal exchange of the bromine substituents and quench the resulting 
dilithiated intermediate with dry ice (Solid CO2). Before performing this reaction it was 
necessary to protect the hydroxyl groups of diol (123) with MOM-Cl to generate (+/−)-
6,6-dibromo-3,3’-diphenyl-2,2’-bis(methoxymethoxy)-1,1’-binaphthyl (125) in 68% 
yield after column chromatography. With the MOM-protected intermediate (125) a 
halogen metal exchange of bromine substituents was performed using 1.6 M n-
butyllithium in hexanes as base and the resultant dilithiated intermediate was reacted with 
dry ice to furnish (+/−)-6,6’-dicarboxyl-3,3’-diphenyl-2,2’-bis(methoxymethoxy)-1,1’-
binaphthyl (126) in 44% yield after column chromatography. Next step involved the 
123 
removal of MOM protecting groups by acidic hydrolysis to yield (+/−)-6,6’-dicarboxyl-
3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (115) in 77% yield as final product. 
 
For the introduction of n-butyl substituents, a Kumada metal coupling reaction7 was 
performed using the MOM-protected (125). This coupling procedure involved reacting 
MOM-protected (125) with a nickel catalyst (1,3-dppp)NiCl2 and a Grignard reagent (2 
M n-butylmagnesiumchloride in THF) to yield (+/−)-6,6’-dibutyl-3,3’-diphenyl-2,2’-
bis(methoxymethoxy)-1,1’-binaphthyl (127) in 35 % yield after column chromatography. 
The monosubstituted compound (128) and intermediate (121) were also obtained as side 
products for this reaction (Figure 3.6). 
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Fig. 3.6 Side products obtained from Kumada coupling reaction 
 
Purification of 127 (Rf = 0.79, Hex/EA 5/1) was tedious due to the monosubstituted 
product (128) (Rf = 0.71, Hex/EA 5/1) eluting very close on the TLC. Monosubstituted 
product (128) was obtained in 27% yield and compound (121) was isolated in 18% yield. 
In addition a mix fraction of 11% yield was obtained containing both 127 and 128. 
Subsequent removal of the MOM groups for 127 by acidic hydrolysis yielded (+/−)-
6,6’dibutyl-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (114) in 74% yield after 
column chromatography.  
 
An attempt to make 127 via a halogen-metal exchange of bromine substitutents on 125 to 
generate a dilithiated intermediate and the subsequent quenching with bromobutane8 
124 
proved unsuccessful for the synthesis of 127 as only 121 was obtained after work-up and 
column chromatography. 
 
The acyl functional group was to be introduced at the 6,6’-position via hydration of an 
alkyne substituent. Using the Sonogashira coupling reaction,9 the introduction of an 
alkyne substituent at the 6,6’- position was possible. The Sonogashira methodology 
reported by Beller and coworkers was adopted for this reaction.10 For this metal coupling 
reaction the MOM protection of the hydroxyl groups for key intermediate (123) was not 
necessary. 
Initially, to ensure that the conditions used by Beller for the Sonogashira reaction worked 
for the polysubstituted BINOL key intermediate (123), the preparation of (+/−)-6,6’-
bis(2-(trimethylsilyl)ethynyl)-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (116) was 
investigated. Synthesis of (+/−)-6,6’-bis(2-(trimethylsilyl)ethynyl)-3,3’-diphenyl-2,2’-
dihydroxy-1,1’-binaphthyl (116) involved reacting (123) in TMEDA with 
ethynyltrimethylsilane using sodium tetrachloropalladate(ІІ), 2-(di-tert-butylphosphino)-
1-phenylindole (PIntB) and copper(І) iodide as catalytic reagents. Product (116) was 
obtained in 60% yield after column chromatography. Similarly, (+/−)-6,6’-dipentynyl-
3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (117) was prepared by reacting (123) in 
TMEDA with 1-pentyne using sodium tetrachloropalladate(ІІ), PIntB and copper(І) 
iodide as catalytic reagents to give a 50% yield after work-up and column 
chromatography. 
 
Alami and coworkers have reported the use of PTSA for the hydration of internal 
arylalkynes.11 Since PTSA is a greener alternative compared to the mercury based 
catalysts, it was applied for the hydration of (+/−)-6,6’-dipentynyl-3,3’-diphenyl-2,2’-
dihydroxy-1,1’-binaphthyl (117). For this step (117) was hydrated using 1 equivalent of 
PTSA monohydrate in refluxing ethanol and the desired product (+/−)-6,6’-dipentan-1-
one-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (118) was obtained in 59% yield after 
column chromatography. 
Overall the synthesis of racemic key intermediate (123) was accomplished in 5 steps with 
an overall yield of 23%. The synthetic steps of intermediate 120 and key intermediate 123 
125 
were optimised as problems arose in the reported method. Novel polysubstituted BINOLs 
(Figure 3.1) were successfully synthesised. 
 
As well, optically pure BINOL derivatives were required for asymmetric catalysis 
studies. The synthesis of chiral key intermediate (+)-(R)-(123b) was needed before chiral 
polysubstituted BINOLs could be made.  
 
3.4 Synthesis of chiral polysubstituted BINOL derivatives 
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Scheme 3.2: Synthesis of key chiral intermediate (+)-(R)-6,6’-dibromo-3,3’-diphenyl-
2,2’-dihydroxy-1,1’-binaphthyl (123b) 
  
First step in the synthesis of key chiral intermediate (+)-(R)-(123b) involved the 
protection of (+)-(R)-BINOL (45b)  hydroxyl groups with chloromethyl methyl ether to 
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yield (+)-(R)-(119b) as a white solid in 85% yield after column chromatography. Next 
step was to introduce Br atoms at the 3,3’-position of compound (+)-(R)-(119b). These 
bromine atoms were introduced by a directed ortho-lithiation reaction followed by 
bromination. Firstly, the dilithiated (R)-2,2’-bis(methoxymethoxy)-1,1’-binaphthyl 
intermediate was formed by the addition of an excess (3 equivalents) 1.6 M n-
butyllithium in hexanes to a solution of (+)-(R)-(119b) in dry diethyl ether. After the 
dilithiated intermediate was allowed to form for 3 h, THF was added and after additional 
1 h of stirring, the reaction was quenched with the electrophile 1,2-dibromo-
tetrachloroethane to yield (+)-(R)-(120b) in 74% yield after work-up and column 
chromatography.  
Following the synthesis of (+)-(R)-(120b), phenyl groups were attached to the 3,3’-
position of the BINOL scaffold via Suzuki coupling. For this step, (+)-(R)-(120b) was 
reacted with phenylboronic acid using 2M sodium carbonate and 
tetrakis(triphenylphosphine)palladium(0) as catalyst to yield (−)-(R)-(121b) in 91% yield. 
The MOM protecting group was removed by acidic hydrolysis using concentrated HCl to 
yield (+)-(R)-(122b) in 92% yield. The final step towards the key intermediate (+)-(R)-
(123b) involved the bromination of (+)-(R)-(122b) with molecular bromine (3.88 
equivalents) to yield (+)-(R)-(123b) in 72% yield after recrystallisation. Next step was to 
synthesise the novel chiral polysubstituted BINOLs ((−)-(R)-125b, (+)-(R)-111b and (+)-
(R)-114b) (Figure 3.7).  
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Fig 3.7 Novel chiral polysubstituted BINOLs ((+)-(R)-111b, (+)-(R)-114b and (−)-(R)-
125b) 
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(+)-(R)-6,6’-Dimethoxy-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (111b) was 
synthesised from (+)-(R)-(123b) by a copper coupling reaction (Ullmann-type 
condensation).5,6 By refluxing the key intermediate (+)-(R)-(123b) in DMF with 4.4 M 
sodium methoxide in methanol and copper(І) iodide as catalyst, it was possible to obtain 
compound (+)-(R)-(111b) in 67% yield after work-up and column chromatography.  
 
Synthesis of intermediate (−)-(R)-(125b) involved MOM protection of the diol (+)-(R)-
(123b) with chloromethyl methyl ether to yield (−)-(R)-6,6’-dibromo-3,3’-diphenyl-2,2’-
bis(methoxymethoxy)-1,1’-binaphthyl (125b) in 56% yield after column chromatography. 
For the introduction of n-butyl substituents, a Kumada metal coupling reaction7 was 
performed using the MOM-protected (−)-(R)-(125b). This coupling procedure involved 
reacting MOM-protected (−)-(R)-(125b) with a nickel catalyst (1,3-dppp)NiCl2 and a 
Grignard reagent (2 M n-butylmagnesiumchloride in THF) to give crude (R)-6,6’-dibutyl-
3,3’-diphenyl-2,2’-bis(methoxymethoxy)-1,1’-binaphthyl which was not isolated and 
directly deprotected by acidic hydrolysis to yield (+)-(R)-6,6’-dibutyl-3,3’-diphenyl-2,2’-
dihydroxy-1,1’-binaphthyl (114b) in 42 % yield after column chromatography. The 
monosubstituted compound (129b) and intermediate (122b) were also obtained as side 
products for this reaction (Figure 3.8). 
 
 
OH
OH
OH
OH
122b 129b
 
 
 Fig. 3.8 Side products obtained from Kumada coupling reaction   
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Chiral key intermediate (+)-(R)-(123b) was synthesised in 5 steps with an overall yield of 
38%. Intermediates (+)-(R)-(119b), (+)-(R)-(120b), (−)-(R)-(121b), (+)-(R)-(122b) and 
(+)-(R)-(123b) were prepared in yields of 85%, 74%, 91%, 92% and 72%, respectively. 
The overall yield obtained for the chiral key intermediate (+)-(R)-(123b) (38%) is higher 
than the overall yield obtained for the racemic key intermediate 123 (23%).  
 
The literature synthesis for (+)-(R)-(123b) was accomplished in 5 steps with an overall 
yield of 94%.2 Reported yields for intermediates (+)-(R)-(119b), (+)-(R)-(120b), (+)-(R)-
(122b) and (+)-(R)-(123b) in the literature were 100% (without column chromatography), 
96%, 100% and 98%, respectively. Intermediate (−)-(R)-(121b) was not isolated in the 
literature procedure. The overall yield obtained in our laboratory for (+)-(R)-(123b) 
(38%) is lower than that obtained in the literature (94%). The reason for the overall yield 
being lower could be due to additional column chromatography performed on the first 
step to remove the residual dispersion oil and also the intermediate (−)-(R)-(121b) was 
isolated. The other group did not perform column chromatography on the first step 
therefore residual dispersion oil may have been taken into account for their reported 
yield, unless an extra step in the work-up was omitted in the method reported. Problems 
arose in the reported method for the synthesis of (+)-(R)-(123b) and also the required 
recrystallisation step resulted in a lower yield of 72% being obtained. These differences 
contributed to a lower overall yield being obtained for (+)-(R)-(123b). 
 
Final chiral compounds 111b and 114b were successfully synthesised in 67% and 42% 
yield, respectively, and applied as catalysts in the Morita-Baylis-Hillman reaction 
(Chapter 5).  
 
3.5 Optical rotations of chiral BINOL derivatives 
 
The optical rotation values were recorded for chiral BINOL derivatives at 20 °C in THF 
at a concentration of 1 gram per 100 mL (C=1). Optical rotation values obtained for chiral 
BINOL derivatives are presented in Table 3.1. Most compounds gave a positive sign for 
optical rotation. However, an inversion for optical rotation was noted for MOM-protected 
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BINOLs (−)-(R)-121b and (−)-(R)-125b which resulted in a negative sign for optical 
rotation values. Slight variations were noted for optical rotation values compared to those 
reported in the literature, probably due to the differences in conditions used for measuring 
the optical rotation values (temperature). 
 
 
Compound Optical rotation from literature Optical rotation from our 
study 
(+)-(R)-(45b) [α]21D = +34 ° (1.0 c, THF) [α]20D= +34.5 ° (1.0 c, THF) 
(+)-(R)-(119b) [α]25589 = +95.0 ° (1.0 c, THF)4 [α]20D = +84.2 ° (1.0 c, THF) 
(+)-(R)-(120b) [α]25589 = +28.3 ° (1.0 c, THF)4 [α]20D = +25.7 ° (1.0 c, THF) 
(−)-(R)-(121b) Not reported [α]20D = −67.7 ° (1.0 c, THF) 
(+)-(R)-(122b) [α]D= +69.1 ° (1.0 c, CHCl3)12 [α]20D= +64.3 ° (1.0 c, CHCl3) 
(+)-(R)-(123b) [α]25589 = +96.6 ° (1.0 c, THF)2 [α]20D = +85.1 ° (1.0 c, THF) 
(−)-(R)-(125b) Novel compound [α]20D = −2.0 ° (1.0 c, THF) 
(+)-(R)-(111b) Novel compound [α]20D = +68.1 ° (1.0 c, THF) 
(+)-(R)-(114b) Novel compound [α]20D = +53.2 ° (1.0 c, THF) 
 
Table 3.1: Optical rotation values for chiral BINOL derivatives 
 
 
Optical purity for chiral intermediate (+)-(R)-(122b) was further verified by chiral HPLC.  
An ee of 99.5 % was determined for (+)-(R)-(122b) via chiral HPLC analysis (Figure 
3.9). 
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Fig 3.9 HPLC chromatogram for chiral (+)-(R)-122b (Lux 2 column, 9:1 hexane:i-PrOH, 
1.0 mL/min, 240 nm) 
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3.6 Antimicrobial screening of BINOL and polysubstituted derivatives 
 
The antimicrobial activities of 45, 122, 111, 114, 115 and 118 were evaluated by our 
collaborator Dr Marcel Špulák of Charles University Czech Republic. Bacteria screened 
against were the four Gram positive organisms Staphylococcus aureus ATCC 6538, 
Staphylococcus aureus MRSA HK5996/08, Staphylococcus epidermidis HK6966/08, 
Enterococcus sp. HK14365/08 and four Gram negative organisms Escherichia coli ATCC 
8739, Klebsiella pneumoniae HK11750/08, Klebsiella pneumoniae-ESBL positive 
HK14368/08 and Pseudomonas aeruginosa ATCC 9027. MIC values for antibacterial 
study were defined as 95 % inhibition (IC95) of the growth of control. The results in Table 
3.2 represent the MIC values obtained for BINOL and polysubstituted BINOLs (Figure 
3.10). Antimicrobial screening of BINOL and derivatives is an essential preliminary 
screen before compounds can be evaluated for biodegradation. 
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Fig 3.10 BINOL (45) and substituted derivatives (111, 114, 115, 118 and 122) screened 
for antimicrobial activity 
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BINOL and derivatives 
Organism Time 
(h) 
45 122 111 114 115 118 
        
S.aureus 24 h 31.25 >2000 >125 >125 >250 >125 
        
 48 h 125 >2000 >125 >125 >250 >125 
        
MRSA 24 h 31.25 >2000 >125 >125 >250 >125 
        
 48 h 125 >2000 >125 >125 >250 >125 
        
S.epidermidis 24 h 31.25 500 >125 >125 >250 >125 
        
 48 h 62.5 500 >125 >125 >250 >125 
        
Enterococcus sp. 24 h 62.5 250 >125 >125 >250 >125 
        
 48 h 125 250 >125 >125 >250 >125 
        
E.coli 24 h >500 >2000 >125 >125 >250 >125 
        
 48 h >500 >2000 >125 >125 >250 >125 
        
K.pneumoniae 24 h >500 >2000 >125 >125 >250 >125 
        
 48 h >500 >2000 >125 >125 >250 >125 
        
K.pneumoniae  
ESBL positive 
24 h >500 >2000 >125 >125 >250 >125 
 48 h >500 >2000 >125 >125 >250 >125 
        
P.aeruginosa 24 h >500 >2000 >125 >125 >250 >125 
        
 48 h >500 >2000 >125 >125 >250 >125 
        
 
Results obtained by collaborator 
 
Table 3.2: MIC/IC95 (µM) values of BINOL (45) and substituted derivatives (111, 114, 
115, 118 and 122) 
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(+/−)-1,1’-Bi-2-naphthol (45) was screened at 500 µM, (+/−)-3,3’-diphenyl-2,2’-
dihydroxy-1,1’-binaphthyl (122) was screened at the highest concentration of 2000 µM, 
while compounds 111, 114 and 118 were screened at a lower concentration of 125 µM 
due to the low solubility for these molecules in test medium (Mueller Hinton broth). 
Derivative 115 was screened at 250 µM as it was slightly more soluble in the test 
medium. MIC (minimum inhibitory concentration)/IC95 results for BINOL (45) and 
derivatives (111, 114, 115, 118 and 122) are displayed in Table 3.2.  
 
BINOL (45) proved inhibitory for all Gram positive bacteria while Gram negative 
bacteria showed low inhibition (>500 µM). Enterococcus sp. was noted with an MIC 
value of 62.5 µM after 24 h and a value of 125 µM was observed after 48 h for 45. 
Staphylococcus aureus and MRSA exhibited an MIC value of 31.25 µM after 24 h and a 
value of 125 µM after 48 h for BINOL (45). An MIC value of 31.25 µM was noted for 45 
towards Staphylococcus epidermidis after 24 h while at 48 h the MIC value was 62.5 µM. 
A trend is noted for the MIC values of 45 whereby a lower MIC is recorded after 24 h 
than at 48 h. This is due to the fact that viable cells are still present at 24 h and the 
remaining viable bacterial cells grow substantial over the addtional 24 h period to 
increase the IC95 value observed after 48 h. Among the inhibited bacteria, Escherichia 
coli and Enterococcus sp. showed the greatest recovery.  
 
(+/−)-3,3’-Diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (122) proved inhibitory for 2 
bacteria, Staphylococcus epidermidis (MIC value of 500 µM after 24 h and 48 h) and 
Enterococcus sp. (MIC value of 250 µM after 24 h and 48 h). Remaining bacteria proved 
non-inhibitory for 122 (>2000 µM).  
 
 
MIC values were not observed for polysubstituted BINOLs 111, 114, 118 (>125 µM) and 
115 (>250 µM). Polysubstituted BINOLs (111, 114, 115 and 118) were observed with low 
antimicrobial activity compared to 45 and 122. Unsubstituted BINOL (45) proved the 
most toxic for bacteria. A trend noted for this case of antibacterial screening is that MIC 
values are lower at 24 h than at 48 h. Novel polysubstituted BINOLs (111, 114, 115 and 
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118) and BINOL derivative (99) are less toxic towards test bacteria when compared to 
brominated BINOLs (50b and 50a) and BINOL (45b and 45a) (Figure 3.11). 
 
 
 
 
OH
OH
Br
Br
OH
OH
Br
Br
OH
OH
OH
OH
OH
OH
i Pr
i Pr i Pr
i Pr
i Pr
i Pr
OH
OH
O
O
OH
OH
OH
OH
HO
O
HO
O
OH
OH
O
O
OH
OH
50b 50a 45b 45a
122 11199
114 115 118
> >
> >
 
Fig 3.11 Overall trend for antibacterial activity of BINOL, BINOL derivatives and novel 
polysubstituted BINOLs (50b >50a >45b, 45a >122 >99, 111, 114, 115 and 118) 
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For the antifungal studies, compounds were screened against the following yeast strains 
(Candida albicans ATCC 44859, Candida albicans ATCC 90028, Candida parapsilosis 
ATCC 22019, Candida krusei ATCC 6258, Candida krusei E28, Candida tropicalis 156, 
Candida glabrata 20/I, Candida lusitaniae 2446/I, Trichosporan asahii 1188) and 
filamentous fungi (Aspergillus fumigatus 231, Absidia corymbifera 272, Trichophyton 
mentagrophytes 445). MIC values for antifungal study were defined as 80% inhibition 
(IC80) of the growth of control for yeast and 50% inhibition (IC50) of the growth of 
control for filamentous fungi. The MIC values for most fungi were recorded after 24 h 
and 48 h except for the dermatophytic strain (T. mentagrophytes 445) which was 
determined after 72 h and 120 h.  
 
BINOL (45) was screened at 500 µM, while BINOL derivatives 111, 114, 115, 118 and 
122 were screened at 125 µM due to low solubility in the test medium. 
BINOL derivatives 111, 114, 115, 118 and 122 all proved non-inhibitory for the fungal 
strains tested (Table 3.3). BINOL (45) inhibited Trichosporon asahii at 62.5 µM after 24 
h and an MIC value of 500 µM was noted after 48 h. Trichophyton mentagrophytes gave 
an MIC value of 31.25 µM after 72 h and at 120 h for BINOL (45). An MIC value of 250 
µM was noted for BINOL (45) towards Candida albicans ATCC 44859 after 24 h while 
at 48 h no inhibition was observed (>500 µM). 
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BINOL and derivatives 
Organism Time(h) 45 122 111 114 115 118 
C.albicans 
(ATCC44859) 
24 h 250 >125 >125 >125 >125 >125 
 48 h >500 >125 >125 >125 >125 >125 
        C.albicans 
(ATCC90028) 
24 h >500 >125 >125 >125 >125 >125 
 48 h >500 >125 >125 >125 >125 >125 
        C.parapsilosis 
(ATCC22019) 
24 h >500 >125 >125 >125 >125 >125 
 48 h >500 >125 >125 >125 >125 >125 
        C.krusei 
(ATCC6258) 
24 h >500 >125 >125 >125 >125 >125 
 48 h >500 >125 >125 >125 >125 >125 
        C.krusei (E28) 24 h >500 >125 >125 >125 >125 >125 
        
 48 h >500 >125 >125 >125 >125 >125 
        C.tropicalis 
(156) 
24 h >500 >125 >125 >125 >125 >125 
 48 h >500 >125 >125 >125 >125 >125 
        C.glabrata (20/I) 24 h >500 >125 >125 >125 >125 >125 
 48 h >500 >125 >125 >125 >125 >125 
        C.lusitaniae 
(2446/I) 
24 h >500 >125 >125 >125 >125 >125 
 48 h >500 >125 >125 >125 >125 >125 
        T. asahii (1188) 24 h 62.5 >125 >125 >125 >125 >125 
        
 48 h 500 >125 >125 >125 >125 >125 
        A.fumigatus 
(231) 
24 h >500 >125 >125 >125 >125 >125 
 48 h >500 >125 >125 >125 >125 >125 
        A.corymbifera 
(272) 
24 h >500 >125 >125 >125 >125 >125 
 48 h >500 >125 >125 >125 >125 >125 
        T.mentagrophytes 
(445) 
72 h 31.25 >125 >125 >125 >125 >125 
 120 h 31.25 >125 >125 >125 >125 >125 
Table 3.3: Antifungal IC80/IC50 (µM) values of BINOL (45) and derivatives (111, 114, 
115, 118 and 122) 
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Fig 3.12 Overall trend for antifungal activity of BINOL, BINOL derivatives and novel 
polysubstituted BINOLs (50a, 50b >45a, 45b >122, 99, 111, 114, 115 and 118) 
 
 
Novel polysubstituted BINOLs (111, 114, 115 and 118) and BINOL derivatives (99 and 
122) showed low inhibition towards fungal organisms (> 125 µM) and were less toxic 
when compared to BINOLs (45a, 45b, 50a and 50b) (Figure 3.12). Chiral BINOL (45a 
and 45b) was observed with a number of cases of antifungal activity. Brominated 
BINOLs (50a and 50b) proved inhibitory for all test fungi. 
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3.7 Biodegradation study of BINOL and polysubstituted derivatives 
 
BINOL (45) and derivatives (111, 113, 114, 115, 118 and 122) were evaluated for 
biodegradation using the CO2 headspace test (ISO 14593). This study was performed by 
our collaborator Dr Teresa Garcia at the department of surfactant technology in 
Barcelona, Spain. General procedure for this assay was discussed in section 1.3.4. Results 
from this study are presented in Table 3.4 and the biodegradation curve is displayed in 
Figure 3.13. 
 
 
 
 
% Biodegradation 
 
Compound 
6 d 14 d 21 d 28 d 
SDS 
 
45 
 
111 
 
113 
 
114 
 
115 
 
118 
 
122 
75 
 
0 
 
0 
 
1 
 
0 
 
0 
 
0 
 
1 
87 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
93 
 
2 
 
1 
 
2 
 
0 
 
0 
 
0 
 
1 
93 
 
0 
 
3 
 
4 
 
1 
 
3 
 
1 
 
1 
Table 3.4: Biodegradation results for BINOL (45) and derivatives (111, 113, 114, 115, 
118 and 122) 
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Figure 3.13 Biodegradation curves for BINOL (45), 111, 113, 114, 115, 118 and 122 
 
The readily biodegradable reference substance SDS was evaluated as the control 
experiment and exhibited 75% biodegradation after 6 days. Days 14, 21 and 28 gave 
biodegradation values of 87%, 93% and 93%, respectively. These data points verify that 
the inoculum is active and capable of mineralising biodegradable organic chemicals. 
BINOL (45) and derivatives (111, 113, 114, 115, 118 and 122) were non-biodegradable 
as less than 5% CO2 output was measured for these molecules (Table 3.4). In order for a 
chemical to be deemed readily biodegradable it must evolve >60% CO2 over a period of 
28 days. Therefore, BINOL (45) and derivatives (111, 113, 114, 115, 118 and 122) failed 
the CO2 headspace test and can be classified as being non-biodegradable as negligible 
CO2 output occurred (Figure 3.13).  These results suggest that biodegradation of BINOL 
is a considerable task, as well the modified BINOL derivatives failed to enhance 
biodegradation.  
As no biodegradation was apparent for BINOL (45) and derivatives (111, 113, 114, 115, 
118 and 122), a control experiment was run to determine if compounds were having an 
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inhibitory effect on the activity of the inoculum. For this experiment reference substance 
(SDS) and test substance (BINOL and derivatives individually) were added together to 
the inoculum and if inhibition of SDS biodegradation occurred, this implied that the test 
substance is inhibiting the inoculum. Results from this experiment are presented in Table 
3.5. BINOL (45) gave the largest % inhibition (9%) for the inhibitory control 
biodegradation assay. This is not surprising as BINOL proved to be inhibitory for the 
preliminary antimicrobial screening. The concentration of 83.26 µM used for BINOL 
(45) in the inhibitory control biodegradation assay lies within the inhibitory concentration 
range observed in the antibacterial screen. Remaining derivatives (111, 113, 114, 115, 
118 and 122) were observed with low inhibition to the inoculum (Table 3.5).  
 
Compound Concentration 
(mgC/L) 
Molar 
concentration of 
test sample 
Inhibition (%) 
    
45 + SDS 20 + 20 83.26 µM 9 
    
111 + SDS 20 + 20 48.98 µM 1 
    
113 + SDS 20 + 20 52.0 µM 0 
    
114 + SDS 20 + 20 41.63 µM 1 
    
115 + SDS 20 + 20 48.98 µM 1 
    
118 + SDS 20 + 20 39.65 µM 0 
    
122 + SDS 20 + 20 52.04 µM 1 
    
Table 3.5: Inhibition of SDS biodegradation by 45, 111, 113, 114, 115, 118 and 122 
 
These % inhibition values for BINOL (45) and derivatives (111, 113, 114, 115, 118 and 
122) are lower than the limit (>25% inhibition) generally accepted to consider an 
inhibitory effect on the activity of the inoculum. Therefore, BINOL (45) and derivatives 
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(111, 113, 114, 115, 118 and 122) can be classified as being non-biodegradable chemicals 
within the parameters of the CO2 headspace test (ISO 14593). 
 
 
3.8 Conclusions 
 
 
The synthesis and characterisation of a series of novel polysubstituted BINOLs has been 
carried out. Eleven novel achiral polysubstituted BINOLs and three novel chiral 
polysubstituted BINOLs were synthesised from the key intermediates (+/−)-(123) and 
(+)-(R)-(123b) respectively. The five step synthesis towards both key intermediates has 
been discussed. Target compounds (Figure 3.1) were synthesised in low to moderate 
yields. Final compounds obtained were verified by 1H and 13C NMR. Antimicrobial 
studies were performed with 45, 111, 114, 115, 118 and 122. BINOL derivatives (111, 
114, 115, 118 and 122) were non-inhibitory (within concentration range) towards the 
fungal strains tested. BINOL (45) was observed with three cases of antifungal activity. 
Some cases of anti-bacterial activity were noted for BINOL (45) and 122. BINOL (45) 
proved to be the most toxic with inhibition being observed for all Gram positive bacteria. 
(+/−)-3,3’-Diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (122) showed inhibition for two 
bacteria, Staphylococcus epidermidis (MIC value of 500 µM after 24 h and 48 h) and 
Enterococcus sp. (MIC value of 250 µM after 24 h and 48 h). The remaining 
polysubstituted BINOLs (111, 114, 115 and 118) exhibited low anti-bacterial activity with 
no MIC values being observed within tested concentration range. Known BINOL 
derivative (99) and novel polysubstituted BINOL derivatives (111, 114, 115 and 118) 
were found to be less toxic towards test bacteria when compared to BINOL (45, 45a and 
45b). The CO2 headspace test (ISO 14593) was applied for evaluating the biodegradation 
of BINOL and derivatives. Both BINOL (45) and derivatives (111, 114, 115, 118 and 122) 
were found to be non-biodegradable within the parameters of the CO2 headspace test 
(ISO 14593). 
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Chapter 4: Results and Discussion 
 
4 Biquinoline derivatives 
4.1 Aim 
 
The objective for this part of the project was to synthesise biquinoline compounds with 
substituents that are known to promote biodegradation in accordance with the ‘rules of 
thumb’ (section 1.3.3). Stemming from work already completed by the Scammells 
research group on biodegradable pyridinium ionic liquids (see section 1.3.5), we decided 
to adopt those features that were applied for the design and development of biodegradable 
pyridinium ionic liquids. Such features included the N-alkylation of pyridine with ethyl 
bromoacetate and the introduction of an ester group on the heteroaromatic ring (Figure 
4.1). For instance, compounds 60 and 64 proved to be readily biodegradable giving >60% 
biodegradation after 28 days in the CO2 Headspace test (ISO 14593).1 
 
N
O
O
Br N
O
O
I
60 64
71% biodegradation after 7 days,
87% biodegradation after 28 days
>60% biodegradation after 7 days,
  72% biodegradation after 28 days
 
 
Fig 4.1 Readily biodegradable pyridinium ionic liquids  
 
These modifications incorporate ester groups that are susceptible to enzymatic hydrolysis 
and also provide a site for cleavage of the heterocycle thus allowing for the microbial 
degradation of 60 and 64. 
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4.2 Introduction 
 
Using (+/−)-6,6’-dihydroxy-5,5’-biquinoline (BIQOL) (130) as a scaffold, it was decided 
to alkylate the nitrogen position with methyl, n-butyl and ethoxycarbonylmethyl 
substituents generating N-alkylated salts that should be water soluble. Also the 
introduction of an ester group at the C3 position was investigated. 
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Fig 4.2 (+/−)-6,6’-dihydroxy-5,5’-biquinoline (BIQOL) (130) with numbering 
 
BIQOL has been resolved and applied as an asymmetric catalyst for the enantioselective 
addition of diethylzinc to a variety of aldehydes in the literature.2 The resolution of this 
compound was achieved by converting the phenolic hydroxyl groups to triflates, then 
separation of the racemic triflated BIQOL (132) via HPLC on a chiral preparative OD 
column and subsequent hydrolysis of enantiopure triflated BIQOL to yield both (R)-
BIQOL and (S)-BIQOL enantiomers in 91% yield (Scheme 4.1). As a ligand (R)-BIQOL 
was added to titanium tetraisopropoxide to generate a titanium-BIQOL catalyst, which 
promoted enantioselective addition of diethylzinc to a range of aldehydes. Excellent 
conversions and high enantioselectives were obtained with aromatic aldehydes while for 
the aliphatic aldehyde, heptanal, a lower conversion of 61.7% with an ee of 83% was 
reported (Scheme 4.2).    
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Scheme 4.1: Synthesis and resolution of BIQOL 2 
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Scheme 4.2: Enantioselective addition of diethylzinc to aldehydes 2 
 
 
4.3 Synthesis of biquinoline derivatives 
 
Firstly, it was possible to synthesise (+/−)-6,6’-dihydroxy-5,5’-biquinoline (130) via a 
copper mediated oxidative coupling of 6-hydroxyquinoline (131) in 65% yield. 
(+/−)-6,6’-Dihydroxy-5,5’-biquinoline (130) can be modified by alkylation of the 
nitrogen position. N-alkylated biquinoline derivatives that were synthesised can be seen 
in Figure 4.3.  
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Fig 4.3 N-alkylated biquinoline derivatives synthesised (134, 135 and 136) 
 
 
Initially, the N-alkylation of BIQOL (130) with methyl iodide was tried using DMF as 
solvent. The reaction was attempted at room temperature, however, due to incompletion 
of reaction as confirmed by TLC, it was heated to 90°C and after 24 h the reaction was 
complete. Desired product (136) was obtained and verified by proton and carbon NMR, 
however, it was found to contain a significant impurity. In the proton spectrum a signal at 
3.12 ppm with an integration of 24 protons was noticeable (Figure 4.4) and in the carbon 
spectrum a strong signal at 54.38 ppm was present (Figure 4.5), these additional signals 
did not correlate with the structure. 
This signal could be attributed to dimethylamine and the source of this impurity is due to 
the decomposition of DMF during the reaction. DMF decomposes slightly at its boiling 
point to give dimethylamine and carbon monoxide, in addition decomposition can occur 
at room temperature in the presence of some acidic or basic materials.3 
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Fig. 4.4 1H NMR spectrum of impure (+/−)-1,1’-dimethyl-6,6’-dihydroxy-5,5’-
biquinoline (136) 
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Fig. 4.5 13C NMR spectrum of impure (+/−)-1,1’-dimethyl-6,6’-dihydroxy-5,5’-
biquinoline (136) 
150 
On TLC it was not possible to move the product (136) from the baseline using methanol 
as mobile phase, therefore column chromatography was not attempted. Removal of 
dimethylamine by doing an aqueous wash was not possible as the compound (136) was 
water soluble. Drying under high vacuum for a period of 3 days at room temperature also 
failed to remove the impurity. Next we decided to switch solvent for the alkylation step. 
The choice of solvent was NMP, which dissolves (+/−)-6,6’-dihydroxy-5,5’-biquinoline 
(130) and can facilitate alkylation reactions. N-alkylation of (+/−)-6,6’-dihydroxy-5,5’-
biquinoline (130) with methyl iodide in NMP was tried at room temperature but the 
reaction did not go to completion. However, the reaction went to completion when heated 
at 90 °C for 2 h to give a yield of 79% for (+/−)-1,1’-dimethyl-6,6’-dihydroxy-5,5’-
biquinoline (136)  after work-up.   
 
Alkylation of (+/−)-6,6’-dihydroxy-5,5’-biquinoline (130) with ethyl bromoacetate was 
achieved at room temperature after 72 h with a yield of 86% for (+/−)-1,1’-
diethoxycarbonylmethyl-6,6’-dihydroxy-5,5’-biquinoline (135) after work up. The reason 
for this reaction occurring without heating is due to ethyl bromoacetate being a more 
reactive electrophile. As well, alkylation of (+/−)-6,6’-dihydroxy-5,5’-biquinoline (130) 
with ethyl bromoacetate was tried under neat conditions, as ethyl bromoacetate could 
dissolve the starting material and play the role as a solvent. But the reaction did not go to 
completion even upon heating at 110 °C for 4 days.  Purification of N-alkylated salts 135 
and 136 involved precipitating out the product with diethyl ether, the resulting suspension 
was filtered and washed with diethyl ether to give the desired compounds.  
 
Alkylation of BIQOL (130) with bromobutane was tried in NMP at room temperature but 
no conversion was noted on TLC. When heated at 110 °C for 48 h, conversion was 
observed but an additional faint spot was also present on the TLC that did not correlate 
with starting material or the product, the addition of extra equivalents (36 in total) of 
bromobutane did not help to drive the reaction to completion. Previously, it was possible 
to obtain the dibutylated product (+/−)-1,1’-dibutyl-6,6’-dihydroxy-5,5’-biquinoline 
(134) when the reaction was carried out in DMF at 110 °C for 48 h using 14 equivalents 
of bromobutane with 30 mol% of potassium iodide and after filtration compound 134 was 
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obtained with a yield of 26%. A low yield was obtained due to the presence of residual 
DMF in the crude product prior to filtration which resulted in a loss of product to the 
filtrate. The residual impurity from DMF decomposition was also observable in the 1H 
and 13C NMR spectra for compound 134. However, for (+/−)-1,1’-dibutyl-6,6’-
dihydroxy-5,5’-biquinoline (134)  it was possible to remove the residual impurity by 
heating the compound at 150 °C under high vacuum for 36 h. 
All salts (134, 135 and 136) were soluble in polar media such as water, DMSO and 
methanol.  
 
 
 
Also the biquinoline derivatives with an ester group at the 3-position (137a and 137b) 
were proposed as targets (Figure 4.6). 
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Fig. 4.6 Proposed targets 137a and 137b 
 
 In order to make this class of compound, a 6-hydroxyquinoline derivative (140) with an 
ester group at the 3-position was required. Recently reported in the literature was that the 
introduction of an ethyl ester at the 3 position is possible by making the substituted 
quinoline via a modified Friedländer synthesis.4 Venkatesan and coworkers reported the 
one step procedure for the synthesis of 2,4-unsubstituted quinoline-3-carboxylic acid 
ethyl esters.  They performed a reductive cyclization by treating various substituted 
ortho-nitro-benzaldehydes with 3,3-diethoxypropionic acid ethyl ester (139) and tin(ІІ) 
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chloride dihydrate in refluxing ethanol. 6-Hydroxy-quinoline-3-carboxylic acid ethyl 
ester (140) was one of the reported products with a 46% yield (Scheme 4.3). 
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Scheme 4.3: Modified Friedländer synthesis of 140 4  
 
This product (140) contains an ester group at the 3-position which should enhance 
biodegradation and the hydroxyl group at the 6-position (β-position) is required for the 
oxidative coupling reaction. As a result, 6-hydroxy-quinoline-3-carboxylic acid ethyl 
ester (140) was synthesised in 44% yield. Attempts were made to dimerise this compound 
following the previous methodology employed for the synthesis of (+/−)-6,6’-dihydroxy-
5,5’-biquinoline.2 However, due to the use of methanol as solvent, a transesterified 
compound was proposed to be obtained as additional signals were present in the proton 
and carbon NMR spectra. Next the reaction was performed in ethanol, however, the 
desired product (137b) was never obtained. No conversion was noted on TLC, only the 
remaining starting material. From the literature, methanol is the only solvent that has 
been used for oxidative coupling reactions involving copper(ІІ) chloride dihydrate and 
benzylamine as reagents.5,6 Therefore, for methanol to be employed as solvent for the 
dimerisation reaction, synthesis of the quinoline derivative with the methyl ester (142) 
was embarked upon. 6-Hydroxy-quinoline-3-carboxylic acid methyl ester (142) was 
made in 46% yield by reacting 5-hydroxy-2-nitro-benzaldehyde (138) with 3,3-
dimethoxypropionic acid methyl ester (141) and tin(ІІ) chloride dihydrate in refluxing 
methanol. 
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Scheme 4.4: Modified Friedländer synthesis of 142 
 
 
6-Hydroxy-quinoline-3-carboxylic acid methyl ester (142) was tested for the dimerisation 
reaction employing copper(ІІ) dihydrate and benzylamine as catalyst in refluxing 
methanol and after work-up, the target molecule 137a was obtained in 21% yield as 
verified by proton and carbon NMR. However, due to the broadness of some proton 
signals, one possibility is that residual copper salts are present. The remaining copper 
could be bound to the nitrogen atoms, giving broad proton signals in the 1H NMR 
spectrum (Appendix: Figure 17). As a result of low yield and possible copper 
contamination it was decided not to send this sample for antimicrobial and 
biodegradation analysis. 
 
 
4.4 Antimicrobial study of biquinoline and derivatives 
 
The antimicrobial activities of biquinoline (130) and N-biquinoline salts (134, 135 and 
136) were evaluated by our collaborator Dr Marcel Špulák of Charles University Czech 
Republic. Bacteria screened against were Staphylococcus aureus ATCC 6538, 
Staphylococcus aureus MRSA HK5996/08, Staphylococcus epidermidis HK6966/08, 
Enterococcus sp. HK14365/08, Escherichia coli ATCC 8739, Klebsiella pneumoniae 
HK11750/08, Klebsiella pneumoniae-ESBL positive HK14368/08 and Pseudomonas 
aeruginosa ATCC 9027. MIC values for antibacterial study were defined as 95 % 
inhibition (IC95) of the growth of control. The results in table 4.1 represent the MIC/IC95 
values obtained for biquinoline and N-alkylated salts (Figure 4.7). 
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Fig 4.7 Biquinoline (130) and N-alkylated salts (134, 135, 136) screened for 
antimicrobial activity 
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Biquinoline and derivatives 
Organism Time (h) 130 134 135 136 
  
    
S. aureus 24 >2000 >1000 >2000 >2000 
      
 48 >2000 >1000 >2000 >2000 
      
MRSA 24 >2000 >1000 >2000 >2000 
      
 48 >2000 >1000 >2000 >2000 
      
S. epidermidis 24 >2000 >1000 >2000 >2000 
      
 48 >2000 >1000 >2000 >2000 
      
Enterococcus sp. 24 250 125 >2000 >2000 
  
 
   
 48 500 500 >2000 >2000 
  
 
   
E. coli 24 250 >1000 >2000 >2000 
  
 
   
 48 500 >1000 >2000 >2000 
  
 
   
K. pneumoniae 24 15.62 >1000 >2000 >2000 
  
 
   
 48 125 >1000 >2000 >2000 
      
K. pneumoniae -ESBL 24 >2000 >1000 >2000 >2000 
      
 48 >2000 >1000 >2000 >2000 
      
P. aeruginosa 24 >2000 >1000 >2000 >2000 
      
 48 >2000 >1000 >2000 >2000 
 
Results obtained by collaborator 
 
Table 4.1: MIC/IC95 (µM) values of biquinoline (130) and N-alkylated salts (134, 135 
and 136) 
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N-alkylated salts 135 and 136 displayed low antimicrobial activity to all bacteria (>2000 
µM) as a MIC/IC95 was not observed within the tested concentration range. Biquinoline 
(130) proved inhibitory for Enterococcus sp, E. coli and K. pneumoniae with MIC values 
of 250 µM, 250 µM and 15.62 µM after 24 h, respectively, and after 48 h MIC values 
were 500 µM, 500 µM and 125 µM. A trend is seen as MIC value is lower at 24 h than 48 
h. While this is slight for Enterococcus sp and E. coli, it is very significant for K. 
pneumoniae. A change in MIC value after 48 h signifies that viable bacteria are present at 
24 h and grow substantial over a 24 h period which increases the MIC/IC95 value. 
Remaining bacteria were not inhibited by 130. Inhibition of Enterococcus sp was also 
noted for 134 at 125 µM after 24 h and at 500 µM after 48 h. The highest concentration 
screened for 134 was 1000 µM as the compound was less soluble in test medium.   
 
 
For the antifungal studies, compounds were screened against the following yeast strains 
(Candida albicans ATCC 44859, Candida albicans ATCC 90028, Candida parapsilosis 
ATCC 22019, Candida krusei ATCC 6258, Candida krusei E28, Candida tropicalis 156, 
Candida glabrata 20/I, Candida lusitaniae 2446/I, Trichosporan asahii 1188) and 
filamentous fungi (Aspergillus fumigatus 231, Absidia corymbifera 272 and  
Trichophyton mentagrophytes 445). MIC values for antifungal study were defined as 80% 
inhibition (IC80) of the growth of control for yeast and 50% inhibition (IC50) of the 
growth of control for filamentous fungi. The MIC values for most fungi were recorded 
after 24 h and 48 h except for the dermatophytic strain (T. mentagrophytes 445) which 
was determined after 72 h and 120 h.  Biquinoline (130) and derivatives (134, 135 and 
136) all proved non-inhibitory for the fungal strains tested (Table 4.2). N-alkylated salt 
(134) was screened at a lower concentration of 1000 µM as it was less soluble in test 
medium. 
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Biquinoline derivatives 
Organism Time(h) 130 134 135 136 
  
    C. albicans (ATCC44859) 24 >2000 >1000 >2000 >2000 
      
 48 >2000 >1000 >2000 >2000 
      C. albicans (ATCC90028) 24 >2000 >1000 >2000 >2000 
      
 48 >2000 >1000 >2000 >2000 
      C. parapsilosis (ATCC22019) 24 >2000 >1000 >2000 >2000 
      
 48 >2000 >1000 >2000 >2000 
      C. krusei (ATCC6258) 24 >2000 >1000 >2000 >2000 
      
 48 >2000 >1000 >2000 >2000 
      C. krusei (E28) 24 >2000 >1000 >2000 >2000 
      
 48 >2000 >1000 >2000 >2000 
      C. tropicalis (156) 24 >2000 >1000 >2000 >2000 
      
 48 >2000 >1000 >2000 >2000 
      C. glabrata (20/I)  24 >2000 >1000 >2000 >2000 
      
 48 >2000 >1000 >2000 >2000 
      C. lusitaniae (2446/I) 24 >2000 >1000 >2000 >2000 
      
 48 >2000 >1000 >2000 >2000 
      T. asahii (1188) 24 >2000 >1000 >2000 >2000 
      
 48 >2000 >1000 >2000 >2000 
      A. fumigatus (231) 24 >2000 >1000 >2000 >2000 
      
 48 >2000 >1000 >2000 >2000 
      A. corymbifera (272) 24 >2000 >1000 >2000 >2000 
      
 48 >2000 >1000 >2000 >2000 
      T. mentagrophytes (445) 72 >2000 >1000 >2000 >2000 
      
 120 >2000 >1000 >2000 >2000 
 
Table 4.2: Antifungal IC80/IC50 (µM) values of biquinoline (130) and N-alkylated salts 
(134, 135 and 136) 
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4.5 Biodegradation study of biquinoline and derivatives  
 
Biquinoline (130) and derivatives 135 and 136 were evaluated using the CO2 headspace 
test (ISO 14593). General procedure for this assay was mentioned in Section 1.3.4. The 
results from this study are presented in Table 4.3 and the biodegradation curve is 
displayed in Figure 4.8. 
 
% Biodegradation 
 
Compound 
6 d 14 d 21 d 28 d 
SDS 
 
130 
 
135 
 
136 
75 
 
0 
 
9 
 
0 
87 
 
1 
 
8 
 
0 
 
93 
 
1 
 
19 
 
0 
93 
 
1 
 
15 
 
0 
 
Table 4.3: CO2 Headspace test results for biquinoline (130) and derivatives (135 and 
136) 
 
 
The readily biodegradable reference substance SDS was evaluated as the control 
experiment and exhibited % biodegradation values of 75%, 87%, 93% and 93% after 6 
days, 14 days, 21 days and 28 days, respectively. These results ensure that the inoculum 
is viable and capable of mineralising biodegradable organic chemicals. Biquinoline (130) 
and derivative 136 were found to be non-biodegradable as negligible CO2 evolution was 
recorded. For 135 a value of 15% biodegradation was recorded after 28 days. This 
degradation can be attributed to the hydrolysis of the ester group. Biquinoline (130) and 
derivatives 135 and 136 failed the CO2 headspace test (ISO 14593) as both compounds 
did not attain the pass rate of >60% CO2 output within the 28 day timescale. 
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Figure 4.8 Biodegradation curve for SDS, biquinoline (130) and derivatives (135 and 
136) 
 
 
 An inhibitory control experiment was run to determine if biquinoline (130) and 
derivatives 135 and 136 were having an inhibitory effect on the activity of the inoculum. 
For this experiment reference substance (SDS) and test substance (biquinoline and 
derivatives individually) were added together to the inoculum and if inhibition of SDS 
biodegradation occurred, this implied that the test substance is inhibiting the inoculum. 
Results from this experiment are presented in Table 4.4.  
For 130 and 135 no inhibition was observed towards the inoculum while for 136 a 5% 
inhibition of the inoculum was noted, however, this is not significant enough to prevent 
the inoculum from mineralising biodegradable organic chemicals. Therefore, 130, 135 
and 136 are non-biodegradable within the parameters of the CO2 headspace test (ISO 
14593). 
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Compound Concentration 
(mgC/L) 
Molar 
concentration of 
sample 
Inhibition (%) 
    
SDS + 130 20 + 20 92.5 µM 0 
    
SDS + 135 20 + 20 64.05 µM 0 
    
SDS + 136 20 + 20 83.3 µM 5 
 
Table 4.4: Inhibition of SDS biodegradation by 130, 135 and 136 
 
 
4.6 Conclusion 
 
N-alkylated biquinoline salts 134, 135 and 136 were synthesised in moderate to good 
yields. As well, the synthesis of a biquinoline compound (137a) with a methyl ester at the 
3 position was achieved. However, low yield and possible copper contamination 
prevented further antimicrobial and biodegradation studies. Antimicrobial studies were 
performed for biquinoline (130) and N-alkylated biquinoline salts (134, 135 and 136). 
Some cases of antibacterial inhibition were noted for 130 (Enterococcus sp, E.coli and 
K.pneumoniae) and 134 (Enterococcus sp). A trend was observed for antibacterial 
inhibition as MIC value was lower at 24 h than 48 h for both compounds.  
No case of anti-fungal activity was observed for biquinoline (130) and N-alkylated 
biquinoline salts (134, 135 and 136).  
For the biodegradation studies, 130, 135 and 136 were evaluated using the CO2 
headspace test (ISO 14593) and all molecules failed the test indicating that they are non-
biodegradable within the parameters of the test. 
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5 Morita-Baylis-Hillman reaction 
 
5.1 Aim 
 
The aim for this part of the project was to evaluate novel chiral polysubstituted BINOLs 
as asymmetric catalysts for the Morita-Baylis-Hillman reaction. A model reaction from 
the literature, which can be promoted by BINOL, was selected for a preliminary 
screening of catalysts.1  
 
5.2 Introduction 
 
The Morita-Baylis-Hillman (MBH) reaction involves the addition of electrophilic alkenes 
to carbonyl electrophiles and is catalyzed by nucleophilic amines or phosphines to 
generate β-hydroxy-α-methylene carbonyl products.2   
 
Enantiomerically enriched β-hydroxy-α-methylene carbonyl compounds are useful 
building blocks for natural product synthesis.3 The usage of organocatalysts to catalyse 
the MBH reaction has been investigated by many research groups.4,5,6 Newly designed 
organocatalysts are overcoming the drawbacks that have been associated with the 
asymmetric MBH reaction such as long reaction times (a week to a month), low 
conversion and low enantioselectivity.3 Organocatalysts are assisting in the development 
of a more efficient asymmetric MBH reaction. The proposed mechanism for the MBH 
reaction is presented in Scheme 5.1. Initially, the nucleophilic catalyst either a tertiary 
amine or a tertiary phosphine undergoes a reversible 1,4-Michael addition with the 
electron deficient alkene 143 (Step 1) to generate a nucleophilic zwitterionic enolate 
intermediate 144 which then undergoes an Aldol reaction with the carbonyl electrophile 
145 to give the zwitterionic intermediate 146 (Step 2).  Step 2 is considered to be the rate 
determining step for the MBH reaction.3 Step 3 involves a proton shift from the α-carbon 
atom to the β-alkoxide within intermediate 146 to give the zwitterionic intermediate 147. 
Subsequent β-elimination of the organic catalyst (tertiary amine or phosphine) from 
164 
intermediate 147 yields the β-hydroxy-α-methylene carbonyl product 148 (Step 4). The 
regenerated organic catalyst undergoes further cycles to generate many β-hydroxy-α-
methylene carbonyl products. Overall the MBH can be considered an atom economic 
reaction as atoms in both starting materials end up in the product. 
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Scheme 5.1: Proposed mechanism for the MBH reaction3 
 
5.3 Morita-Baylis-Hillman reaction promoted by diols 
 
In 2000 Ikegami and Yamada reported a catalytic Morita-Baylis-Hillman (MBH) reaction 
that was promoted by tributylphosphine and (+/−)-1,1’-bi-2-naphthol (BINOL) in THF to 
furnish β-hydroxy-α-methylene carbonyl products in high yields.7 Ikegami and coworkers 
envisioned that a mild Brønsted acid as co-catalyst would activate the carbonyl groups of 
the enolate intermediate and the aldehyde to accelerate the reaction rate for the MBH 
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reaction. Initially, test substrates 149a and 150a were selected for their preliminary study 
(Scheme 5.2).  Tributylphosphine was found to catalyse the MBH reaction furnishing a 
yield of 23% for the MBH adduct 151a while the Lewis bases DABCO and 
triphenylphosphine failed to give any conversion (Table 5.1). A variety of mild Brønsted 
acids were examined as co-catalysts for this reaction and quantitative yields for 151a 
were obtained in the presence of BINOL, 2-napthol and phenol. It was found that free 
hydroxyl groups are necessary for promoting the MBH reaction as BINOL derivatives 
153 and 154 (Figure 5.1) gave lower yields of 80% and 24%, respectively, for 151a. 
 
 
 
O
H
O O OH
catalysts
THF, rt, 1 h
149a 150a (1.5 eq) 151a
 
 
Scheme 5.2: MBH reaction for test substrates 149a and 150a 
 
 
 
Catalyst Co-catalyst Yield (%) 
   DABCO (20 mol %) − no reaction 
   Bu3P (152) (20 mol %) − 23 
   (152) (20 mol %) methanol (20 mol %) 23 
   (152) (20 mol %) (+/−)-1,1’-bi-2-naphthol 
(45) (10 mol %) 
quantitative 
   (152) (20 mol %) 2-naphthol (20 mol %) quantitative 
   (152) (20 mol %) 153 (10 mol %) 80 
   (152) (20 mol %) 154 (10 mol %) 24 
   DABCO (20 mol %) 45 (10 mol %) no reaction 
   Ph3P (20 mol %) 45 (10 mol %) no reaction 
   (152) (20 mol %) phenol (20 mol %) quantitative 
 
 
Table 5.1: Results from Ikegami preliminary study of MBH reaction.7  
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Fig. 5.1 BINOL (45) and BINOL derivatives (153 and 154) evaluated for MBH reaction 
 
 
For their extensive study, tributylphosphine (152) and (+/−)-BINOL (45) were evaluated 
as catalysts against a broad range of Michael acceptors and aldehydes (Table 5.2).7 2-
Cyclopenten-1-one (149a) was reacted with benzaldehyde (150b) and propanal (150c) 
with yields of 92% and 91% being obtained, respectively. 2-Cyclohexen-1-one (149b) 
was reacted with hydrocinnamaldehyde (150a) and benzaldehyde (150b) with yields of 
88% and 57%, respectively. Methyl acrylate (149c) was found to give a lower yield of 
52% when reacted with heptanal (150d). From their results, cyclic enones performed 
better than acyclic enones for the MBH reaction. 
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Scheme: 5.3 Generic scheme for Ikegami extended study  
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Table 5.2: Results for Ikegami extended study.7 
 
Schaus and coworkers extended the idea of Brønsted acid catalysis for the asymmetric 
Morita-Baylis-Hillman using chiral BINOL derived organocatalysts.1 They reported the 
addition of a cyclic enone to aldehydes and found chiral saturated BINOLs to be superior 
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catalysts for promoting the asymmetric MBH reaction. Test substrates used for their 
preliminary study were cyclohexeneone (149b) and hydrocinnamaldehyde (150a) 
(Scheme 5.4).  
 
H
O OOH2 mol% cat
Et3P (0.5 eq)
THF
0oC, 48h
150a (1 eq) 151d
O
149b (1 eq)
Scheme 5.4: Schaus MBH reaction of test substrate 149b and 150a 
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Fig 5.2 BINOL derivatives used in Schaus study.1 
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catalyst % yield % ee 
   
no catalyst 5 not applicable 
   45b 74 32 
 
  48b 73 48 
 
  105b 73 79 
 
  155 69 86 
 
  156 9 31 
 
  98 70 88 
 
  157 84 86 
 
  153b 43 3 
 
  158b 15 3 
 
  
 
Table 5.3: Results for Schaus preliminary study of MBH reaction.1 
 
A variety of chiral diols (45b, 48b, 98, 105b, 153b, 155, 156, 157 and 158b) (Figure 5.2) 
along with the catalyst triethylphosphine were screened for the MBH reaction with test 
substrates 149b and 150a (Table 5.3).  
Triethylphosphine as catalyst afforded a low yield of 5% for the MBH adduct (151d) 
(Table 5.3). The addition of BINOL (45b) increased the yield substantial to 74% and gave 
an ee of 32% for 151d. This is not surprising considering the report made by Ikegami.7 
However, saturation of the BINOL scaffold (48b) was found to increase the ee to 48% for 
151d. Further modification of the reduced BINOL scaffold at the 3,3’-position with bulky 
substituents was found to enhance the ee substantial.  
Catalysts 98, 105b, 155 and 157 yielded the MBH adduct (151d) with high ee, with 
catalyst 98 giving the highest ee (88%) and 157 generating the highest yield (84%). They 
found that removal of one Brønsted acid equivalent from the BINOL-derived catalyst 
(153b and 158b) resulted in diminished catalytic activity. Interestingly, the addition of 
methyl substituents at the ortho position of the phenyl substituent at position 3 for 
catalyst 156 resulted in a detrimental low yield of 9% and gave an ee of 31% for 151d. 
Triethylphosphine was the optimal catalyst for their MBH reaction as trimethylphosphine 
and tributylphosphine gave similar yields for 151d but lower enantioselectivities. From 
there preliminary study, it is apparent that key structural features like saturation of the 
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BINOL scaffold, substitution at the 3,3’-position and free diols are required for an 
efficient BINOL derived catalyst in the asymmetric MBH reaction. 
 
Catalysts 98 and 157 were selected for further study and were evaluated against a range 
of aldehydes to assess substrate scope (Table 5.4). Catalyst 157 proved to be the optimal 
catalyst for aliphatic aldehydes while catalyst 98 gave the best results for more hindered 
aldehydes. Conjugated aldehydes performed poorly for their MBH reaction as low yields 
and low enantioselectivities were obtained. For their further study, 2 equivalents of 
triethylphosphine and cyclohexenone (149b), 10-20 mol% of catalyst 98 and 157 at -10 
°C in THF were found to be the optimum conditions for affording the MBH adduct in 
high yield. 
5.4 Our study of MBH reaction 
 
The MBH reaction was selected for our study as BINOL and other related diols have 
been reported to promote this reaction by Ikegami and Schaus. Therefore, it was ideal to 
validate our catalysts against the MBH reaction. 
It was decided to adopt the model reaction used by Schaus for our investigation of chiral 
polysubstituted BINOL as catalysts for the asymmetric MBH reaction. Similar conditions 
were employed to those that Schaus used for his preliminary study such as 2-cyclohexen-
1-one (149b) (1 equivalent) and hydrocinnamaldehyde (150a) (1 equivalent) as test 
substrates, triethylphosphine (0.5 equivalent) as nucleophilic promoter and THF as 
solvent. The only exception was that the reaction could not be performed at 0 °C for the 
full 48 h. Therefore, reaction was run at 0 °C for 3 h and the remaining 45 hrs were at 
room temperature. Each catalyst was screened at a loading of 2 mol%.  
Our hypothesis for using polysubstituted BINOLs were that they shared similar features 
to those identified in Schaus study such as substitution at the 3,3’-position and free chiral 
diols. However, they do not contain a saturated ring. We feel that the placement of 
substituents at the 6,6’-position will have an affect on the bite angle, whether this would 
have a positive effect on the MBH reaction was the main reason for investigating these 
catalysts. 
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Table 5.4: Schaus extended study of MBH reaction.1 
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Initially, a racemic sample of the MBH adduct (+/−)-2-(1-hydroxy-3-
phenylpropyl)cyclohex-2-enone (151d) was required. This was synthesised by reacting 2-
cyclohexen-1-one (149b) and hydrocinnamaldehyde (150a), catalyzed by 1M 
triethylphosphine in THF and (+/−)-BINOL (45) to yield MBH adduct 151d in 59% yield 
after column chromatography. A sample of 151d was used to identify conditions for 
separating the enantiomers via chiral High Performance Liquid Chromatography (HPLC) 
analysis. Optimum conditions for separating enantiomers are presented in Chapter 7 
(section 7.9). 
 
 
The results obtained from our MBH study are presented in Table 5.5. Chiral (+)-(R)-
BINOL (45b) was evaluated at a loading of 2 mol% and furnished the MBH adduct 151d 
with a yield of 57% and an ee of 32.5% (Table 5.5, entry 1). In the literature (+)-(R)-
BINOL (45b) has been reported to generate the MBH adduct 151d with a yield of 74% 
and an ee of 32%. In our laboratory the yield is slightly lower than that reported but the 
ee is the same. The commercial available Schaus catalyst (+)-(R)-(98) was also evaluated 
and gave a yield of 59% and an ee of 87% for 151d (Table 5.5, entry 5). Schaus reported 
a yield of 70% and an ee of 88% with catalyst (+)-(R)-(98). Our yield is slightly lower but 
the ee is similar to that reported in the literature with catalyst (+)-(R)-(98). Next 
intermediate (+)-(R)-122b was screened and the MBH adduct 151d was obtained in 43% 
yield with an ee of 44% (Table 5.5, entry 2). A slight decrease in yield is noted for (+)-
(R)-122b compared to (+)-(R)-BINOL (45b) (entry 1 vs 2), however, an increase in ee 
was obtained for the product 151d. The reason for the increase in enantioselectivity could 
be due to the bulky phenyl substituent present in (+)-(R)-122b.  
 
Polysubstituted derivative (+)-(R)-123b gave a low yield of 28% and a low ee of 9% for 
151d (entry 3). A dramatic loss in yield and ee for 151d is apparent for the catalyst (+)-
(R)-123b. Novel polysubstituted BINOL (+)-(R)-111b afforded 151d with a yield of 15% 
and an ee of 7% (entry 4). Novel polysubstituted (+)-(R)-114b furnished the MBH adduct 
151d in 24% yield and with an ee of 29% (entry 8). Derivative (+)-(R)-114b gave better 
results in terms of yield and ee for 151d compared to (+)-(R)-111b (entry 4 vs 8).  
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Overall polysubstituted derivatives gave a low yield and a lower ee for the MBH adduct 
151d compared to chiral (+)-(R)-BINOL (45b). Another commercial catalyst (−)-(S)-159 
was evaluated and this yielded 151d with a 35% yield and with an ee of 12% (entry 7). 
Racemic biquinoline (+/−)-(130) was evaluated for the conversion of 151d and a yield of 
58% was obtained for adduct 151d (entry 6). From our study it is apparent that saturation 
of the BINOL scaffold is necessary in order to obtain high yields and high ee for the 
MBH adduct 151d. Due to time constraints and unpromising results further catalysis 
studies were not carried out. Priority was now given to completing the toxicity and 
biodegradation studies of the saturated BINOL examples, as positive results from those 
studies would be a significant development. 
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Entry Catalyst Loading Yield ee 
 
 
1 
OH
OH
(+)-(R)-45b
 
 
 
2 mol% 
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32.5% ee 
 
 
 
2 
OH
OH
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2 mol% 
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44%ee 
 
 
 
3 
OH
OH
Br
Br
(+)-(R)-123b
 
 
 
 
2 mol% 
 
 
 
28% 
 
 
 
 
9%ee 
 
 
 
4 
OH
OH
O
O
(+)-(R)-111b
 
 
 
 
2 mol% 
 
 
 
15% 
 
 
 
7%ee 
 
 
 
5 
OH
OH
(+)-(R)-98
 
 
 
 
2 mol% 
 
 
 
59% 
 
 
 
87% ee 
 
 
6 
N
N
OH
OH
(+/-)-(R)-130
 
 
 
2 mol% 
 
 
58% 
 
 
 
 
7 
OH
OH
CF3
CF3
CF3
CF3
(-)-(S)-159
 
 
 
 
2 mol% 
 
 
 
35% 
 
 
 
12% ee 
 
 
8 OHOH
(+)-(R)-114b
 
 
 
2 mol% 
 
 
 
24% 
 
 
29% ee 
 
Table 5.5: Catalysts screened for MBH reaction with yields and ee for compound 151d  
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5.5 Conclusion 
 
A range of chiral diols have been evaluated as catalysts for the MBH reaction. Novel 
polysubstituted BINOLs (+)-(R)-111b and (+)-(R)-114b were assessed for the MBH 
reaction as part of a preliminary study. Results for novel catalysts (+)-(R)-111b and (+)-
(R)-114b compared poorly with (+)-(R)-BINOL (45b) and the Schaus catalyst (+)-(R)-
(98). Further studies are needed in the future to determine if other substrates work better 
for these catalysts ((+)-(R)-111b and (+)-(R)-114b). As the saturated BINOL examples are 
known to give high enantioselectivity, priority was now given to completing the toxicity 
and biodegradation studies of these saturated BINOL examples, as positive results from 
those studies would be a significant development.  
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6 Conclusion and Future work 
 
 
6.1 Conclusion 
 
Toxicity and biodegradation data for organocatalysts was lacking in the literature prior to 
starting this project. Our objectives for this work was to establish the environmental 
impact for commercial organocatalysts by obtaining their antimicrobial data, affect on 
human blood cell lines and biodegradation data. This thesis presents the first 
comprehensive toxicity and biodegradation study for organocatalysts. New 
organocatalysts with improved biodegradation and lower toxicity was a primary target. 
By working with our collaborators we have managed to assess novel and commercial 
organocatalysts for toxicity and biodegradation 
 
The antimicrobial activity for a range of known organocatalysts was established by 
growth inhibition assays. Antimicrobial screening was carried out both in DCU and by 
our collaborator Dr. Marcel Špulák of Charles University Czech Republic. Amino acids, 
proline derivatives, BINOL, BINOL derivatives, TADDOL, Jacobsen thioureas, 
Cinchona alkaloid derivatives, MacMillan imidazolidinones, chiral phosphoric acids and 
a Maruoka phase-transfer catalyst are the classes of organocatalysts that were studied for 
antimicrobial activity.  
The data obtained from the screening studies of amino acids exhibited some cases of anti-
microbial activity. However, the MIC values determined for inhibitory amino acids 
proved high (>2.5 mM). For proline derivatives, compounds 95 and 96 were shown to 
exhibit anti-microbial activity for M.luteus, B.subtilis and E.coli using the microtiter 
broth dilution technique. Other proline derivatives proved non-inhibitory within tested 
concentration range (3.45 mM-0.007 mM). BINOL (45) exhibited inhibition towards 
M.luteus and B.subtilis (0.107 mM) while BINOL derivatives and TADDOL proved to be 
non-inhibitory for test organisms within studied concentration range. 
 
Antimicrobial studies performed by our collaborator Dr Marcel Špulák showed a number 
of organocatalysts inhibiting test microorganisms. Growth inhibition was found with 
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proline derivatives (101 and 102) for both bacterial and fungal organisms. 102 was found 
to be more toxic (lower MIC values) than 101 towards test microorganisms. Jacobsen 
thioureas showed more inhibition for bacteria than for fungi. All three Jacobsen thioureas 
inhibited different bacteria with 15 being the most active. 15 was the only Jacobsen 
thiourea found to inhibit fungal strains (4 in total). Cinchona alkaloid derivatives were 
observed with low inhibition for bacteria, with only 81a exhibiting antifungal activity in 
some cases. MacMillan imidazolidinones were found to be mostly non-inhibitory towards 
both bacterial and fungal strains (>2000 µM). The only exceptions were 109 which 
inhibited MRSA at 2000 µM after 24 h and at 48 h and 110 was found to inhibit 
Staphylococcus epidermidis at 2000 µM after 24 h and at 48 h. 110 inhibited 2 fungal 
strains.  Chiral phosphoric acids (26a and 26b) proved inhibitory for most Gram positive 
bacteria while Gram negative bacteria showed low inhibition. 26b was observed with two 
cases of inhibition for fungal organisms. Maruoka phase-transfer catalyst (40) inhibited 
all Gram positive bacteria but Gram negative bacteria were not inhibited (>125 µM). 40 
inhibited a number of fungal organisms with MIC values ranging from 3.9 µM to 62.5 
µM. 
 
TADDOL (100) and BINOL derivatives (98 and 99) showed low inhibition towards all 
bacterial and fungal organisms (>125 µM). (S)-BINOL (45a) and (R)-BINOL (45b) 
inhibited all Gram positive bacteria while Gram negative bacteria showed low inhibition. 
Both 45a and 45b showed a few cases of anti-fungal activity. However, most fungal 
organisms were not inhibited by 45a and 45b (>500 µM). Brominated BINOL derivatives 
(50a and 50b) were found to be more toxic than BINOL (45a and 45b) as lower MIC 
values were obtained for Gram positive bacteria. 50a and 50b inhibited all Gram positive 
bacteria while Gram negative bacteria showed low inhibition (>2000 µM). A trend noted 
was that the R enantiomer (50b) was more active than the S enantiomer (50a). H8-
BINOLs (48a and 48b) inhibited all Gram positive bacteria while Gram negative bacteria 
were not inhibited (>2000 µM). Brominated H8-BINOL derivatives (105a and 105b) 
were found to be more toxic towards Gram positive bacteria than the non-brominated H8-
BINOLs (48a and 48b). (R)-3,3’-Dibromo-H8-BINOL (105b) was observed with lower 
MIC values when compared to (S)-3,3’-dibromo-H8-BINOL (105a). 
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Cytotoxicity, apoptosis and cell viability studies were performed for organocatalysts (8, 
15, 26a, 38a, 40, 81a, 102, 103, 104, 106, 107, 108 and 109) against 3 blood cell lines 
(erythroid progenitors, HL-60 and K-562). These studies were carried out by our 
collaborator Dr. Petr Bartunek in the Czech Republic. 102 and 107 reduced cell viability 
by less than 50% for all 3 cell lines at 10 µM. Maruoka catalyst (40) was found to induce 
apoptosis for all three cell lines. A loss of cell viability for all three cell lines was 
observed with 40. The integrity of the plasma membranes for the blood cell lines was not 
disrupted by 40. EC50 values were determined for the affect 40 has on apoptosis. 
Erythroid progenitors, HL-60 and K-562 cell lines gave EC50 values of 6.0 µM, 2.1 µM 
and 5.5 µM, respectively for 40. IC50 values were determined for the affect 40 has on cell 
viability. Erythroid progenitors, HL-60 and K-562 cell lines gave IC50 values of 1.2 µM, 
0.8 µM and 1.7 µM, respectively for 40. Remaining organocatalysts were found to be 
non-toxic for all 3 cell lines within the studied concentration range (0.1 – 10 µM). 
 
Biodegradation studies were performed on organocatalysts (8, 15, 19, 26a, 26b, 38a, 40, 
41a, 45a, 45b, 48a, 48b, 50a, 50b, 81a, 89, 92, 97, 100, 101, 102, 103, 104, 105a, 105b, 
106, 107, 108, 109 and 110) using the CO2 headspace test (ISO 14593). Organocatalysts 
(8, 15, 19, 26a, 26b, 38a, 40, 41a, 45a, 45b, 48a, 48b, 50a, 50b, 81a, 92, 97, 100, 101, 
102, 103, 104, 105a, 105b, 106, 107, 108, 109 and 110) failed the test and cannot be 
classified as readily biodegradable. L-Prolinamide (89) passed the CO2 headspace test 
(ISO 14593) with a biodegradation value of 77% after 28 days. 81a and 8 were found to 
have a slight inhibitory effect on the inoculum (19% and 8% respectively), however, 
these % inhibitions are lower than the limit (>25% inhibition) generally accepted to 
consider a significant inhibitory effect on the activity of the inoculum. Maruoka phase-
transfer catalyst (40) had an inhibitory effect on the activity of the inoculum, as a % 
inhibition value of 30% is higher than the limit (>25% inhibition) accepted for an 
inhibitory effect on the inoculum. 
 
The synthesis of novel polysubstituted BINOLs from the key intermediate (123) were 
performed in 1 to 2 steps. Key intermediate (123) was synthesised in 5 steps according to 
a literature known procedure. Each step provided intermediates (119, 120, 121, 122, 123) 
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in moderate to good yields. However, difficulty was initially encountered for the 
synthesis of 120, as a low yield of 25% was obtained. By changing the addition of 
electrophile, an improvement in yield to 86% was obtained (A yield that is more 
comparable to that reported in literature). The procedure for the synthesis of key 
intermediate (123) was modified as the addition of extra equivalents of bromine was 
required to drive the reaction to completion. Using the key intermediate (123), synthesis 
of polysubstituted BINOLs was achieved. A range of polysubstituted BINOLs were 
prepared via different synthetic methods. Target molecules 111 and 112 were made with 
yields of 65% and 55% respectively using an Ullmann-type condensation reaction. 
Demethylation of 111 yielded compound 113 in 49%. 127 was obtained using a modified 
Kumada metal coupling reaction in 35% yield and subsequent MOM deprotection 
furnished 114 in 74% yield. 126 was made in 44% yield via a halogen metal exchange 
route and subsequent MOM deprotection gave 115 in 77% yield. Using a Sonogashira 
coupling reaction, compounds 116 and 117 were obtained in 60% and 50% yields 
respectively. Hydration of 117 furnished 118 in 59% yield. 
 
Optically pure BINOL derivatives were synthesised in 1-2 steps from the chiral key 
intermediate (+)-(R)-(123b). BINOL derivative (+)-(R)-(111b) was synthesised from (+)-
(R)-(123b) by an Ullmann-type condensation in 67% yield. A modified Kumada metal 
coupling reaction was performed using (−)-(R)-(125b) and subsequent MOM 
deprotection yielded (+)-(R)-(114b) in 42% yield.  
 
Achiral BINOL (45) and BINOL derivatives (111, 114, 115, 118 and 122) were screened 
for antibacterial and antifungal activity. Achiral polysubstituted BINOLs (111, 114, 115 
and 118) showed low inhibition towards bacteria and fungi. BINOL derivative (122) 
inhibited Staphylococcus epidermidis (500 µM) and Enterococcus sp. (250 µM) while 
remaining bacteria showed low inhibition (>2000 µM). BINOL (45) was found to be 
active against all Gram positive bacteria. MIC values ranging from 31.25 µM to 125 µM 
were noted for 45. A number of fungal organisms showed inhibition for 45.  
 
Achiral BINOL (45) and BINOL derivatives (111, 114, 115, 118 and 122) failed the CO2 
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headspace test (ISO 14593) and can be classified as non-biodegradable. BINOL (45) was 
found to have a slight inhibitory effect on the inoculum (9%), however, this % inhibition 
is lower than the limit (>25% inhibition) generally accepted to consider a significant 
inhibitory effect on the activity of the inoculum. 
 
 
Biquinoline derivatives 134, 135 and 136 were synthesised in one step from BIQOL 
(130) via N-alkylation reactions to furnish yields of 26%, 86% and 79% respectively. The 
quinoline derivatives 140 and 142 were prepared by a modified Friedländer synthesis 
with yields of 44% and 46% being obtained respectively. Dimerisation of these 
intermediates was investigated by employing an oxidative copper coupling reaction. 142 
dimerised under reaction conditions, however, the synthesis needs further optimization 
due to low yields and the possibility that residual copper salts are still present. 
The antimicrobial activities of 130 and N-biquinoline salts (134, 135 and 136) were 
determined for bacteria and fungi. These compounds showed low inhibition for all fungal 
organisms studied. Biquinoline (130) inhibited Enterococcus sp., E.coli and Klebsiella 
pneumoniae while remaining bacteria were not inhibited (>2000 µM). N-biquinoline salt 
(134) inhibited Enterococcus sp. but remaining bacteria showed low inhibition (>1000 
µM). Test bacteria were not inhibited by 135 and 136 (>2000 µM).  
The asymmetric Morita-Baylis-Hillman reaction was investigated using chiral (+)-(R)-
BINOL (45b) and substituted BINOL derivatives ((+)-(R)-(111b), (+)-(R)-(114b), (+)-
(R)-(122b) and (+)-(R)-(123b),). Catalysts performed poorly for the model reaction as 
low yields and ee were obtained for the MBH adduct 151d. Due to time constraints and 
unpromising results further catalysis studies were not carried out. 
 
6.2 Future work 
 
From our biodegradation studies of BINOL and novel polysubstituted BINOL 
derivatives, it is apparent that biodegradation for these scaffolds is a considerable task. 
Work towards a more biodegradable biaryl scaffold should be continued. For instance the 
placement of an ester or a methyl group on the 3-position of biquinoline (137) may lead 
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to a more biodegradable scaffold (Figure 6.1). Optimization for the dimerisation of 142 
needs further investigation. Reduced BINOL derivatives (160) that are modified with 
substituents to enhance biodegradation are another possibility. Evaluation of biphenyl 
atropisomers (161) may lead to a more biodegradable scaffold as these compounds 
contain less aromatic rings which would make it easier for microorganisms to degrade. 
Modification of the biphenyl scaffold with substituents that are in line with the ‘rules of 
thumb’ could enhance biodegradation for that respective scaffold.  
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Fig. 6.1 Potential biaryl scaffolds for future biodegradation studies. 
 
 
Further ecotoxicity studies with known organocatalysts should be done to determine their 
toxicity towards algae and aquatic organisms. 
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Chapter 7: Experimental 
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7.1 Introduction 
 
7.1.1 Chemicals 
All chemicals used in Chapters 2, 3, 4 and 5 were purchased from Sigma-Aldrich and 
Strem chemicals. THF and diethyl ether were dried over sodium wire and benzophenone 
and distilled before use. DMF and DME were purchased in anhydrous form from Sigma-
Aldrich. Merck silica 60 (particle size 0.063-0.200 nm) was used for flash 
chromatography. Thin layer chromatography (TLC) was performed on aluminium sheets 
coated with 0.20 mm of fluka silica gel containing fluorescent indicator 254 nm. 
Müeller Hinton broth and nutrient broth were obtained from Sigma-Aldich and Oxoid. 
Well plates were sourced from Corning. 
 
7.1.2 NMR Spectroscopy 
All NMR analysis was performed on a Bruker AC 400 MHz spectrometer in either 
deuterated chloroform, DMSO, acetone and methanol, operating at 400 MHz for 1H 
NMR and 100 MHz for 13C NMR. A 600 MHz spectrometer, operating at 600 MHz for 
1H NMR and 150 MHz for 13C NMR, was also used for the analysis of some compounds. 
Chemical shifts are reported in parts per million (ppm) are relative to the internal 
standard TMS and coupling constants (J) are reported in Hertz (Hz). When stating 
multiplicity of peaks in NMR the following abbreviations are used; s-singlet, d-doublet, t-
triplet, q-quartet, qt-quintet, dd-doublet of doublets, dt-doublet of triplets, dq-doublet of 
quartets, tt-triplet of triplets, tq-triplet of quartets, m-multiplet, br-broad. 
 
7.1.3 Optical Rotation 
Optical rotations were measured using a Perkin Elmer 343 Polarimeter in THF or 
methanol at 20 °C. 
 
7.1.4 Melting point 
Melting points were determined using a Griffin melting point apparatus and the values 
are expressed in degrees Celcius (°C) uncorrected. 
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7.1.5 IR analysis 
All IR analysis was carried out on a Perkin Elmer 100 FT-IR spectrometer with ATR. 
 
7.1.6 Mass spectrometry 
High resolution mass spectrometry was obtained for all novel compounds using the 
Waters LCT premier time of flight instrument. 
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7.2 Experimental for antimicrobial studies 
 
7.2.1 Microtiter broth dilution technique 
 
Minimum inhibitory concentrations (MICs) for compounds were determined by serial 
two-fold dilutions in Mueller-hinton or nutrient broth using the microtiter broth dilution 
technique described by Amsterdam.1 All assays were done in triplicate. 
 
Method 
Test strains were grown in nutrient broth at 30 °C overnight. Next day, cultures were 
centrifuged at 5000 rpm for 10 minutes. Pellet was washed twice with 10 ml 0.01 M 
sodium phosphate buffer (pH 7). Optical density of cultures was adjusted to give an 
optical density of 0.07 at 660 nm. 
The compound solution and 96 well plates were ready before the cultures were adjusted 
to the desired optical density. 
For stock solution of chemical, the compound to be tested was dissolved in 1 ml of sterile 
water or organic solvents such as methanol and DMSO dependant on the chemicals 
solubility. 
For microplate preparation, 190 µl of Mueller-hinton broth was dispensed into wells in 
column 1. 100 µl of Mueller-hinton broth was dispensed into all wells from column 2 to 
column 12. 10 µl of the compound solution was pipetted into wells in column 1 (far left 
of plate). The compound was mixed into the wells in column 1 by pipetting up and down 
6-8 times. 100 µl was withdrawn from column 1 and added to column 2. This made 
column 2 a two-fold dilution of column 1. This was mixed up and down 6-8 times. 100 µl 
was transferred to column 3. This procedure was repeated down to column 10 only. 100 
µl was discarded from column 10 rather than putting it in column 11. 5 µl of the strain to 
be tested was dispensed into wells in columns 11 to 1 in that order. Column 11 was used 
as a growth control and column 12 was the sterility control.  The plates were incubated at 
30 °C overnight. Growth on the plates was noted and optical density measured after 24 
hours. 
Results from this screening are presented in chapter 2 (Section 2.3). 
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7.2.2 Antibacterial and antifungal procedure for Czech screening  
 
7.2.2.1 Antibacterial activity – experimental method 
 
In vitro antibacterial activities2 of the compounds were evaluated on a panel of three 
ATCC strains (Staphylococcus aureus ATCC 6538, Escherichia coli ATCC 8739, 
Pseudomonas aeruginosa ATCC 9027) and five clinical isolates (Staphylococcus aureus 
MRSA HK5996/08, Staphylococcus epidermidis HK6966/08, Enterococcus sp. 
HK14365/08, Klebsiella pneumoniae HK11750/08, Klebsiella pneumoniae ESBL 
HK14368/08) from the collection of bacterial strains deposited at the Department of 
Biological and Medical Sciences, Faculty of Pharmacy, Charles University, Hradec 
Králové, Czech Republic. The above-mentioned ATCC strains also served as the quality 
control strains. All the isolates were maintained on Mueller-Hinton agar prior to being 
tested. 
Dimethyl sulfoxide (100 %) served as a diluent for all compounds; the final concentration 
did not exceed 2 %. Mueller-Hinton broth (MH, HiMedia, Čadersky-Envitek, Czech 
Republic) buffered to pH 7.4 (±0.2) was used as the test medium. The wells of the 
microdilution tray contained 200 µl of the Mueller-Hinton medium with 2-fold serial 
dilutions of the compounds (2000 to 0.488 µmol/l) and 10 µl of inoculum suspension. 
Inoculum in MH medium was prepared to give a final concentration of 0.5 McFarland 
scale (1.5 × 108 cfu.ml-1). The trays were incubated at 37°C and MICs were read visually 
after 24 h and 48 h. The MICs were defined as 95 % inhibition of the growth of control. 
MICs were determined twice and in duplicate. The deviations from the usually obtained 
values were no higher than the nearest concentration value up and down the dilution 
scale. 
 
7.2.2.2 Antifungal activity – experimental method 
 
In vitro antifungal activities3,4 of the compounds were evaluated on a panel of four ATCC 
strains (Candida albicans ATCC 44859, Candida albicans ATCC 90028, Candida 
parapsilosis ATCC 22019, Candida krusei ATCC 6258) and eight clinical isolates of 
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yeasts (Candida krusei E28, Candida tropicalis 156, Candida glabrata 20/I, Candida 
lusitaniae 2446/I, Trichosporon asahii 1188) and filamentous fungi (Aspergillus 
fumigatus 231, Absidia corymbifera 272, Trichophyton mentagrophytes 445) from the 
collection of fungal strains deposited at the Department of Biological and Medical 
Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic. 
Three ATCC strains were used as the quality control strains. All the isolates were 
maintained on Sabouraud dextrose agar prior to being tested. 
Minimum inhibitory concentrations (MICs) were determined by modified CLSI standard 
of microdilution format of the M27-A3 and M38-A2 documents.3,4 Dimethyl sulfoxide 
(100 %) served as a diluent for all compounds; the final concentration did not exceed 2 
%. RPMI 1640 (Sevapharma, Prague) medium supplemented with L-glutamine and 
buffered with 0.165 M morpholinepropanesulfonic acid (Serva) to pH 7.0 by 10 M NaOH 
was used as the test medium. The wells of the microdilution tray contained 200 µl of the 
RPMI 1640 medium with 2-fold serial dilutions of the compounds (2000 to 0.488 µmol/l 
for the new compounds) and 10 µl of inoculum suspension. Fungal inoculum in RPMI 
1640 was prepared to give a final concentration of 5 × 103 ± 0.2 cfu.ml-1. The trays were 
incubated at 35°C and MICs were read visually after 24 h and 48 h. The MIC values for 
the dermatophytic strain (T. mentagrophytes) were determined after 72 h and 120 h. The 
MICs were defined as 80 % inhibition (IC80) of the growth of control for yeasts and as 50 
% inhibition (IC50) of the growth of control for filamentous fungi. MICs were determined 
twice and in duplicate. The deviations from the usually obtained values were no higher 
than the nearest concentration value up and down the dilution scale. 
 
7.3 Experimental for cytotoxicity, apoptosis and cell viability studies 
 
 
Normal human erythroid progenitor cells were grown according to a previous report.5 
HL-60 (ATCC CCL-240) and K-562 (ATCC CCL-243) were grown in DMEM (D5546, 
Sigma) with 10% fetal bovine serum (10270, Gibco) supplemented with 2 mM glutamine 
(25030, Gibco) and PenStrep: Penicillin 100 units/mL + Streptomycin 100 µg/mL (15140, 
Gibco) in a humidified atmosphere (95%) with 5% CO2 at 37 ºC. Assays were performed 
as follows: Cells were plated at 5000 (for HL-60 and K-562) or 10000 (for erythroid 
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progenitor cells) cells per well per 25 µL in 384-well plates immediately before 
compound addition. Cell viability and cytotoxicity have a fluorescent readout, and cells 
were plated into black 384-well plates (Corning, Cat. No.3571). Apoptosis has a 
luminescent readout and cells were plated into white 384-well plates (Corning, Cat. No. 
3570). Test compounds diluted in DMSO were acoustically transferred to the cell 
supernatant (Echo 520, Labcyte). Cytotoxicity and apoptosis were measured 3 h after 
compound addition using the CytoTox-ONE homogeneous membrane integrity assay 
(G7892, Promega)6 and the Caspase-Glo 3/7 assay (G8091, Promega)7, respectively. Cell 
viability was measured using the CellTiter-Blue cell viability assay (G8082. Promega)8 
48 h after compound addition. All assays were measured using the EnVision plate reader 
(PerkinElmer). Data were analyzed using GraphPad Prism 5.0 statistical software.  
7.4 Experimental for biodegradation studies -CO2 headspace test (ISO 14593) 
    
To evaluate the biodegradability of the compounds, the ‘CO2 Headspace’ test (ISO 
14593) was applied.9 This method allows the evaluation of the ultimate aerobic 
biodegradability of an organic compound in aqueous medium at a given concentration of 
microorganisms by analysis of inorganic carbon. The test compound, as the only source 
of carbon and energy, was added to a buffer-mineral salts medium which had been 
inoculated with a mixed population of microorganisms derived from an activated sludge 
collected from a sewage treatment plant to give a final organic carbon concentration of 20 
mg/L. These solutions were incubated in sealed vessels with a headspace of air, which 
provided a reservoir of oxygen for aerobic biodegradation. Biodegradation 
(mineralization to carbon dioxide) was determined by measuring the net increase in total 
inorganic carbon (TIC) levels over time compared to unamended blanks. Sodium n-
dodecyl sulfate (SDS) was used as a reference substance. The test ran for 28 days. The 
extent of biodegradation was expressed as a percentage of the theoretical amount of 
inorganic carbon (ThID) based on the amount of test compound added initially. Assuming 
100% mineralization of the test compound, the theoretical amount of inorganic carbon 
(ThID) in excess of that produced in the blank controls equals the amount of total organic 
carbon (TOC) added as the test compound to each vessel at the start of the test, that is: 
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ThIC = TOC 
 
Percentage biodegradation Dt in each case is given by : 
 
 
 
 
 
 
where:  
 
TICt is the TIC, in milligrams, in vessel at time t; 
 
TICb is the mean TIC, in milligrams, in blank control vessels at time t 
 
TOCi is the TOC, in milligrams, initially added to the test vessel 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                           
 (TICt − TICb)  
                  Dt =         TOCi x 100 
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7.5 Preparation of achiral polysubstituted BINOL derivatives 
  
(+/−)-6,6’-Dimethoxy-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (111) 
 
(+/−)-6,6’-Dibromo-3,3’-diphenyl -2,2’-dihydroxy-
1,1’-binaphthyl (123) (260 mg, 0.44 mmol) and 
copper (І) iodide (348 mg, 1.83 mmol) were stirred 
in dry DMF (1.30 mL) at room temperature under 
nitrogen for 10 minutes. 4.4 M Sodium methoxide in 
methanol (2.62 mL, 11.53 mmol) was added and the 
reaction mixture was refluxed for 24 h, then allowed 
cool to room temperature. Ice-water mixture (6 mL) 
was added, followed by 4N HCl (2 mL) and mixture 
was allowed to stir for 10 minutes. Mixture was filtered and remaining solid was washed 
with ethyl acetate. Filtrate was extracted with ethyl acetate (3 x 10 mL) and the combined 
organic phase was washed with brine (10 mL), dried over anhydrous magnesium sulfate, 
filtered and volatiles removed via rotary evaporation to yield the crude product. Crude 
product was purified by column chromatography (SiO2, hexane/ethyl acetate 10:1) to 
yield the title compound as a beige solid in 65% yield (142 mg, 0.29 mmol). 
 
Mpt = 230-232 °C 
Molecular formula C34H26O4 
Molecular weight 498.57 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   7.96 (s, 2H, H4, H4’), 7.78 (dd, J= 7.2 Hz, 1.4 Hz, 
4H, H12, H12’, H16, H16’), 7.54 (dd, J= 7.2 Hz, 1.4 Hz, 4H, H13, H13’, H15, H15’), 
7.45 (tt, J= 7.2 Hz, 1.4 Hz,  2H, H14, H14’), 7.28 (d, J=  2.8 Hz, 2H, H5, H5’), 7.19 (d, 
J= 9.0 Hz, 2H, H8, H8’), 7.04 (dd, J= 9.0 Hz, 2.8 Hz, 2H, H7, H7’), 5.31 (s, 2H, OH), 
3.94 (s, 6H, H17, H17’) 
13C NMR (100 MHz, CDCl3) δ ppm    
156.59 (C, C6, C6’), 148.38 (C, C2, C2’), 137.69 (C, C11, C11’), 131.07 (C, C3, C3’), 
130.38 (C, C9/C10, C9’/C10’ ), 130.12 (CH, C4, C4’), 129.65 (2CH, C12, C12’, C16 
C16’), 128.51 (2CH, C13, C13’ ,C15, C15’), 128.24 (C, C9/C10, C9’/C10’), 127.76 (CH, 
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C14, C14’), 125.98 (CH, C8, C8’), 119.88 (CH, C7, C7’), 112.91 (C, C1, C1’), 106.72 
(CH, C5, C5’), 55.44 (CH3, C17, C17’) 
IR   (neat) (cm-1) 3509, 2932, 2836, 1624, 1603, 1504, 1461, 1371, 1225, 1173, 1124, 
1029 
HRMS (EI, 70 eV, m/z) Found [M+H]+ 499.1900, C34H27O4+ requires 499.1909 
 
 
(+/−)-6,6’-Diethoxy-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (112) 
 
(+/−)-6,6’-Dibromo -3,3’-diphenyl -2,2’-
dihydroxy-1,1’-binaphthyl (123) (250 mg, 0.42 
mmol) and copper (І) iodide (331 mg, 1.74 
mmol) were stirred in dry DMF (1 mL) at room 
temperature under nitrogen for 10 minutes. 2.2 M 
Sodium ethoxide in ethanol (5.24 mL, 11.54 
mmol) was added and the reaction mixture was 
refluxed for 24 h, then allowed cool to room 
temperature. Ice-water mixture (6 mL) was 
added, followed by 4N HCl (2 mL) and allowed to stir for 10 minutes. Mixture was 
filtered and the remaining solid was washed with ethyl acetate. Filtrate was extracted 
with ethyl acetate (3 x 10 mL) and the combined organic phase was washed with brine 
(10 mL), dried over anhydrous magnesium sulfate, filtered and the solvent was removed 
via rotary evaporation to yield the crude product. Crude product was purified by column 
chromatography (SiO2, hexane/ethyl acetate 10:0.3) to yield the title compound as beige 
solid in 55 % yield (122 mg, 0.23 mmol). 
 
Mpt = 211-213 °C 
Molecular formula C36H30O4 
Molecular weight 526.62 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   7.90 (s, 2H, H4, H4’), 7.74 (dd, J= 7.0 Hz, 1.4 Hz, 
4H, H12, H12’, H16, H16’), 7.49 (dd, J= 7.0 Hz, 1.4 Hz, 4H, H13, H13’, H15, H15’), 
6
7
8
10
9
5
1
2
3
4
1'
10'
9'
4'
3'
2'
8'
7'
6'
5'
OH
OH
11
11'
16'
15'
14'
13'
12'
16
15
14
13
12
O
17
O
17'
18
18'
193 
7.41 (tt, J= 7.0 Hz, 1.4 Hz, 2H, H14, H14’), 7.23  (d, J= 2.4 Hz, 2H, H5, H5’), 7.14 (d, J= 
9.2 Hz, 2H, H8, H8’), 7.00 (dd, J= 9.2 Hz, 2.4 Hz, 2H, H7, H7’), 5.23 (s, 2H, OH), 4.15 
(q, J= 7.0 Hz, 4H, H17, H17’), 1.47 (t, J= 7.0 Hz, 6H, H18, H18’) 
13C NMR (100 MHz, CDCl3) δ ppm    
155.90 (C, C6, C6’), 148.28 (C, C2, C2’), 137.71 (C, C11, C11’), 130.97 (C, C3, C3’), 
130.40 (C, C9/C10, C9’/C10’), 130.05 (CH, C4, C4’), 129.62 (2CH, C12, C12’, C16, 
C16’), 128.46 (2CH, C13, C13’, C15, C15’), 128.13 (C, C9/C10, C9’/C10’), 127.70 (CH, 
C14, C14’), 125.92 (CH, C8, C8’), 120.14 (CH, C7, C7’), 112.82 (C, C1, C1’), 107.50 
(CH, C5, C5’), 63.58 (CH2, C17, C17’), 14.88 (CH3, C18, C18’) 
IR (neat) (cm-1) 3480, 3361, 3034, 2923, 1626, 1600, 1506, 1473, 1351, 1226, 1172, 
1130, 1112, 1039, 1028 
HRMS (EI, 70 eV, m/z) Found [M+H]+ 527.2214, C36H31O4+ requires 527.2222 
 
 
(+/−)-6,6’-Dihydroxy-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (113) 
 
To a stirred solution of (+/−)-6,6’-dimethoxy-3,3’-
diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (111) (100 
mg, 0.19 mmol) in DCM (4 mL) at 0 °C under a 
nitrogen atmosphere was added dropwise 1 M boron 
tribromide in DCM (1.77 mL, 440 mg, 1.77 mmol). 
Reaction mixture was allowed to reach room 
temperature and stirred overnight. Reaction was 
quenched at 0 °C by the slow addition of deionised 
water (5 mL). Product was extracted with DCM (3 x 5 
mL) and the combined organic phase was washed with brine (5 mL), dried over 
anhydrous magnesium sulfate, filtered and volatiles removed to yield crude product. 
Crude product was purified by column chromatography (SiO2, hexane/ethyl acetate 
1.25:1) to yield the title compound as a white solid in 49% yield (46 mg, 0.10 mmol) 
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Mpt = 239-240 °C 
Molecular formula C32H22O4 
Molecular weight 470.51 gmol-1 
1H NMR (400 MHz, (CD3)2SO) δ ppm   9.43 (s, 2H, OH), 7.92 (s, 2H, OH), 7.78 (s, 
2H, H4, H4’ ), 7.77 (d, J= 7.4 Hz, 4H, H12, H12’, H16, H16’), 7.54 (dd, J= 7.4 Hz, 7.4 
Hz, 4H, H13, H13’, H15, H15’), 7.43 (t, J= 7.4 Hz, 2H, H14, H14’), 7.25 (d, J= 2.2 Hz, 
2H, H5, H5’), 6.90 (dd, J= 9.0 Hz, 2.2 Hz, 2H, H7, H7’), 6.86 (d, J= 9.0 Hz, 2H, H8, 
H8’) 
13C NMR (100 MHz, (CD3)2CO) δ ppm 154.53 (C, C6, C6’), 150.36 (C, C2, C2’), 
140.14 (C, C11, C11’), 132.95 (C, C3, C3’), 131.43 (C, C9/C10, C9’/C10’) 130.64 (2CH, 
C12, C12’, C16, C16’), 129.70 (CH, C4, C4’), 129.41 (C, C9/C10, C9’/C10’), 128.79 
(2CH, C13, C13’, C15, C15’), 127.84 (CH, C14, C14’), 126.91 (CH, C8, C8’), 119.55 
(CH, C7, C7’), 115.16 (C, C1, C1’), 110.58 (CH, C5, C5’)  
IR   (neat) (cm-1) 3342, 3051, 1607, 1505, 1379, 1199, 1180, 1129, 1072 
HRMS (EI, 70 eV, m/z) Found [M+H]+ 471.1578, C32H23O4+ requires 471.1596 
 
(+/−)-6,6’-Dibutyl-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (114) 
 
To a stirred solution of (+/−)-6,6’-dibutyl-
3,3’-diphenyl-2,2’-bis(methoxymethoxy)- 1 
,1’-binaphthyl (127) (232 mg, 0.36 mmol) in 
THF (11 mL) at room temperature, was added 
concentrated hydrochloric acid (0.25 mL, 
32%, 10.17 M). Reaction mixture was 
warmed to 50 °C and after 24 h allowed to 
cool to room temperature. Solvent was 
removed via rotary evaporation. Deionised 
water (5 mL) was added and the product was extracted with DCM (3 x 10 mL) and the 
combined organic phase was washed with brine (10 mL), dried over anhydrous 
magnesium sulfate, filtered and solvent removed via rotary evaporation to yield the crude 
product. Crude product was purified by column chromatography (SiO2, hexane/ethyl 
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acetate 10:0.3) to yield the title compound as a yellow solid in 74% yield (148 mg, 0.27 
mmol).  
 
Mpt = 130-131 °C 
Molecular formula C40H38O2 
Molecular weight 550.73 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   7.98 (s, 2H, H4, H4’), 7.76 (dd, J= 7.2 Hz, 1.4 Hz, 
4H, H12, H12’, H16, H16’), 7.71 (s, 2H, H5, H5’), 7.51 (dd, J= 7.2 Hz, 1.4 Hz, 4H, H13, 
H13’, H15, H15’), 7.42 (tt, J= 7.2 Hz, 1.4 Hz, 2H, H14, H14’), 7.20 (d, J= 1.2 Hz, 4H, 
H7, H7’, H8, H8’),  5.32 (s, 2H, OH), 2.76 (t, J= 7.4 Hz, 4H, H17, H17’), 1.69 (tt, J= 7.4 
Hz, 7.4 Hz, 4H, H18, H18’), 1.41 (qt, J= 7.4 Hz, 7.4 Hz, 4H, H19, H19’), 0.96 (t, J= 7.4 
Hz, 6H, H20, H20’) 
13C NMR (100 MHz, CDCl3) δ ppm    
149.52 (C, C2, C2’), 138.90 (C, C6, C6’), 137.77 (C, C11, C11’), 131.32 (C, C9/C10, 
C9’/C10’), 130.90 (CH, C4, C4’), 130.58 (C, C3, C3’), 129.66 (2CH, C12, C12’, C16, 
C16’), 129.63 (C, C9/C10, C9’/C10’), 128.99 (CH, C7, C7’), 128.46 (2CH, C13, C13’, 
C15, C15’), 127.67 (CH, C14, C14’), 126.93 (CH, C5, C5’), 124.27 (CH, C8, C8’), 
112.39 (C, C1, C1’), 35.56 (CH2, C17, C17’), 33.59 (CH2, C18, C18’), 22.43 (CH2, C19, 
C19’), 14.05 (CH3, C20, C20’) 
IR (neat) (cm-1) 3517, 2955, 2925, 2856, 1604, 1496, 1457, 1428, 1369, 1235, 1178, 
1136 
HRMS (EI, 70 eV, m/z) Found [M+H]+ 551.2953, C40H39O2+ requires 551.2950 
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(+/−)-6,6’-Dicarboxyl-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (115) 
 
To a stirred mixture of (+/−)-6,6’-dicarboxyl-3,3’-
diphenyl-2,2’-bis(methoxymethoxy)-1,1’-binaphthyl 
(126) (79 mg, 0.13 mmol) in THF (1 mL) at room 
temperature, was added concentrated hydrochloric 
acid (0.03 mL, 32%, 10.17 M). Reaction mixture 
was warmed to 50 °C and after 4 h allowed to cool 
to room temperature. Solvent was removed via 
rotary evaporation. Deionised water (1 mL) was 
added and product was extracted with DCM (3 x 1 
mL) and the combined organic phase was washed with brine (1 mL), dried over 
anhydrous magnesium sulfate, filtered and solvent removed via rotary evaporation to 
yield crude product. Crude product was purified by column chromatography (SiO2, ethyl 
acetate/ethanol 10:0.2) to yield title compound as a white solid in 77% yield (52 mg, 0.10 
mmol). 
 
 
Mpt = 254-255 °C 
Molecular formula C34H22O6 
Molecular weight 526.53 gmol-1 
1H NMR (400 MHz, (CD3)2SO) δ ppm   12.84 (s, 2H, OH), 8.85 (s, 2H, OH) 8.65 (s, 
2H, H5, H5’), 8.18 (s, 2H, H4, H4’), 7.73 (d, J = 8.0 Hz, 2H, H7, H7’), 7.73 (d, J= 7.6 
Hz, 4H, H12, H12’, H16, H16’), 7.50 (dd, J= 7.6 Hz, 7.6 Hz, 4H, H13, H13’, H15, 
H15’), 7.40 (t, J= 7.6 Hz,  2H, H14, H14’), 6.98 (d, J= 9.2 Hz, 2H, H8, H8’) 
13C NMR (100 MHz, (CD3)2SO) δ ppm  172.83 (C, C17, C17’), 158.95 (C, C2, C2’), 
143.58 (C, C11, C11’), 141.02 (C, C10, C10’), 137.85 (C, C3, C3’), 136.92 (CH, C4, C4’ 
), 136.36 (CH, C5, C5’), 134.88 (2CH, C12, C12’, C16, C16’), 133.27 (2CH, C13, C13’, 
C15, C15’), 132.94 (C, C6/C9, C6’/C9’), 132.45 (CH, C14, C14’), 130.99 (CH, C7, C7’), 
130.39 (C, C6/C9, C6’/C9’), 129.23 (CH, C8, C8’), 119.79 (C, C1, C1’)  
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IR (neat) (cm-1) 3436, 2923, 2532, 1678 (COOH), 1618, 1458, 1431, 1263, 1197, 1165, 
1133, 1065, 1030 
HRMS (EI, 70 eV, m/z) Found [M+H]+ 527.1481, C34H23O6+ requires 527.1495 
 
 
 
 
(+/−)-6,6’-Bis(2-(trimethylsilyl)ethynyl)-3,3’-diphenyl-2,2’-dihydroxy-1,1’-
binaphthyl (116) 
 
(+/−)-6,6’-Dibromo -3,3’-diphenyl- 2,2’-
dihydroxy-1,1’-binaphthyl (123) (550 mg, 
0.92 mmol) was dissolved in TMEDA (3 mL) 
under a nitrogen atmosphere and allowed to 
stir for 5 minutes. Sodium 
tetrachloropalladate (ІІ) (54 mg, 0.19 mmol), 
2-(di-tert-butylphosphino) -1-phenylindole 
(PIntB) (93 mg, 0.28 mmol) and copper (І) 
iodide (44 mg, 0.23 mmol) were added under 
nitrogen and the solution was warmed to 70 °C. Under a slow flow of nitrogen, 
ethynyltrimethylsilane (0.55 mL, 362 mg, 3.69 mmol) was added quickly and the reaction 
mixture was heated at 80 °C for 4 h. Dry THF (10 mL) was added and the reaction was 
allowed to reflux at 80 °C overnight. The reaction mixture was allowed cool to room 
temperature and concentrated in vacuo. Deionised water (10 mL) was added and the 
product was extracted with ethyl acetate (3 x 10 mL). The combined organic phase was 
washed with brine (10 mL), dried over anhydrous magnesium sulfate, filtered and the 
solvent was evaporated to yield crude product. Crude product was purified by column 
chromatography (SiO2, hexane/ethyl acetate 10:0.3) to yield the title compound as a 
yellow solid in 60% yield (347 mg, 0.55 mmol). 
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Mpt = 215-216 °C 
Molecular formula C42H38O2Si2 
Molecular weight 630.92 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   8.10 (d, J= 1.4 Hz, 2H, H5, H5’), 7.97 (s, 2H, H4, 
H4’), 7.73 (dd, J= 7.4 Hz, 1.2 Hz, 4H, H12, H12’, H16, H16’), 7.53 (dd, J= 7.4 Hz, 1.2 
Hz, 4H, H13, H13’, H15, H15’), 7.45 (tt, J= 7.4 Hz, 1.2 Hz, 2H, H14, H14’), 7.38 (dd, J= 
8.8 Hz, 1.4 Hz, 2H, H7, H7’), 7.14 (d, J= 8.8 Hz, 2H, H8, H8’), 5.45 (s, 2H, OH), 0.31 (s, 
18H, H19, H19’, H20, H20’, H21, H21’) 
13C NMR (100 MHz, CDCl3) δ ppm    
150.77 (C, C2, C2’), 136.90 (C, C11, C11’), 132.47 (C, C6/C9/C10, C6’/C9’/C10’), 
132.43 (CH, C5, C5’), 131.30 (C, C3, C3’), 131.14 (CH, C4, C4’), 130.06 (CH, C7, C7’), 
129.48 (2CH, C12, C12’, C16, C16’), 128.83 (C, C6/C9/C10, C6’/C9’/C10’), 128.61 
(2CH, C13, C13’, C15, C15’), 128.00 (CH, C14, C14’), 124.22 (CH, C8, C8’), 118.91 
(C, C6/C9/C10, C6’/C9’/C10’), 112.44 (C, C1, C1’), 105.20 (C, C17, C17’), 94.45 (C, 
C18, C18’), 0.00 (3CH3, C19, C19’, C20, C20’, C21, C21’) 
IR (neat) (cm-1) 3486, 3355, 2956, 2154, 1605, 1498, 1455, 1432, 1248, 1210, 1186, 
1139, 1075 
HRMS (EI, 70 eV, m/z) Found [M+H]+ 631.2478, C42H39O2Si2+ requires 631.2489 
 
 
(+/−)-6,6’-Dipentynyl-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (117) 
 
(+/−)-6,6’-Dibromo -3,3’-diphenyl -2,2’-
dihydroxy-1,1’-binaphthyl (123) (751 mg, 
1.26 mmol) was dissolved in TMEDA (5 
mL) under a nitrogen atmosphere and 
allowed to stir for 5 minutes. Sodium 
tetrachloropalladate (ІІ) (74 mg, 0.25 
mmol), 2-(di-tert-butylphosphino)-1-
phenylindole (PIntB) (127 mg, 0.38 
mmol), copper (І) iodide (60 mg, 0.32 
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mmol) and 1-pentyne (0.75 mL, 515 mg, 7.56 mmol) were added. The reaction mixture 
was refluxed at 80 °C overnight, then allowed cool to room temperature and concentrated 
in vacuo. Deionised water (25 mL) was added and the product was extracted with ethyl 
acetate (3 x 25 mL). The combined organic phase was washed with brine (25 mL), dried 
over anhydrous magnesium sulfate, filtered and the solvent was evaporated to yield crude 
product. Crude product was purified by column chromatography (SiO2, hexane/ethyl 
acetate 10:0.3) to yield the title compound as a yellow solid in 50 % yield (358 mg, 0.63 
mmol). 
 
Mpt = 119-121 °C 
Molecular formula C42H34O2 
Molecular weight 570.72 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   7.99 (d, J= 1.6 Hz, 2H, H5, H5’), 7.95 (s, 2H, H4, 
H4’), 7.72 (dd, J= 7.2 Hz, 1.6 Hz, 4H, H12, H12’, H16, H16’), 7.51 (dd, J= 7.2 Hz, 1.6 
Hz, 4H, H13, H13’, H15, H15’), 7.43 (tt, J= 7.2 Hz, 1.6 Hz, 2H, H14, H14’), 7.32 (dd, J= 
8.8 Hz, 1.6 Hz, 2H, H7, H7’), 7.13 (d, J= 8.8 Hz, 2H, H8, H8’), 5.40 (s, 2H, OH), 2.44 (t, 
J= 7.2 Hz, 4H, H19, H19’), 1.67 (qt, J= 7.2 Hz, J= 7.2 Hz, 4H, H20, H20’), 1.08 (t, J= 
7.2 Hz, 6H, H21, H21’) 
13C NMR (100 MHz, CDCl3) δ ppm150.45 (C, C2, C2’), 137.16 (C, C11, C11’), 132.02 
(C, C6/C9/C10, C6’/ C9’/C10’), 131.53 (CH, C5, C5’), 131.18 (C, C3, C3’), 131.05 (CH, 
C4, C4’), 130.33 (CH, C7, C7’), 129.60 (2CH, C12, C12’, C16, C16’), 129.12 (C, 
C6/C9/C10, C6’/C9’/C10’), 128.63 (2CH, C13, C13’, C15, C15’), 127.99 (CH, C14, 
C14’), 124.26 (CH, C8, C8’), 119.98 (C, C6/C9/C10, C6’/C9’/C10’), 112.43 (C, C1, 
C1’), 90.63 (C, C18, C18’), 80.85 (C, C17, C17’), 22.30 (CH2, C20, C20’),  21.55 (CH2, 
C19, C19’) , 13.67 (CH3, C21, C21’) 
IR (neat) (cm-1) 3506, 3050, 2960, 2930, 2188, 1601, 1495, 1455, 1425, 1365, 1232, 
1162, 1133, 1070, 1030 
HRMS (EI, 70 eV, m/z) Found [M+H]+ 571.2646, C42H35O2+ requires 571.2637 
 
 
 
200 
(+/−)-6,6’-Dipentan-1-one-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (118) 
 
(+/−)-6,6’-Dipentynyl -3,3’-diphenyl-2,2’-
dihydroxy-1,1’-binaphthyl (117) (358 mg, 
0.63 mmol) was dissolved in ethanol (2.5 
mL) and PTSA monohydrate (119 mg, 
0.63 mmol) was added. Reaction mixture 
was refluxed at 80 °C for 36 h, allowed to 
cool to room temperature and volatiles 
were removed via rotary evaporation. 
Residual solid was dissolved in ethyl 
acetate (25 mL), washed with deionised water (10 mL), brine (10 mL), dried over 
anhydrous magnesium sulfate, filtered and volatiles were removed via rotary evaporation 
to yield the crude product. Crude product was purified by column chromatography (SiO2, 
hexane/ethyl acetate 10:1) to yield the title compound as a yellow solid in 59% yield (225 
mg, 0.37 mmol). 
 
Mpt = 133-135 °C 
Molecular formula C42H38O4 
Molecular weight 606.75 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   8.51 (d, J= 1.6 Hz, 2H, H5, H5’), 8.12 (s, 2H, H4, 
H4’), 7.82 (dd, J= 8.8 Hz, 1.6 Hz, 2H, H7, H7’), 7.73 (dd, J= 7.2 Hz, 1.4 Hz, 4H, H12, 
H12’, H16, H16’), 7.51 (dd, J= 7.2 Hz, 1.4 Hz, 4H, H13, H13’, H15, H15’), 7.44 (tt, J= 
7.2 Hz, 1.4 Hz, 2H, H14, H14’), 7.21 (d, J= 8.8 Hz, 2H, H8, H8’)  5.84 (s, 2H, OH), 3.01 
(t, J= 7.4 Hz, 4H, H18, H18’), 1.72 (tt, J= 7.4 Hz, 7.4 Hz, 4H, H19, H19’), 1.41 (qt, J= 
7.4 Hz, 7.4 Hz, 4H, H20, H20’), 0.95 (t, J= 7.4 Hz, 6H, H21, H21’) 
13C NMR (100 MHz, CDCl3) δ ppm 200.17 (CO, C17, C17’), 152.20 (C, C2, C2’), 
136.62 (C, C11, C11’), 135.42 (C, C10, C10’), 133.01 (C, C6/C9, C6’/C9’), 132.97 (CH, 
C4, C4’), 131.69 (C, C3, C3’), 130.24 (CH, C5, C5’), 129.53 (2CH, C12, C12’, C16, 
C16’), 128.80 (2CH, C13, C13’, C15, C15’), 128.47 (C, C6/C9, C6’/C9’), 128.27 (CH, 
C14, C14’), 125.64 (CH, C7, C7’), 124.60 (CH, C8, C8’), 112.73 (C, C1, C1’), 38.36 
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(CH2, C18, C18’), 26.72 (CH2, C19, C19’), 22.55 (CH2, C20, C20’), 13.99 (CH3, C21, 
C21’) 
IR (neat) (cm-1) 3313, 2956, 2925, 2865, 1664 (C=O), 1614, 1456, 1428, 1374, 1325, 
1153 
HRMS (EI, 70 eV, m/z) Found [M+H]+ 607.2858, C42H39O4+ requires 607.2848 
 
 
 
 
(+/−)-2,2’-Bis(methoxymethoxy)-1,1’-binaphthyl (119) 
  
 
To a stirred solution of sodium hydride (2.680 g, 60% in 
mineral oil, 66.88 mmol) in dry THF (100 mL) at 0 °C under 
a nitrogen atmosphere was added dropwise a solution 
containing (+/−)-1,1’-bi-2-naphthol (45) (6.000 g, 20.95 
mmol) in dry THF (50 mL). After stirring at 0 °C for 1 h, 
chloromethyl methyl ether (3.49 mL, 3.700 g, 45.96 mmol) was added dropwise. Upon 
complete addition, the reaction mixture was allowed to warm up to room temperature and 
stirred for 4 h. Saturated aqueous ammonium chloride (30 mL) was added slowly to 
quench the reaction and volatiles removed in vacuo. Residue was extracted with DCM (3 
x 30 mL) and the combined organic phase was washed with brine (30 mL), dried over 
anhydrous magnesium sulfate, filtered and solvent removed via rotary evaporation to 
yield the crude product. Crude product was purified by column chromatography (SiO2, 
using a gradient solvent system of hexane, hexane/ethyl acetate 10:0.5) to yield the title 
compound as a white solid in 80% yield (6.290 g, 16.80 mmol). 
 
Mpt = 82-84 °C, Lit Mpt = 89-92 ºC11 
Molecular formula C24H22O4 
Molecular weight 374.43 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   7.97 (d, J= 9.2 Hz, 2H), 7.89 (d, J= 8.2 Hz, 2H), 
7.60 (d, J= 9.2 Hz, 2H), 7.38-7.34 (m, 2H), 7.26-7.22 (m, 2H), 7.18 (d, J= 8.2 Hz, 2H), 
5.10 (d, JAB= 6.6 Hz, 2H), 4.99 (d, JAB= 6.6 Hz, 2H), 3.16 (s, 6H)  
O O
O O
202 
13C NMR (100 MHz, CDCl3) δ ppm   152.65 (C), 134.03 (C), 129.89 (C), 129.42 (CH), 
127.90 (CH), 126.33 (CH), 125.57 (CH), 124.10 (CH), 121.30 (C), 117.29 (CH), 95.20 
(CH2), 55.86 (CH3) 
 
1H and 13C NMR data in agreement with the literature.10,11 
 
 
(+/−)-3,3’-Dibromo-2,2’-bis(methoxymethoxy)-1,1’-binaphthyl (120) 
 
To a stirred solution of (+/−)-2,2’-bis(methoxymethoxy)-
1,1’-binaphthyl (119) (5.276 g, 14.11 mmol) in dry diethyl 
ether (220 mL) at room temperature under a nitrogen 
atmosphere was added dropwise n-butyllithium (1.6 M in 
hexanes, 26.50 mL, 42.32 mmol). After stirring at room 
temperature for 3 h, THF (100 mL) was added. After 1 h, 
reaction mixture was cooled to 0 °C and dibromotetrachloroethane (13.780 g, 42.32 
mmol) was added in one portion. Reaction mixture was allowed to reach room 
temperature over 2 h. Saturated aqueous ammonium chloride (60 mL) was added to 
quench the reaction and phases separated. Aqueous layer was extracted with diethyl ether 
(3 x 60 mL) and the combined organic phase was washed with brine (60 mL), dried over 
anhydrous magnesium sulfate, filtered and solvent removed via rotary evaporation to 
yield the crude product. Crude product was purified by column chromatography (SiO2, 
hexane/ethyl acetate 10:0.3) to yield the title compound as a white solid in 86% yield 
(6.459 g, 12.14 mmol). 
 
Mpt = 118-120 °C, Lit Mpt = 125-126 ºC11 
Molecular formula C24H20Br2O4 
Molecular weight 532.22 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   8.28 (s, 2H), 7.81 (d, J= 8.4 Hz, 2H), 7.47-7.43 
(m, 2H), 7.33-7.29 (m, 2H), 7.19 (d, J= 8.4 Hz, 2H), 4.84 (d, JAB= 5.6 Hz, 2H), 4.82 (d, 
JAB= 5.6 Hz, 2H), 2.57 (s, 6H) 
O O
O O
Br
Br
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13C NMR (100 MHz, CDCl3) δ ppm   150.14 (C), 133.09 (C), 133.03 (CH), 131.50 (C), 
127.41 (C), 126.93 (2CH), 126.58 (CH), 126.09 (CH), 117.37 (C), 99.18 (CH2), 56.31 
(CH3)   
 
1H and 13C NMR data in agreement with the literature.10,11 
 
(+/−)-3,3’-Diphenyl-2,2’-bis(methoxymethoxy)-1,1’-binaphthyl (121) 
 
(+/−)-3,3’-Dibromo-2,2’ -bis(methoxymethoxy)- 1,1’-
binaphthyl (120) (300 mg, 0.56 mmol) and 
tetrakis(triphenylphosphine)palladium(0) (60 mg, 0.06 
mmol) were added to dry DME (3.70 ml) at room 
temperature under a nitrogen atmosphere. To the stirred 
mixture was added phenylboronic acid (240 mg, 1.96 mmol) 
and 2 M aqueous sodium carbonate (1.5 mL). Reaction 
mixture was refluxed for 18 h, allowed cool to room 
temperature and filtered through a pad of celite. Solvent was removed via rotary 
evaporation to give a crude residue. Residue was dissolved in DCM (15 mL), washed 
with saturated aqueous ammonium chloride (15 mL), deionised water (15 mL), brine (15 
mL), dried over anhydrous magnesium sulfate, filtered and solvent removed via rotary 
evaporation to yield crude product. Crude product was purified by column 
chromatography (SiO2, hexane/ethyl acetate 10:1) to yield the title compound as a white 
solid in 72% yield (212 mg, 0.40 mmol).  
 
Mpt = 119-121 °C 
Molecular formula C36H30O4 
Molecular weight 526.62 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm 7.99 (s, 2H), 7.93 (d, J= 8.2 Hz, 2H), 7.80 (d, J= 8.2 
Hz, 4H), 7.52-7.49 (m, 4H), 7.47-7.39 (m, 4H), 7.36-7.30 (m, 4H), 4.45 (d, JAB= 6 Hz, 
2H), 4.41 (d, JAB= 6 Hz, 2H), 2.38 (s, 6H)   
13C NMR (100 MHz, CDCl3) δ ppm 151.36 (C), 139.07 (C), 135.50 (C), 133.64 (C), 
O O
O O
204 
130.87 (C), 130.60 (CH), 129.67 (2CH), 128.36 (2CH), 127.89 (CH), 127.33 (CH), 
126.55 (C), 126.46 (CH), 126.34 (CH), 125.21 (CH), 98.66 (CH2), 55.87 (CH3)  
 
1H and 13C NMR data in agreement with the literature.10,11 
 
(+/−)-3,3’-Diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (122) 
 
To a stirred mixture of  (+/−)-3,3’-diphenyl-2,2’-
bis(methoxymethoxy)-1,1’-binaphthyl (212 mg, 0.40 mmol) 
(121) in THF (2 mL) at room temperature, was added 
concentrated hydrochloric acid (0.06 mL, 32%, 10.17 M). 
Reaction mixture was warmed to 50 °C and after 4 h allowed 
cool to room temperature. Solvent was removed via rotary 
evaporation. Deionised water (2 mL) was added and product 
was extracted with DCM (3 x 2 mL). The combined organic 
phase was washed with brine (2 mL), dried over anhydrous magnesium sulfate, filtered 
and solvent removed via rotary evaporation to yield the crude product. Crude product was 
purified by column chromatography (SiO2, hexane/ ethyl acetate 10:1) to yield the title 
compound as a white solid in 68% yield (119 mg, 0.27 mmol). 
 
Mpt = 204-205 °C, Lit Mpt = 209-210 ºC11 
Molecular formula C32H22O2 
Molecular weight 438.52 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   8.05 (s, 2H), 7.95 (d, J= 8.2 Hz, 2H), 7.76 (d, J= 
7.0 Hz, 4H), 7.52 (t, J= 7.0 Hz, 4H), 7.45-7.39 (m, 4H), 7.36-7.32 (m, 2H), 7.26 (d, J= 
8.2 Hz, 2H), 5.40 (s, 2H)  
13C NMR (100 MHz, CDCl3) δ ppm   150.18 (C), 137.50 (C), 132.99 (C), 131.45 (CH), 
130.71 (C), 129.65 (2CH), 129.48 (C), 128.54 (2CH), 128.50 (CH), 127.82 (CH), 127.40 
(CH), 124.38 (CH), 124.33 (CH), 112.43 (C) 
 
1H and 13C NMR data in agreement with the literature.10,11 
OH
OH
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(+/−)-6,6’-Dibromo-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (123) 
 
To a stirred solution of (+/−)-3,3’-diphenyl-2,2’-
dihydroxy-1,1’-binaphthyl (122) (1.320 g, 3.01 mmol) 
in DCM (46 mL) at −78 °C under a nitrogen 
atmosphere was added slowly a solution of bromine 
(598 µL, 1.867 g, 11.68 mmol) in DCM (8 mL) over a 
period of 60 minutes. Reaction mixture was allowed to 
reach room temperature over 2 h, then allowed to stir at 
room temperature for 2 h. The reaction was quenched 
with 10% sodium bisulfite (40 mL). Product was 
extracted with DCM (3 x 50 mL) and the combined organic extracts were washed with 
brine (30 mL), dried over anhydrous magnesium sulfate, filtered and solvent was 
removed via rotary evaporation to yield crude product. Crude product was purified by 
recrystallisation from hexane/DCM at room temperature and filtered to yield the title 
compound as a light yellow solid in 69% yield (1.238 g, 2.08 mmol). 
 
Mpt = 207-208 °C  
Molecular formula C32H20Br2O2 
Molecular weight 596.31 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   8.07 (d, J= 2.0 Hz, 2H, H5, H5’), 7.91 (s, 2H, H4, 
H4’), 7.69 (dd, J= 7.6 Hz, 1.2 Hz, 4H, H12, H12’, H16, H16’), 7.51 (dd, J= 7.6 Hz, 1.2 
Hz, 4H, H13, H13’, H15, H15’), 7.44 (tt, J= 7.6 Hz, 1.2 Hz, 2H, H14, H14’), 7.38 (dd, J= 
9.0 Hz, 2.0 Hz, 2H, H7, H7’), 7.06 (d, J= 9.0 Hz, 2H, H8, H8’), 5.39 (s, 2H, OH)  
13C NMR (100 MHz, CDCl3) δ ppm   150.26 (C), 136.73 (C), 131.85 (C), 131.48 (C), 
130.64 (CH, C7, C7’), 130.53 (C), 130.41 (CH, C4/C5, C4’/C5’), 130.37 (CH, C4/C5, 
C4’/C5’), 129.54 (2CH, C12, C12’, C16, C16’), 128.78 (2CH, C13, C13’, C15, C15’), 
128.25 (CH, C14, C14’), 126.08 (CH, C8, C8’), 118.18 (C), 112.63 (C) 
 
1H and 13C NMR data in agreement with the literature.10,11 
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(+/−)-6,6’-Dibromo-3,3’-diphenyl-2,2’-bis(methoxymethoxy)-1,1’-binaphthyl (125) 
 
To a stirred solution of sodium hydride (230 mg, 
60% in mineral oil, 5.80 mmol) in dry THF (10 mL) 
at 0 °C under a nitrogen atmosphere was added 
dropwise a solution of (+/−)-6,6’-dibromo-3,3’-
diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (123) (1.24 
g, 1.93 mmol) in dry THF (4 mL). After stirring at 0 
°C for 1 h, chloromethyl methyl ether (0.44 mL, 
0.467 g, 5.80 mmol) was added dropwise. Upon 
complete addition, the reaction mixture was allowed 
to warm up to room temperature and stirred for 4 h. Saturated aqueous ammonium 
chloride (10 mL) was added slowly to quench the reaction and volatiles removed in 
vacuo. Residue was extracted with DCM (3 x 10 mL) and the combined organic phase 
was washed with brine (10 mL), dried over anhydrous magnesium sulfate, filtered and 
solvent removed via rotary evaporation to yield the crude product. Crude product was 
purified by column chromatography (SiO2, hexane/ethyl acetate 10:0.3) to yield the title 
compound as a white solid in 68% yield (0.894 g, 1.31 mmol).  
 
Mpt = 66-68 °C 
Molecular formula C36H28Br2O4 
Molecular weight 684.41 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   8.06 (d, J= 2.0 Hz, 2H, H5, H5’), 7.87 (s, 2H, H4, 
H4’), 7.73 (dd, J= 7.2 Hz, 1.6 Hz, 4H, H14, H14’, H18, H18’), 7.49 (dd, J= 7.2 Hz, 1.6 
Hz, 4H, H15, H15’, H17, H17’), 7.40 (tt, J= 7.2 Hz, 1.6 Hz, 2H, H16, H16’), 7.37 (dd, J= 
9.0 Hz, 2.0 Hz, 2H, H7, H7’), 7.14 (d, J= 9.0 Hz, 2H, H8, H8’), 4.38 (s, 4H, H11, H11’), 
2.34 (s, 6H, H12, H12’) 
13C NMR (100 MHz, (CD3)2CO) δ ppm    
152.84 (C, C2, C2’), 139.38 (C, C13, C13’), 137.69 (C, C3, C3’), 133.09 (C, C6/C10, 
C6’/C10’), 132.85 (C, C6/C10, C6’/C10’), 130.88 (CH, C4/C5, C4’/C5’), 130.80, (CH, 
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C4/C5, C4’/C5’) 130.41, (CH, C7, C7’), 130.34 (2CH, C14, C14’, C18, C18’), 129.39 
(2CH, C15, C15’, C17, C17’), 129.20 (CH, C16, C16’), 128.59 (CH, C8, C8’), 127.22 
(C, C9, C9’), 119.66 (C, C1, C1’), 99.21 (CH2, C11, C11’), 56.06 (CH3, C12, C12’)  
IR   (neat) (cm-1) 2924, 2823, 1600, 1584, 1480, 1422, 1350, 1180, 1155, 1140 
HRMS (EI, 70 eV, m/z) Found [M+NH4]+ 700.0720, C36H32NO4Br2+ requires 700.0698 
 
 
 
(+/−)-6,6’-Dicarboxyl-3,3’-diphenyl-2,2’-bis(methoxymethoxy)-1,1’-binaphthyl (126) 
 
To a stirred solution of (+/−)-6,6’-dibromo-3,3’-
diphenyl -2,2’-bis(methoxymethoxy)- 1,1’- 
binaphthyl (125) (200 mg, 0.29 mmol) in dry 
diethyl ether (7 mL) at room temperature under a 
nitrogen atmosphere was added dropwise n-
butyllithium (1.6M in hexanes, 0.73 mL, 1.17 
mmol). After stirring for 2 h at room 
temperature, pellets of dry ice were added to the 
reaction mixture at 0 °C and the reaction mixture 
was left to stir for 2 h. Reaction was quenched by the addition of deionised water (5 mL) 
and phases separated. Aqueous layer was washed with diethyl ether (3 x 50 mL) and then 
was acidified to pH 2 with 5% aqueous HCl. Acidified aqueous layer was extracted with 
ethyl acetate (3 x 50 mL) and the combined organic phase was washed with brine (20 
mL), dried over anhydrous magnesium sulphate, filtered and volatiles removed to yield 
crude product. Crude product was purified by column chromatography (SiO2, ethyl 
acetate) to yield the product as a pale yellow solid in 44 % yield (79 mg, 0.13 mmol).  
 
Mpt = 207-209 °C 
Molecular formula C38H30O8 
Molecular weight 614.64 gmol-1 
1H NMR (400 MHz, (CD3)2SO) δ ppm    13.13 (s, 2H, OH), 8.75 (s, 2H, H5, H5’), 8.34 
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(s, 2H, H4, H4’), 7.84 (dd, J = 8.8 Hz, 1.0 Hz, 2H, H7, H7’), 7.73 (d, J = 7.4 Hz, 4H, 
H14, H14’, H18, H18’), 7.54 (dd, J = 7.4 Hz, 7.4 Hz, 4H, H15, H15’, H17, H17’), 7.45 
(t, J= 7.4 Hz, 2H, H16, H16’), 7.23 (d, J= 8.8 Hz, 2H, H8, H8’), 4.35 (d, JAB= 5.6 Hz, 
2H, H11/H11’), 4.29 (d, JAB= 5.6 Hz, 2H, H11/H11’), 2.25 (s, 6H, H12, H12’)   
13C NMR (100 MHz, CDCl3) δ ppm   172.16 (CO, C19, C19’), 154.06 (C, C2, C2’), 
138.23 (C, C11, C11’), 136.47 (C, C3, C3’), 136.14 (C, C6/C9/C10, C6’/C9’/C10’), 
132.43 (CH, C4, C4’), 132.18 (CH, C5, C5’), 129.91 (C, C6/C9/C10, C6’/C9’/C10’), 
129.54 (2CH, C14, C14’, C18, C18’), 128.60 (2CH, C15, C15’, C17, C17’), 127.80 (CH, 
C16, C16’), 126.71 (CH, C8, C8’), 126.32 (C, C6/C9/C10, C6’/C9’/C10’), 126.14 (C, 
C1, C1’), 126.04 (CH, C7, C7’), 98.73 (CH2, C11, C11’), 55.96 (CH3, C12, C12’) 
IR (neat) (cm-1) 2923, 2852, 2532, 1679 (COOH), 1619, 1496, 1456, 1427, 1261, 1241, 
1179, 1137 
HRMS (EI, 70 eV, m/z) Found [M+NH4]+ 632.2310, C38H34NO8+ requires 632.2284 
 
 
 
(+/−)-6,6’-Dibutyl-3,3’-diphenyl-2,2’-bis(methoxymethoxy)-1,1’-binaphthyl (127) 
 
To a stirred solution of (+/−)-6,6’-dibromo 
-3,3’-diphenyl-2,2’-bis(methoxymethoxy)-
1,1’-binaphthyl (125) (300 mg, 0.44 
mmol) in THF (6 mL) was added (1,3-
dppp)NiCl2 (24 mg, 0.044 mmol) under a 
nitrogen atmosphere. Reaction mixture 
was allowed to stir for 10 minutes. 2 M 
Butylmagnesium chloride in THF (2.26 
mL, 528 mg, 4.52 mmol) was added 
dropwise and the reaction mixture was refluxed at 60 °C for 24 h. The reaction mixture 
was allowed cool to room temperature and quenched with 1 M HCL (8 mL). Volatiles 
were removed in vacuo. Residue was dissolved in DCM (10 mL), washed with deionised 
water (5 mL), brine (5 mL), dried over anhydrous magnesium sulfate, filtered and solvent 
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removed via rotary evaporation to yield crude product. Crude product was purified by 
column chromatography (SiO2, hexane/ethyl acetate 5:1) to yield the title compound as a 
greasy solid in 35% yield (97 mg, 0.15 mmol). 
 
Mpt = 56-58 °C 
Molecular formula C44H46O4 
Molecular weight 638.83 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm  7.79 (s, 2H, H4, H4’), 7.67 (d, J= 7.2 Hz, 4H, H14, 
H14’, H18, H18’), 7.57 (s, 2H, H5, H5’), 7.38 (dd, J= 7.2 Hz, 7.2 Hz,  4H, H15, H15’, 
H17, H17’) 7.28 (t, J= 7.2 Hz, 2H, H16, H16’), 7.15 (d, J= 8.6 Hz, 2H, H8, H8’), 7.06 
(dd, J= 8.6 Hz  1.6 Hz, 2H, H7, H7’), 4.32 (d, Jab = 5.8 Hz, 2H, H11, H11’), 4.28 (d, Jab = 
5.8 Hz, 2H, H11, H11’), 2.65 (t, J= 7.6 Hz, 4H, H19, H19’), 2.27 (s, 6H, H12, H12’), 1.59 
(tt, J= 7.6 Hz, 7.6 Hz, 4H, H20, H20’), 1.30 (qt, J= 7.6 Hz, 7.6 Hz, 4H, H21, H21’), 0.86 
(t, J= 7.6 Hz, 6H, H22, H22’) 
 
 
13C NMR (100 MHz, CDCl3) δ ppm    
150.56 (C, C2, C2’), 139.70 (C, C6, C6’), 139.28 (C, C13, C13’), 135.39 (C, C3, C3’), 
132.08 (C, C9/C10, C9’/C10’), 131.05 (C, C9/C10, C9’/C10’), 130.02 (CH, C4, C4’), 
129.68 (2CH, C14, C14’, C18, C18’), 128.31 (2CH, C15, C15’, C17, C17’), 127.99 (CH, 
C16, C16’), 127.20 (CH, C7, C7’), 126.50 (C, C1, C1’), 126.37 (CH, C8, C8’), 126.21 
(CH, C5, C5’), 98.51 (CH2, C11, C11’), 55.87 (CH3, C12, C12’), 35.61 (CH2, C19, C19’), 
33.41 (CH2, C20, C20’), 22.47 (CH2, C21, C21’), 14.04 (CH3, C22, C22’) 
IR   (neat) (cm-1) 2954, 2925, 2869, 1602, 1493, 1454, 1425, 1186, 1156, 1142, 1077, 
1005 
HRMS (EI, 70 eV, m/z) Found [M+NH4]+ 656.3715, C44H50NO4+ requires 656.3740 
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7.6 Preparation of chiral polysubstituted BINOL derivatives and prolinol 
hydrochloride salts 
 
(S)-α,α-Diphenyl-2-pyrrolidinemethanol hydrochloride salt (95) 
 
To a stirred solution of (S)-α,α-diphenyl-2-pyrrolidinemethanol 
(41a)  (79 mg, 0.31 mmol) in diethyl ether (1 mL) at room 
temperature was added dropwise 1M HCl in diethyl ether (932 µL, 
0.93 mmol). Reaction mixture was allowed to stir for 4 h, product 
was filtered and washed with diethyl ether (3 × 4 mL) to yield the 
title compound as a white solid in 83% yield (75 mg, 0.26 mmol). 
 
Mpt = >270 °C 
[α]20D= +71.0 ° (0.1 c, MeOH) 
Molecular formula C17H20ClNO 
Molecular weight 289.80 gmol-1 
1H NMR (400 MHz, (CD3)2SO) δ ppm 9.27 (s, NH, 1H), 8.17 (s, NH, 1H), 7.62 (d, J= 
7.6 Hz, 2H), 7.53 (d, J= 7.6 Hz, 2H), 7.37-7.31 (m, 4H), 7.27-20 (m, 2H), 6.57 (s, OH, 
1H), 4.88 (m, 1H), 3.13 (m, 2H), 1.92-1.79 (m, 4H) 
13C NMR (100 MHz, (CD3)2SO) δ ppm 145.04 (C), 144.61 (C), 128.35 (2CH), 128.18 
(2CH), 127.14 (CH), 126.89 (CH), 125.83 (2CH), 125.36 (2CH), 77.08 (C), 64.92 (CH), 
46.66 (CH2), 25.98 (CH2), 24.04 (CH2)   
IR (neat) (cm-1) 3346, 2909, 2827, 2723, 1603, 1586, 1492, 1449, 1387, 1362, 1216, 
1178, 1067, 1032 
HRMS (EI, 70 eV, m/z) Found [M]+ 254.1546, C17H20NO+ requires 254.1545 
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(S)-α,α-Bis(3,5-dimethyl-phenyl)-2-pyrrolidinemethanol hydrochloride salt (96) 
 
To a stirred solution of (S)-α,α-bis(3,5-dimethyl-phenyl)-2-
pyrrolidinemethanol (101)   (95 mg, 0.31 mmol) in diethyl 
ether (1 mL) at room temperature was added dropwise 1M HCl 
in diethyl ether (932 µL, 0.93 mmol). Reaction mixture was 
allowed to stir for 4 h, product was filtered and washed with 
diethyl ether (3 × 4 mL) to yield the title compound as a white 
solid in 89% yield (94 mg, 0.27 mmol). 
 
Mpt = >270 °C 
[α]20D= +86.0 ° (0.1 c, MeOH) 
Molecular formula C21H28ClNO 
Molecular weight 345.906 gmol-1 
1H NMR (400 MHz, (CD3)2SO) δ ppm 9.76 (s, NH, 1H), 8.21 (s, NH, 1H), 7.25 (s, 2H), 
7.09 (s, 2H), 6.86 (s, 1H), 6.82 (s, 1H), 6.31 (s, OH, 1H), 4.79-4.74 (m, 1H), 3.14-3.06 
(m, 2H), 2.26 (s, 6H), 2.23 (s, 6H),  1.88-1.69 (m, 4H)  
13C NMR (100 MHz, (CD3)2SO) δ ppm 145.00 (C), 144.51 (C), 137.20 (2C), 137.03 
(2C), 128.47 (CH), 128.22 (CH), 123.60 (2CH), 123.00 (2CH), 76.89 (C), 64.90 (CH), 
46.63 (CH2), 26.01 (CH2), 24.11 (CH2), 21.14 (2CH3), 21.10 (2CH3)  
IR (neat) (cm-1) 3225, 2978, 2948, 2920, 1606, 1597, 1552, 1454, 1407, 1305, 1294, 
1181, 1149, 1104, 1032 
HRMS (EI, 70 eV, m/z) Found [M]+ 310.2185, C21H28NO+ requires 310.2171 
 
 
 
 
 
 
 
 
N OHHH
Cl
212 
 
(+)-6,6’-Dimethoxy-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (111b) 
 
(+)-6,6’-Dibromo- 3,3’-diphenyl -2,2’-dihydroxy-
1,1’-binaphthyl (123b) (789 mg, 1.32 mmol) and 
copper (І) iodide (1.04 g, 5.48 mmol) were stirred in 
dry DMF (6 mL) at room temperature under 
nitrogen for 10 minutes. 4.4 M Sodium methoxide in 
methanol (8.00 mL, 34.42 mmol) was added and the 
reaction mixture was refluxed for 24 h, then allowed 
cool to room temperature. Ice-water mixture (18 
mL) was added, followed by 4N HCl (6 mL) and 
mixture was allowed to stir for 10 minutes. Mixture was filtered and remaining solid was 
washed with ethyl acetate. Filtrate was extracted with ethyl acetate (3 x 30 mL) and the 
combined organic phase was washed with brine (30 mL), dried over anhydrous 
magnesium sulfate, filtered and volatiles removed via rotary evaporation to yield the 
crude product. Crude product was purified by column chromatography (SiO2, 
hexane/ethyl acetate 10:1) to yield the title compound as a yellow solid in 67% yield (442 
mg, 0.89 mmol). 
 
Mpt = 208-210 °C 
[α]20D = +68.1 ° (1.0 c, THF) 
Molecular formula C34H26O4 
Molecular weight 498.57 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   7.92 (s, 2H, H4, H4’), 7.74 (dd, J= 7.2 Hz, 1.4 Hz, 
4H, H12, H12’, H16, H16’), 7.50 (dd, J= 7.2 Hz, 1.4 Hz, 4H, H13, H13’, H15, H15’), 
7.42 (tt, J= 7.2 Hz, 1.4 Hz,  2H, H14, H14’), 7.25 (d, J=  2.6 Hz, 2H, H5, H5’), 7.15 (d, 
J= 9.2 Hz, 2H, H8, H8’), 7.01 (dd, J= 9.2 Hz, 2.6 Hz, 2H, H7, H7’), 5.26 (s, 2H, OH), 
3.92 (s, 6H, H17, H17’) 
13C NMR (100 MHz, CDCl3) δ ppm    
156.59 (C, C6, C6’), 148.36 (C, C2, C2’), 137.67 (C, C11, C11’), 131.06 (C, C3, C3’), 
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130.36 (C, C9/C10, C9’/C10’ ), 130.09 (CH, C4, C4’), 129.62 (2CH, C12, C12’, C16 
C16’), 128.49 (2CH, C13, C13’ ,C15, C15’), 128.23 (C, C9/C10, C9’/C10’), 127.74 (CH, 
C14, C14’), 125.96 (CH, C8, C8’), 119.85 (CH, C7, C7’), 112.90 (C, C1, C1’), 106.71 
(CH, C5, C5’), 55.42 (CH3, C17, C17’) 
IR   (neat) (cm-1) 3506, 2954, 2926, 2869, 1600, 1502, 1460, 1422, 1401, 1371, 1224, 
1196, 1169, 1123, 1029 
HRMS (EI, 70 eV, m/z) Found [M+H]+ 499.1915, C34H27O4+ requires 499.1909 
 
 
 
(+)-6,6’-Dibutyl-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (114b) 
 
To a stirred solution of (−)-6,6’-dibromo-3,3’-
diphenyl -2,2’-bis(methoxymethoxy)-1,1’-
binaphthyl (125b) (444 mg, 0.65 mmol) in 
THF (20 mL) was added (1,3-dppp)NiCl2 (70 
mg, 0.13 mmol) under a nitrogen atmosphere. 
Reaction mixture was allowed to stir for 10 
minutes. 2 M Butylmagnesium chloride in 
THF (7.23 mL, 1.668 g, 14.27 mmol) was 
added dropwise and the reaction mixture was 
refluxed at 60 °C for 24 h. The reaction mixture was allowed cool to room temperature 
and quenched with 1 M HCL (10 mL). Volatiles were removed in vacuo. Residue was 
dissolved in DCM (15 mL) washed with deionised water (5 mL), brine (5 mL), dried over 
anhydrous magnesium sulfate, filtered and solvent removed via rotary evaporation to 
yield crude product. Crude product was dissolved in THF (5 mL) at room temperature 
and concentrated hydrochloric acid (0.5 mL, 32%, 10.17 M) was added. Reaction mixture 
was warmed to 50 °C and after 24 h allowed to cool to room temperature. Solvent was 
removed via rotary evaporation. Deionised water (5 mL) was added, the product was 
extracted with DCM (3 x 10 mL) and the combined organic phase was washed with brine 
(10 mL), dried over anhydrous magnesium sulfate, filtered and solvent removed via 
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rotary evaporation to yield the final crude product. Final crude product was purified by 
column chromatography (SiO2, hexane/ethyl acetate 10:0.3) to yield the title compound 
as a yellow solid in 42% yield (150 mg, 0.27 mmol).  
 
Mpt = 104-106 °C 
[α]20D= +53.2 ° (1.0 c, THF) 
Molecular formula C40H38O2 
Molecular weight 550.73 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   7.97 (s, 2H, H4, H4’), 7.75 (dd, J= 7.4 Hz, 1.6 Hz, 
4H, H12, H12’, H16, H16’), 7.71 (s, 2H, H5, H5’), 7.50 (dd, J= 7.4 Hz, 1.6 Hz, 4H, H13, 
H13’, H15, H15’), 7.42 (tt, J= 7.4 Hz, 1.6 Hz, 2H, H14, H14’), 7.19 (d, J= 1.2 Hz, 4H, 
H7, H7’, H8, H8’),  5.31 (s, 2H, OH), 2.76 (t, J= 7.4 Hz, 4H, H17, H17’), 1.68 (tt, J= 7.4 
Hz, 7.4 Hz, 4H, H18, H18’), 1.41 (qt, J= 7.4 Hz, 7.4 Hz, 4H, H19, H19’), 0.96 (t, J= 7.4 
Hz, 6H, H20, H20’) 
13C NMR (100 MHz, CDCl3) δ ppm    
149.52 (C, C2, C2’), 138.90 (C, C6, C6’), 137.77 (C, C11, C11’), 131.32 (C, C9/C10, 
C9’/C10’), 130.90 (CH, C4, C4’), 130.58 (C, C3, C3’), 129.66 (2CH, C12, C12’, C16, 
C16’), 129.63 (C, C9/C10, C9’/C10’), 128.99 (CH, C7, C7’), 128.46 (2CH, C13, C13’, 
C15, C15’), 127.67 (CH, C14, C14’), 126.93 (CH, C5, C5’), 124.27 (CH, C8, C8’), 
112.39 (C, C1, C1’), 35.56 (CH2, C17, C17’), 33.59 (CH2, C18, C18’), 22.43 (CH2, C19, 
C19’), 14.05 (CH3, C20, C20’) 
IR (neat) (cm-1) 3500, 3055, 2953, 2926, 2862, 1620, 1601, 1497, 1455, 1425, 1382, 
1361, 1236, 1198, 1168, 1145, 1126, 1068, 1027 
HRMS (EI, 70 eV, m/z) Found [M+H]+ 551.2950, C40H39O2+ requires 551.2950 
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(+)-2,2’-Bis(methoxymethoxy)-1,1’-binaphthyl (119b) 
 
To a stirred solution of sodium hydride (2.154 g, 60% in 
mineral oil, 53.79 mmol) in dry THF (175 mL) at 0 °C under 
a nitrogen atmosphere was added dropwise a solution 
containing (R)-1,1’-bi-2-naphthol (45b) (7.000 g, 24.45 
mmol) in dry THF (60 mL). After stirring at 0 °C for 1 h, 
chloromethyl methyl ether (4.09 mL, 4.327 g, 53.79 mmol) was added dropwise. Upon 
complete addition, the reaction mixture was allowed to warm up to room temperature and 
stirred for 4 h. Saturated aqueous ammonium chloride (30 mL) was added slowly to 
quench the reaction and volatiles were removed in vacuo. Residue was extracted with 
DCM (3 x 30 mL) and the combined organic phase was washed with brine (30 mL), dried 
over anhydrous magnesium sulfate, filtered and solvent removed via rotary evaporation 
to yield the crude product. Crude product was purified by column chromatography (SiO2, 
using a gradient solvent system of hexane, hexane/ethyl acetate 10:0.5) to yield the title 
compound as a white solid in 85% yield (7.781 g, 20.78 mmol). 
 
Mpt = 88-89°C, Lit Mpt = 98-100ºC11 
[α]20D = +84.2 ° (1.0 c, THF), Lit [α]25589 = +95.0 º (1.0 c, THF)11 
Molecular formula C24H22O4 
Molecular weight 374.43 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   7.97 (d, J= 9.2 Hz, 2H), 7.89 (d, J= 8.2 Hz, 2H), 
7.60 (d, J= 9.2 Hz, 2H), 7.38-7.34 (m, 2H), 7.26-7.22 (m, 2H), 7.18 (d, J= 8.2 Hz, 2H), 
5.10 (d, JAB= 6.6 Hz, 2H), 4.99 (d, JAB= 6.6 Hz, 2H), 3.16 (s, 6H)  
13C NMR (100 MHz, CDCl3) δ ppm   152.65 (C), 134.03 (C), 129.89 (C), 129.42 (CH), 
127.90 (CH), 126.33 (CH), 125.57 (CH), 124.10 (CH), 121.30 (C), 117.29 (CH), 95.20 
(CH2), 55.86 (CH3) 
 
1H and 13C NMR data in agreement with the literature.10,11 
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(+)-3,3’-Dibromo-2,2’-bis(methoxymethoxy)-1,1’-binaphthyl (120b) 
 
To a stirred solution of (+)-2,2’-bis(methoxymethoxy)-1,1’-
binaphthyl (119b) (4.677 g, 12.51 mmol) in dry diethyl ether 
(220 mL) at room temperature under a nitrogen atmosphere 
was added dropwise n-butyllithium (1.6 M in hexanes, 23.45 
mL, 37.52 mmol). After stirring at room temperature for 3 h, 
THF (140 mL) was added. After 1 h, reaction mixture was 
cooled to 0 °C and dibromotetrachloroethane (12.220 g, 37.52 mmol) was added in one 
portion under a nitrogen atmosphere. Reaction mixture was allowed to reach room 
temperature over 2 h. Saturated aqueous ammonium chloride (60 mL) was added to 
quench the reaction and phases were separated. Aqueous layer was extracted with diethyl 
ether (3 x 60 mL) and the combined organic phase was washed with brine (60 mL), dried 
over anhydrous magnesium sulfate, filtered and solvent removed via rotary evaporation 
to yield the crude product. Crude product was purified by column chromatography (SiO2, 
hexane/ethyl acetate 10:0.3) to yield the title compound as a white solid in 74% yield 
(4.950 g, 9.30 mmol). 
 
 
Mpt = 119-120 °C, Lit Mpt = 123-124ºC11 
[α]20D = +25.7 ° (1.0 c, THF), Lit [α]25589 = +28.3 º (1.0 c, THF)11 
Molecular formula C24H20Br2O4 
Molecular weight 532.22 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   8.28 (s, 2H), 7.81 (d, J= 8.0 Hz, 2H), 7.47-7.43 
(m, 2H), 7.33-7.29 (m, 2H), 7.20 (d, J= 8.0 Hz, 2H), 4.85 (d, JAB= 5.6 Hz, 2H), 4.83 (d, 
JAB= 5.6 Hz, 2H), 2.57 (s, 6H) 
13C NMR (100 MHz, CDCl3) δ ppm   150.16 (C), 133.09 (C), 133.04 (CH), 131.51 (C), 
127.41 (C), 126.94 (2CH), 126.58 (CH), 126.10 (CH), 117.38 (C), 99.18 (CH2), 56.31 
(CH3)   
 
1H and 13C NMR data in agreement with the literature.10,11 
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(−)-3,3’-Diphenyl-2,2’-bis(methoxymethoxy)-1,1’-binaphthyl (121b) 
 
(+)-3,3’-Dibromo-2,2’ -bis(methoxymethoxy)- 1,1’-
binaphthyl (120b) (4.500 g, 8.46 mmol) and 
tetrakis(triphenylphosphine)palladium(0) (0.977 g, 0.85 
mmol) were added to dry DME (60 mL) at room 
temperature under a nitrogen atmosphere. To the stirred 
mixture was added phenylboronic acid (3.609 g, 29.60 
mmol) and 2 M aqueous sodium carbonate (22.5 mL). 
Reaction mixture was refluxed for 18 h, allowed cool to 
room temperature and filtered through a pad of celite. Solvent was removed via rotary 
evaporation to give a crude residue. Residue was dissolved in DCM (150 mL), washed 
with saturated aqueous ammonium chloride (50 mL), deionised water (50 mL), brine (50 
mL), dried over anhydrous magnesium sulfate, filtered and solvent removed via rotary 
evaporation to yield crude product. Crude product was purified by column 
chromatography (SiO2, hexane/ethyl acetate 10:1) to yield the title compound as a white 
solid in 91% yield (4.052 g, 7.69 mmol).  
 
Mpt = 135-137 °C 
[α]20D = −67.7 ° (1.0 c, THF) 
Molecular formula C36H30O4 
Molecular weight 526.62 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm 7.97 (s, 2H), 7.91 (d, J= 8.0 Hz, 2H), 7.78 (d, J= 8.4 
Hz, 4H), 7.51-7.47 (m, 4H), 7.45-7.37 (m, 4H), 7.32-7.30 (m, 4H), 4.43 (d, JAB= 5.6 Hz, 
2H), 4.39 (d, JAB= 5.6 Hz, 2H), 2.35 (s, 6H)   
13C NMR (100 MHz, CDCl3) δ ppm 151.35 (C), 139.04 (C), 135.48 (C), 133.63 (C), 
130.87 (C), 130.62 (CH), 129.67 (2CH), 128.38 (2CH), 127.90 (CH), 127.34 (CH), 
126.55 (C), 126.46 (CH), 126.35 (CH), 125.22 (CH), 98.55 (CH2), 55.87 (CH3)  
 
1H and 13C NMR data in agreement with the literature.10,11 
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(+)-3,3’-Diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (122b) 
 
To a stirred mixture of  (−)-3,3’-diphenyl-2,2’-
bis(methoxymethoxy)-1,1’-binaphthyl (4.198 g, 7.98 mmol) 
(121b) in THF (40 mL) at room temperature, was added 
concentrated hydrochloric acid (0.7 mL, 32%, 10.17 M). 
Reaction mixture was warmed to 50 °C and after 24 h allowed 
cool to room temperature. Solvent was removed via rotary 
evaporation. Deionised water (40 mL) was added and the 
product was extracted with DCM (3 x 50 mL). The combined 
organic phase was washed with brine (50 mL), dried over anhydrous magnesium sulfate, 
filtered and the solvent was removed via rotary evaporation to yield the crude product. 
Crude product was purified by column chromatography (SiO2, toluene) to yield the title 
compound as a white solid in 92% yield (3.23 g, 7.37 mmol). 
 
Mpt = 193-195 °C, Lit Mpt = 200-202 ºC11 
[α]20D = +92.4 ° (1.0 c, THF), Lit [α]25589 = +135.0 (1.0 c, THF)11 
Molecular formula C32H22O2 
Molecular weight 438.52 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   8.10 (s, 2H), 7.99 (d, J= 8.0 Hz, 2H), 7.82 (d, J= 
7.2 Hz, 4H), 7.57 (t, J= 7.2 Hz, 4H), 7.50-7.44 (m, 4H), 7.41-7.37 (m, 2H), 7.32 (d, J= 
8.4 Hz, 2H), 5.45 (s, 2H)  
13C NMR (100 MHz, CDCl3) δ ppm   150.23 (C), 137.55 (C), 133.03 (C), 131.49 (CH), 
130.76 (C), 129.70 (2CH), 129.52 (C), 128.58 (2CH), 128.55 (CH), 127.86 (CH), 127.44 
(CH), 124.43 (CH), 124.37 (CH), 112.48 (C) 
 
 
1H and 13C NMR data in agreement with the literature.10,11 
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(+)-6,6’-Dibromo-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (123b) 
 
To a stirred solution of (+)-3,3’-diphenyl-2,2’-
dihydroxy-1,1’-binaphthyl (122b) (600 mg, 1.37 mmol) 
in DCM (21 mL) at −78 °C under a nitrogen atmosphere 
was added slowly a solution of bromine (270 µL, 848 
mg, 5.31 mmol) in DCM (3.8 mL) over a period of 60 
minutes. Reaction mixture was allowed to reach room 
temperature over 2 h and to stir for a further 2 h at room 
temperature. The reaction was quenched with 10% 
sodium bisulfite (20 mL). Product was extracted with 
DCM (3 x 30 mL) and the combined organic extracts were washed with brine (30 mL), 
dried over anhydrous magnesium sulfate, filtered and solvent was removed via rotary 
evaporation to yield crude product. Crude product was purified by recrystallisation from 
hexane/DCM at room temperature and filtered to yield the title compound as a light 
yellow solid in 72% yield (588 mg, 0.99 mmol). 
 
Mpt = 249-251 °C, Lit Mpt = 262-264 ºC10  
[α]20D = +85.1 ° (1.0 c, THF), Lit [α]25589 = +96.6 º (1.0 c, THF)10 
Molecular formula C32H20Br2O2 
Molecular weight 596.31 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   8.07 (d, J= 2.0 Hz, H5, H5’, 2H), 7.91 (s, H4, H4’, 
2H), 7.69 (dd, J= 7.2 Hz, H12, H12’, H16, H16’, 1.4 Hz,  4H), 7.51 (dd, J= 7.2 Hz, 1.4 
Hz, H13, H13’, H15, H15’, 4H), 7.44 (tt, J= 7.2 Hz, 1.4 Hz, H14, H14’, 2H), 7.38 (dd, J= 
9.0 Hz, 2.0 Hz, H7, H7’, 2H), 7.06 (d, J= 9.0 Hz, H8, H8’, 2H), 5.38 (s, OH, 2H)  
13C NMR (100 MHz, CDCl3) δ ppm   150.26 (C), 136.73 (C), 131.85 (C), 131.48 (C), 
130.64 (CH, C7, C7’), 130.53 (C), 130.41 (CH, C4/C5, C4’/C5’), 130.37 (CH, C4/C5, 
C4’/C5’), 129.54 (2CH, C12, C12’, C16, C16’), 128.78 (2CH, C13, C13’, C15, C15’), 
128.25 (CH, C14, C14’), 126.08 (CH, C8, C8’), 118.18 (C), 112.63 (C) 
 
1H and 13C NMR data in agreement with the literature.10,11 
6
7
8
10
9
5
1
2
3
4 11
OH
16
15
14
13
12
1'
10'
9'
4'
3'
2'
8'
7'
6'
5'
OH
11'
Br
Br
16'
15'
14'
13'
12'
220 
(−)-6,6’-Dibromo-3,3’-diphenyl-2,2’-bis(methoxymethoxy)-1,1’-binaphthyl (125b) 
 
To a stirred solution of sodium hydride (112 mg, 
60% in mineral oil, 2.80 mmol) in dry THF (10 mL) 
at 0 °C under a nitrogen atmosphere was added 
dropwise a solution of (+)-6,6’-dibromo-3,3’-
diphenyl-2,2’-dihydroxy-1,1’-binaphthyl (123b) 
(697 mg, 1.17 mmol) in dry THF (4 mL). After 
stirring at 0 °C for 1 h, chloromethyl methyl ether 
(0.21 mL, 226 mg, 2.80 mmol) was added dropwise. 
Upon complete addition, the reaction mixture was 
allowed to warm up to room temperature and stirred for 4 h. Saturated aqueous 
ammonium chloride (10 mL) was added to quench the reaction and volatiles removed in 
vacuo. Residue was extracted with DCM (3 x 10 mL) and the combined organic phase 
was washed with brine (10 mL), dried over anhydrous magnesium sulfate, filtered and 
solvent removed via rotary evaporation to yield the crude product. Crude product was 
purified by column chromatography (SiO2, hexane/ethyl acetate 10:0.3) to yield the title 
compound as a white solid in 56% yield (444 mg, 0.65 mmol).  
 
Mpt = 87-88 °C 
[α]20D = −2.0 ° (1.0 c, THF) 
Molecular formula C36H28Br2O4 
Molecular weight 684.41 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm   8.05 (d, J= 2.0 Hz, 2H, H5, H5’), 7.86 (s, 2H, H4, 
H4’), 7.72 (dd, J= 7.4 Hz, 1.2 Hz, 4H, H14, H14’, H18, H18’), 7.48 (dd, J= 7.4 Hz, 1.2 
Hz, 4H, H15, H15’, H17, H17’), 7.40 (tt, J= 7.4 Hz, 1.2 Hz, 2H, H16, H16’), 7.36 (dd, J= 
8.8 Hz, 2.0 Hz, 2H, H7, H7’), 7.14 (d, J= 8.8 Hz, 2H, H8, H8’), 4.37 (s, 4H, H11, H11’), 
2.33 (s, 6H, H12, H12’) 
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13C NMR (100 MHz, (CD3)2CO) δ ppm    
152.84 (C, C2, C2’), 139.38 (C, C13, C13’), 137.69 (C, C3, C3’), 133.09 (C, C6/C10, 
C6’/C10’), 132.85 (C, C6/C10, C6’/C10’), 130.88 (CH, C4/C5, C4’/C5’), 130.80, (CH, 
C4/C5, C4’/C5’) 130.41, (CH, C7, C7’), 130.34 (2CH, C14, C14’, C18, C18’), 129.39 
(2CH, C15, C15’, C17, C17’), 129.20 (CH, C16, C16’), 128.59 (CH, C8, C8’), 127.22 
(C, C9, C9’), 119.66 (C, C1, C1’), 99.21 (CH2, C11, C11’), 56.06 (CH3, C12, C12’)  
IR   (neat) (cm-1) 2924, 2823, 1600, 1584, 1480, 1422, 1350, 1180, 1155, 1140 
HRMS (EI, 70 eV, m/z) Found [M+NH4]+ 700.0703, C36H32NO4Br2+ requires 700.0698 
 
 
 
 
 
7.7 Preparation of biquinoline derivatives 
 
 
(+/−)-6,6’-Dihydroxy-5,5’-biquinoline (130) 
 
To a stirred mixture of copper (ІІ) chloride dihydrate (8.589 g, 
50.38 mmol) in methanol (420 mL) under a nitrogen atmosphere 
was added a solution of benzylamine (18.33 mL, 17.982 g, 167.81 
mmol) in methanol (70 mL) and the solution was stirred for 10 
minutes. A solution of 6-hydroxylquinoline (131) (3.045, 20.98 
mmol) in methanol (70 mL) was added and the reaction mixture 
was stirred at room temperature for 48 h. The reaction mixture was filtered and the brown 
precipitate was washed with methanol (3 x 10 mL) and allowed to dry. Brown precipitate 
was dissolved in concentrated hydrochloric acid (44 mL, 32%, 10.17 M), followed by the 
addition of concentrated ammonia (220 mL) at 0 °C and the product precipitated on the 
addition of deionised water (660 mL). Mixture was filtered to yield the title compound as 
a brown solid in 65% yield (1.973 g, 6.84 mmol). 
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Mpt = >270 °C, Lit Mpt = 174-176 ºC12 
Molecular formula C18H12N2O2 
Molecular weight 288.30 gmol-1 
1H NMR (400 MHz, (CD3)2SO) δ ppm   8.90 (br, 2H, OH), 8.66 (s, 2H, H2, H2’), 8.01 
(d, J= 9.0 Hz, 2H, H8, H8’), 7.60 (d, J= 9.0 Hz, 2H, H7, H7’), 7.35 (d, J= 8.4 Hz, 2H, 
H4, H4’), 7.25 (dd, J= 8.4 Hz, 3.8 Hz, 2H, H3, H3’) 
13C NMR (100 MHz, (CD3)2SO) δ ppm   153.29 (C), 146.71 (CH, C2, C2’), 143.32 (C), 
132.29 (CH, C4, C4’), 130.01 (CH, C8, C8’), 128.84 (C), 121.81 (CH, C7, C7’), 121.30 
(CH, C3, C3’), 114.08 (C) 
IR (neat) (cm-1) 3052, 2820, 1606, 1573, 1590, 1480, 1460, 1418, 1373, 1332, 1192, 
1154, 1122, 1134 
 
1H and 13C NMR data in agreement with the literature. 12 
 
(+/−)-1,1’-Dibutyl-6,6’-dihydroxy-5,5’-biquinoline (134) 
 
To a stirred solution of (+/−)-6,6’-dihydroxy-5,5’-biquinoline 
(130) (274 mg, 1.0 mmol) in DMF (6 mL) was added 
bromobutane (1.56 mL, 1.950 g, 13.8 mmol) and potassium 
iodide (47 mg, 0.3 mmol). Reaction mixture was refluxed for 48 
h and allowed cool to room temperature. Volatiles were removed 
via rotary evaporation to yield a crude residue. Residue was 
filtered and washed with diethyl ether (3 x 10 mL) to yield a light 
brown solid. Brown solid was dried under high vacuum at 150 °C 
for 36 h to yield the title compound in 26% yield (139 mg, 0.25 
mmol). 
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Mpt = >270 °C 
Molecular formula C26H30Br2N2O2 
Molecular weight 562.34 gmol-1 
1H NMR (400 MHz, (CD3)2SO) δ ppm   11.14 (s, 2H, OH), 9.41 (d, J= 5.6 Hz, 2H, H2, 
H2’), 8.74 (d, J= 10.0 Hz, 2H, H8, H8’), 8.26 (d, J= 8.8 Hz, 2H, H4, H4’), 8.09 (d, J= 
10.0 Hz, 2H, H7, H7’), 7.92 (dd, J= 8.8 Hz, 5.6 Hz, 2H, H3, H3’), 5.12 (t, J= 7.4 Hz, 4H, 
H11, H11’), 2.01 (tt, J= 7.4 Hz, 7.4 Hz, 4H, H12, H12’), 1.48 (tq, J= 7.4 Hz, 7.4 Hz, 4H, 
H13, H13’), 0.98 (t, J= 7.4 Hz, 6H, H14, H14’) 
13C NMR (100 MHz, (CD3)2SO) δ ppm   156.13 (C, C6, C6’), 145.82 (CH, C2, C2’), 
142.82 (CH, C4, C4’), 132.84 (C, C10, C10’), 131.14 (C, C9, C9’), 127.12 (CH, C7, 
C7’), 122.36 (CH, C3, C3’), 121.37 (CH, C8, C8’), 114.58 (C, C5, C5’), 57.46 (CH2, 
C11, C11’), 31.84 (CH2, C12, C12’), 19.22 (CH2, C13, C13’), 13.49 (CH3, C14, C14’) 
IR (neat) (cm-1) 3042, 2967, 2597, 1609, 1596, 1528, 1493, 1425, 1380, 1357, 1299, 
1277, 1234, 1035 
HRMS (EI, 70 eV, m/z) Found [M-H]+ 401.2222, C26H29N2O2+ requires 401.2229 
 
(+/−)-1,1’-Diethoxycarbonylmethyl-6,6’-dihydroxy-5,5’-biquinoline (135) 
 
To a stirred solution of (+/−)-6,6’-dihydroxy-5,5’-biquinoline 
(130) (400 mg, 1.39 mmol) in NMP (1.20 mL) was added ethyl 
bromoacetate (0.80 mL, 1.21 g, 7.22 mmol). Reaction mixture 
was allowed to stir at room temperature for 72 h. Product 
precipitated on addition of diethyl ether (20 mL), filtered and 
washed with diethyl ether. Crude solid was further dissolved in 
methanol (10 mL) and product precipitated on addition of 
diethyl ether (100 mL), filtered and washed with diethyl ether to 
yield a light brown solid in 86% yield (743 mg, 1.19 mmol). 
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Mpt = >270 °C 
Molecular formula C26H26Br2N2O6 
Molecular weight 622.30 gmol-1 
1H NMR (400 MHz, (CD3)2SO) δ ppm   11.31 (s, 2H, OH), 9.45 (d, J= 5.2 Hz, 2H, H2, 
H2’), 8.56 (d, J= 9.6 Hz, 2H, H8, H8’), 8.40 (d, J= 8.4 Hz, 2H, H4, H4’), 8.14 (d, J= 9.6 
Hz, 2H, H7, H7’), 8.06 (dd, J= 8.4 Hz, 5.2 Hz, 2H, H3, H3’), 6.28 (s, 4H, H11, H11’), 
4.30 (q, J= 6.8 Hz, 4H, H13, H13’), 1.31 (t, J= 6.8 Hz, 6H, H14, H14’) 
13C NMR (100 MHz, (CD3)2SO) δ ppm 166.26 (CO, C12, C12’), 156.29 (C, C6, C6’), 
147.38 (CH, C2, C2’), 144.42 (CH, C4, C4’), 133.71 (C, C10, C10’), 130.71 (C, C9, 
C9’), 127.57 (CH, C7, C7’), 122.44 (CH, C3, C3’), 121.29 (CH, C8, C8’), 114.26 (C, C5, 
C5’), 62.46 (CH2, C13, C13’), 57.72 (CH2, C11, C11’), 13.99 (CH3, C14, C14’)    
IR (neat) (cm-1) 2967, 2907, 1752 (COOEt), 1610, 1593, 1537, 1463, 1426, 1371, 1323, 
1298, 1204, 1091, 1057, 1017 
HRMS (EI, 70 eV, m/z) Found [M-H]+ 461.1699, C26H25N2O6+ requires 461.1713 
 
(+/−)-1,1’-Dimethyl-6,6’-dihydroxy-5,5’-biquinoline (136) 
 
To a stirred solution of (+/−)-6,6’-dihydroxy-5,5’-biquinoline 
(130) (100 mg, 0.35 mmol) in NMP (0.50 mL) was added methyl 
iodide (0.22 mL, 0.49 g, 3.47 mmol). Reaction mixture was 
heated at 90 °C for 2 h and then allowed cool to room 
temperature. Product precipitated on addition of diethyl ether (10 
mL), filtered and washed with diethyl ether. Crude solid was 
further dissolved in methanol (5 mL) and product precipitated on 
addition of diethyl ether (50 mL), filtered and washed with 
diethyl ether to yield a yellow solid in 79% yield (158 mg, 0.28 mmol). 
 
Mpt = >270 °C 
Molecular formula C20H18I2N2O2 
Molecular weight 572.18 gmol-1 
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1H NMR (400 MHz, (CD3)2SO) δ ppm 11.19 (s, 2H, OH), 9.31 (d, J= 5.6 Hz, 2H, H2, 
H2’), 8.62 (d, J= 9.6 Hz, 2H, H8, H8’), 8.21 (d, J= 8.8 Hz, 2H, H4, H4’) 8.03 (d, J= 9.6 
Hz, 2H, H7, H7’), 7.92 (dd, J= 8.8 Hz, 5.6 Hz, 2H, H3, H3’), 4.69 (s, 6H, H11, H11’)   
13C NMR (100 MHz, (CD3)2SO) δ ppm156.34 (C, C6, C6’), 146.40 (CH, C2, C2’), 
142.51 (CH, C4, C4’), 133.72 (C, C10, C10’), 130.58 (C, C9, C9’), 126.93 (CH, C7, 
C7’), 122.32 (CH, C3, C3’), 121.49 (CH, C8, C8’), 114.36 (C, C5, C5’), 45.76 (CH3, 
C11, C11’) 
IR (neat) (cm-1) 3063, 2994, 1611, 1533, 1372, 1321, 1294, 1241, 1183, 1144, 1037 
HRMS (EI, 70 eV, m/z) Found [M-H]+ 317.1281, C20H17N2O2+ requires 317.1290 
 
 
 
6,6’-Dihydroxy-5,5’-biquinoline-3,3’-dicarboxylic acid dimethyl ester (137a) 
 
To a stirred mixture of copper (ІІ) chloride dihydrate 
(0.403 g, 2.36 mmol) in methanol (30 mL) under a 
nitrogen atmosphere was added a solution of 
benzylamine (0.860 mL, 0.844 g, 7.87 mmol) in 
methanol (5 mL) and the solution was stirred for 10 
minutes. A solution of 6-hydroxy-quinoline-3-
carboxylic acid methyl ester (142) (0.200 g, 0.98 
mmol) in methanol (15 mL) was added and the reaction 
mixture was refluxed for 24 h. The reaction mixture was filtered and the green precipitate 
was washed with methanol (3 x 10 mL) and allowed to dry. Green precipitate was 
dissolved in deionised water (6 mL), concentrated hydrochloric acid (12 mL, 32%, 10.17 
M), followed by the addition of concentrated ammonia (30 mL) at 0 °C and product 
precipitated on the addition of deionised water (100 mL). Mixture was filtered to yield 
the title compound as a brown solid in 21% yield (42 mg, 0.10 mmol). 
 
Mpt = >270 °C 
Molecular formula C22H16N2O6 
Molecular weight 404.37 gmol-1 
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1H NMR (400 MHz, (CD3)2SO) δ ppm   10.22 (br, 2H, OH), 9.13 (s, 2H, H2, H2’), 8.16 
(d, J= 8.6 Hz, 2H, H8, H8’), 7.98 (s, 2H, H4, H4’), 7.77 (d, J= 8.6 Hz, 2H, H7, H7’), 3.77 
(s, 6H, H12, H12’) 
13C NMR (100 MHz, (CD3)2SO) δ ppm   165.28 (C), 154.24 (C), 145.85 (CH), 144.87 
(C), 134.25 (CH), 130.57 (CH), 127.43 (C), 124.49 (CH), 122.63 (C), 114.55 (C), 52.35 
(CH3) 
IR (neat) (cm-1) 3057, 2954, 1721 (COOMe), 1599, 1500, 1439, 1418, 1371, 1344, 1291, 
1240, 1195, 1112, 1099 
HRMS (EI, 70 eV, m/z) Found [M+H]+ 405.1086, C22H17N2O6+ requires 405.1087 
 
 
 
 
 
 
 
6-Hydroxy-quinoline-3-carboxylic acid ethyl ester (140) 
 
 
To a stirred solution of 5-hydroxy-2-
nitrobenzaldehyde (138) (334 mg, 2.00 mmol) in 
ethanol (10 mL) was added tin (ІІ) chloride 
dihydrate (1.81 g, 8.00 mmol) and 3,3-
diethoxypropionic acid ethyl ester (139) (0.97 mL, 950 mg, 5.00 mmol) under argon 
atmosphere. Reaction mixture was refluxed at 90 °C for 4 h and allowed to cool 
overnight. Volatiles were removed in vacuo, residue was dissolved in ethyl acetate (20 
mL) and quenched with saturated aqueous NaHCO3 (20 mL). The resulting emulsion was 
filtered through a pad of celite and washed with ethyl acetate. Aqueous layer was 
separated and washed with ethyl acetate (3 x 15 mL). The combined organic layers were 
washed with brine, dried over anhydrous magnesium sulfate, filtered and volatiles were 
removed via rotary evaporation to yield a crude residue. Crude product was purified by 
column chromatography (SiO2, hexane/ethyl acetate 10:1) to yield the title compound as 
a yellow solid in 44% yield (190 mg, 0.88 mmol). 
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Mpt = 208-210 °C, Lit Mpt = 189 ºC13 
Molecular formula C12H11NO3 
Molecular weight 217.22 gmol-1 
1H NMR (400 MHz, (CD3)2SO) δ ppm 10.31 (s, 1H, OH), 9.07 (d, J= 1.4 Hz, 1H, H2) , 
8.75 (d, J= 1.4 Hz, 1H, H4) , 7.95 (d, J= 9.0 Hz, 1H, H8), 7.46 (dd, J= 9.0 Hz, 2.6 Hz, 
1H, H7), 7.35 (d, J= 2.6 Hz, 1H, H5), 4.38 (q, J= 7.0 Hz, 2H, H12), 1.36 (t, J= 7.0 Hz, 
3H, H13)   
13C NMR (100 MHz, (CD3)2SO) δ ppm 164.95 (CO, C11), 156.25 (C, C6), 145.92 (CH, 
C2), 144.46 (C, C10), 136.45 (CH, C4), 130.28 (CH, C8), 127.96 (C, C9), 124.55 (CH, 
C7), 122.69 (C, C3), 109.59 (CH, C5), 61.05 (CH2, C12) 14.11 (CH3, C13) 
IR (neat) (cm-1) 2958, 2909, 2685, 2548, 1724 (COOEt), 1621, 1603, 1476, 1411, 1321, 
1239, 1220, 1136, 1098, 1016 
 
1H and 13C NMR data in agreement with the literature.13 
 
6-Hydroxy-quinoline-3-carboxylic acid methyl ester (142) 
 
To a stirred solution of 5-hydroxy-2-nitrobenzaldehyde 
(138) (1.59 g, 9.50 mmol) in methanol (50 mL) was 
added tin (ІІ) chloride dihydrate (8.58 g, 38.01 mmol) 
and 3,3-dimethoxypropionic acid methyl ester (141) 
(3.36 mL, 3.52 g, 23.75 mmol) under argon atmosphere. Reaction mixture was refluxed 
at 90 °C for 4 h and allowed to cool overnight. Volatiles were removed in vacuo, residue 
was dissolved in ethyl acetate (200 mL) and quenched with saturated aqueous NaHCO3 
(150 mL). The resulting emulsion was filtered through a pad of celite and washed with 
ethyl acetate. Aqueous layer was separated and washed with ethyl acetate (3 x 75 mL). 
The combined organic layers were washed with brine (100 mL), dried over anhydrous 
magnesium sulfate, filtered and volatiles were removed via rotary evaporation to yield a 
crude residue. Crude product was purified by column chromatography (SiO2, 
hexane/ethyl acetate 10:1) to yield the title compound as a yellow solid in 46% yield 
(0.892 g, 4.39 mmol). 
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Mpt = 210-212 °C  
Molecular formula C11H9NO3 
Molecular weight 203.19 gmol-1 
1H NMR (400 MHz, (CD3)2SO) δ ppm 10.32 (s, 1H, OH), 9.06 (d, J= 2.0 Hz, 1H, H2) , 
8.76 (d, J= 2.0 Hz, 1H, H4) , 7.95 (d, J= 9.2 Hz, 1H, H8), 7.46 (dd, J= 9.2 Hz, 2.6 Hz, 
1H, H7), 7.35 (d, J= 2.6 Hz, 1H, H5), 3.92 (s, 3H, H12)   
13C NMR (100 MHz, (CD3)2SO) δ ppm 165.44 (CO, C11), 156.26 (C, C6), 145.88 (CH, 
C2), 144.45 (C, C10), 136.55 (CH, C4), 130.27 (CH, C8), 127.95 (C, C9), 124.60 (CH, 
C7), 122.46 (C, C3), 109.61 (CH, C5), 52.30 (CH3, C12) 
IR (neat) (cm-1) 3009, 2952, 2663, 2580, 1719 (COOMe), 1633, 1587, 1577, 1500, 1445, 
1368, 1358, 1320, 1273, 1264, 1159, 1141, 1109  
HRMS (EI, 70 eV, m/z) Found [M+H]+ 204.0657, C11H10NO3+ requires 204.0661 
 
 
 
 
 
7.8 Catalyst screen for asymmetric Morita-Baylis-Hillman reactions 
 
 
 
 (+/−)-2-(1-Hydroxy-3-phenylpropyl)cyclohex-2-enone (151d) 
 
(+/−)-Bi-2-naphthol (45) (57 mg, 10 mol%) was dissolved in 
anhydrous THF (1 mL) under argon atmosphere. At 0 oC, 2-
cyclohexen-1-one (149b) (0.389 mL, 385 mg, 4 mmol) was 
added, followed by 1 M triethylphosphine in THF (4 mL, 
472 mg, 4 mmol) and hydrocinnamaldehyde (150a) (0.263 mL, 268 mg, 2 mmol). After 1 
h, reaction mixture was allowed to stir at room temperature for 48 h. Volatiles were 
removed via rotary evaporation to yield crude product as an oil. Crude product was 
purified by column chromatography (SiO2, hexane/ethyl acetate 10:0.3) to yield the title 
compound as a yellow oil in 59% yield (273 mg, 1.19 mmol). 
OOH
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Molecular formula C15H18O2 
Molecular weight 230.302 gmol-1 
1H NMR (400 MHz, CDCl3) δ ppm 7.31-7.18 (m, 5H), 6.88 (t, J= 4.4 Hz, 1H), 4.36-
4.33 (m, 1H), 3.08 (s, 1H), 2.87-2.64 (m, 2H), 2.45-2.37 (m, 4H), 2.06-1.92 (m, 4H)  
13C NMR (100 MHz, CDCl3) δ ppm 200.87 (C), 146.23 (CH), 141.88 (C), 140.62 (C), 
128.51 (2CH), 128.39 (2CH), 125.82 (CH), 71.13 (CH), 38.69 (CH2), 37.65 (CH2), 32.26 
(CH2), 25.70 (CH2), 22.54 (CH2)    
 
1H and 13C NMR data in agreement with the literature.14 
 
 
 
 
General procedure for the synthesis of 2-(1-hydroxy-3-phenylpropyl)cyclohex-2-
enone (151d) with chiral substituted BINOLs 
 
Chiral substituted BINOL (Chapter 5, table 5.6) catalyst (2 
mol%) was dissolved in anhydrous THF under argon 
atmosphere. At 0 oC, 2-cyclohexen-1-one (149b) (1 mmol) 
was added, followed by 1 M triethylphosphine in THF (0.5 
mmol) and hydrocinnamaldehyde (150a) (1 mmol). After 3 h, reaction mixture was 
allowed to stir at room temperature for 45 h. Volatiles were removed via rotary 
evaporation to yield crude product as an oil. Crude product was purified by column 
chromatography (SiO2, hexane/ethyl acetate 10:0.3) to yield the title compound as a 
yellow oil (Results are presented in Chapter 5). 
 
Molecular formula C15H18O2 
Molecular weight 230.302 gmol-1 
 
 
 
OOH
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7.9 Conditions used to determine ee of 151d 
 
 
Column Lux 2 
Mobile phase Hexane/isopropanol 
9:1 
Flow rate 1 mL/min 
Detection 
wavelength 
 
254 nm 
Injection 
volume 
 
10 µL 
 
 
 
 
 
7.10 Retention times for racemic and optically active 151d  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Peak Retention 
time 
OOH
(+/−)-151d
 
 
1 
 
2 
 
 
14.399 min 
 
18.116 min 
Peak Retention 
time 
OOH
(−)-151d
 
 
1 
 
2 
(major) 
 
15.861 min 
 
19.073 min 
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HPLC chromatograms for racemic (+/−)-2-(1-hydroxy-3-phenylpropyl)cyclohex-2-enone 
(151d) (Figure 7.1) and for chiral 2-(1-hydroxy-3-phenylpropyl)cyclohex-2-enone (151d) 
(Figure 7.2) are representative examples of chromatograms obtained during this study. 
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Fig 7.1 HPLC chromatogram for racemic 151d (Catalyst (+/−)-45, Lux 2 column, 9:1 
hexane:i-PrOH, 1.0 mL/min, 254 nm). 
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Fig 7.2 HPLC chromatogram for chiral 151d (Catalyst (+)-(R)-114b, Lux 2 column, 9:1 
hexane:i-PrOH, 1.0 mL/min, 254 nm). 
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Antimicrobial and biodegradation data for known organocatalysts 
 
 
Proline derived catalysts 
Organism Time 
(h) 
  89/91  92  94  41a 8 97 
        
S.aureus 24 h >2000 >2000 >2000 >2000 >2000 >2000 
      
 
 
 48 h >2000 >2000 >2000 >2000 >2000 >2000 
      
 
 
MRSA 24 h >2000 >2000 >2000 >2000 >2000 >2000 
      
 
 
 48 h >2000 >2000 >2000 >2000 >2000 >2000 
      
 
 
S.epidermidis 24 h >2000 >2000 >2000 >2000 >2000 >2000 
      
 
 
 48 h >2000 >2000 >2000 >2000 >2000 >2000 
      
 
 
Enterococcus sp. 24 h >2000 >2000 >2000 >2000 >2000 >2000 
      
 
 
 48 h >2000 >2000 >2000 >2000 >2000 >2000 
      
 
 
E.coli 24 h >2000 >2000 >2000 >2000 >2000 >2000 
      
 
 
 48 h >2000 >2000 >2000 >2000 >2000 >2000 
      
 
 
K.pneumoniae 24 h >2000 >2000 >2000 >2000  >2000 >2000 
      
 
 
 48 h >2000 >2000 >2000 >2000  >2000 >2000 
        
K.pneumoniae  
ESBL positive 
24 h >2000 >2000 >2000 >2000 >2000 >2000 
 48 h >2000 >2000 >2000 >2000 >2000 >2000 
        
P.aeruginosa 24 h >2000 >2000 >2000 >2000  >2000 >2000 
      
 
 
 48 h >2000 >2000 >2000 >2000  >2000 >2000 
        
 
Results obtained by collaborator 
 
Table 1: IC95 (µM) values for proline derivatives (8, 41a, 89, 91, 92, 94 and 97) with 
antibacterial activity >2000 µM 
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Proline derived catalysts 
Organism Time 
(h) 
89/91 92 94 41a 8 97 
C.albicans 
(ATCC44859) 
24h >2000 >2000 >2000 >2000  >250 >2000 
 48h >2000 >2000 >2000 >2000  >250 >2000 
        C.albicans 
(ATCC90028) 
24h >2000 >2000 
 2000 >2000  >250 >2000 
 48h >2000 >2000 >2000 >2000  >250 >2000 
        C.parapsilosis 
(ATCC22019) 
24h >2000 >2000 >2000 >2000  >250 >2000 
 48h >2000 >2000 >2000 >2000  >250 >2000 
        C.krusei (ATCC6258) 24h >2000 >2000 >2000 
 2000  >250 >2000 
     
 
  
 48h >2000 >2000 >2000 >2000  >250 >2000 
        C.krusei (E28) 24h >2000 >2000 >2000 >2000  >250 >2000 
        
 48h >2000 >2000 >2000 >2000  >250 >2000 
        C.tropicalis (156) 24h >2000 >2000 
 2000  2000  >250 >2000 
    
  
  
 48h >2000 >2000 >2000 >2000  >250 >2000 
        C.glabrata (20/I) 24h >2000 >2000 >2000 >2000  >250 >2000 
        
 48h >2000 >2000 >2000 >2000  >250 >2000 
        C.lusitaniae (2446/I) 24h >2000 >2000 >2000 >2000  >250 >2000 
        
 48h >2000 >2000 >2000 >2000  >250 >2000 
        Trichosporon asahii 
(1188) 
24h >2000 >2000 >2000 >2000  >250 >2000 
 48h >2000 >2000 >2000 >2000  >250 >2000 
        Aspergillus fumigatus 
(231) 
24h >2000 >2000 >2000 >2000 >250 >2000 
 48h >2000 >2000 >2000 >2000 >250 >2000 
        Absidia corymbifera 
(272) 
24h >2000 >2000 >2000 >2000 >250 >2000 
 48h >2000 >2000 >2000 >2000 >250 >2000 
        Trichophyton 
mentagrophytes (445) 
72h >2000 >2000 
 2000 >2000 >250 >2000 
 120h >2000 >2000 >2000 >2000 >250 >2000 
 
Table 2: Antifungal IC80/IC50 (µM) values for proline derivatives (8, 41a, 89, 91, 92, 94 
and 97) 
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Organism Time (h) 106 15 107 
  
   C. albicans (ATCC44859) 24 >500 >1000 >125 
     
 48 >500 >1000 >125 
     C. albicans (ATCC90028) 24 >500 >1000 >125 
     
 48 >500    >1000 >125 
     C. parapsilosis (ATCC22019) 24 >500 
   1000 >125 
     
 48 >500 
   1000 >125 
     C. krusei (ATCC6258) 24 >500 >1000 >125 
     
 48 >500 >1000 >125 
     C. krusei (E28) 24 >500 >1000 >125 
     
 48 >500 >1000 >125 
     C. tropicalis (156) 24 >500 
  1000 >125 
     
 48 >500 
  1000 >125 
     C. glabrata (20/I)  24 >500 >1000 >125 
     
 48 >500 >1000 >125 
     C. lusitaniae (2446/I) 24 >500 
   1000 >125 
     
 48 >500 
   1000 >125 
     T. asahii (1188) 24 >500 >1000 >125 
     
 48 >500 >1000 >125 
     A. fumigatus (231) 24 >500 >1000 >125 
     
 48 >500 >1000 >125 
     A. corymbifera (272) 24 >500 >1000 >125 
     
 48 >500 >1000 >125 
     T. mentagrophytes (445) 72 >500 
   1000 >125 
     
 120 >500 
   1000 >125 
 
Table 3: Antifungal IC80/IC50 (µM) values for Jacobsen thioureas (15, 106 and 107) 
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Organism Time 
(h) 
108 38a 81a 
  
   
S. aureus 24 >2000 >2000 >500 
     
 48 >2000 >2000 >500 
     
MRSA 24 >2000 >2000 >500 
     
 48 >2000 >2000 >500 
     
S. epidermidis 24 >2000 >2000 >500 
     
 48 >2000 >2000 >500 
     
Enterococcus sp. 24 >2000 >2000 >500 
  
   
 48 >2000 >2000 >500 
  
   
E. coli 24 >2000 >2000 >500 
  
   
 48 >2000 >2000 >500 
  
   
K. pneumoniae 24 >2000 >2000 >500 
  
   
 48 >2000 >2000 >500 
     
K. pneumoniae -
ESBL 
24 >2000 >2000 >500 
 48 >2000 >2000 >500 
     
P. aeruginosa 24 >2000 >2000 >500 
     
 48 >2000 >2000 >500 
 
 
Table 4: MIC/IC95 (µM) values for cinchona alkaloid derivatives (38a, 81a and 108) 
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Organism Time (h) 108 38a 81a 
  
   C. albicans (ATCC44859) 24 >2000 >2000 500 
    
 
 48 >2000 >2000 500 
    
 C. albicans (ATCC90028) 24 >2000 >2000 500 
    
 
 48 >2000 >2000 500 
    
 C. parapsilosis (ATCC22019) 24 >2000 >2000 125 
    
 
 48 >2000 >2000 125 
    
 C. krusei (ATCC6258) 24 >2000 >2000 500 
    
 
 48 >2000 >2000 500 
    
 C. krusei (E28) 24 >2000 >2000 500 
    
 
 48 >2000 >2000 500 
    
 C. tropicalis (156) 24 >2000 >2000 500 
    
 
 48 >2000 >2000 500 
    
 C. glabrata (20/I)  24 >2000 >2000 500 
    
 
 48 >2000 >2000 500 
    
 C. lusitaniae (2446/I) 24 >2000 >2000 125 
    
 
 48 >2000 >2000 125 
     T. asahii (1188) 24 >2000 >2000 >500 
     
 48 >2000 >2000 >500 
     A. fumigatus (231) 24 >2000 >2000 >500 
     
 48 >2000 >2000 >500 
     A. corymbifera (272) 24 >2000 >2000 >500 
     
 48 >2000 >2000 >500 
     T. mentagrophytes (445) 72 >2000 >2000 >500 
     
 120 >2000 >2000 >500 
 
Table 5: Antifungal IC80/IC50 (µM) values for cinchona alkaloid derivatives (38a, 81a 
and 108) 
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Organism Time 
(h) 
109 19 110 
  
   
S. aureus 24 >2000 >2000 >2000 
     
 48 >2000 >2000 >2000 
     
MRSA 24 
 2000 >2000 >2000 
     
 48 
 2000 >2000 >2000 
     
S. epidermidis 24 >2000 >2000 2000 
    
 
 48 >2000 >2000 2000 
     
Enterococcus sp. 24 >2000 >2000 >2000 
  
   
 48 >2000 >2000 >2000 
  
   
E. coli 24 >2000 >2000 >2000 
  
   
 48 >2000 >2000 >2000 
  
   
K. pneumoniae 24 >2000 >2000 >2000 
  
   
 48 >2000 >2000 >2000 
     
K. pneumoniae –
ESBL 
24 >2000 >2000 >2000 
 48 >2000 >2000 >2000 
     
P. aeruginosa 24 >2000 >2000 >2000 
     
 48 >2000 >2000 
 
>2000 
 
Table 6: MIC/IC95 (µM) values for MacMillan imidazolidinones (19, 109 and 110) 
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Organism Time (h) 109 19 110 
  
   C. albicans (ATCC44859) 24 >2000 >2000 >2000 
     
 48 >2000 >2000 >2000 
     C. albicans (ATCC90028) 24 >2000 >2000 >2000 
     
 48 >2000 >2000 >2000 
     C. parapsilosis (ATCC22019) 24 >2000 >2000 >2000 
     
 48 >2000 >2000 >2000 
     C. krusei (ATCC6258) 24 >2000 >2000 >2000 
     
 48 >2000 >2000 >2000 
     C. krusei (E28) 24 >2000 >2000 >2000 
     
 48 >2000 >2000 >2000 
     C. tropicalis (156) 24 >2000 >2000 >2000 
     
 48 >2000 >2000 >2000 
     C. glabrata (20/I)  24 >2000 >2000 >2000 
     
 48 >2000 >2000 >2000 
     C. lusitaniae (2446/I) 24 >2000 >2000 >2000 
     
 48 >2000 >2000 >2000 
     T. asahii (1188) 24 >2000 >2000 
  2000 
     
 48 >2000 >2000 >2000 
     A. fumigatus (231) 24 >2000 >2000 >2000 
     
 48 >2000 >2000 >2000 
     A. corymbifera (272) 24 >2000 >2000 >2000 
     
 48 >2000 >2000 >2000 
     T. mentagrophytes (445) 72 >2000 >2000 
  2000 
    
 
 120 >2000 >2000 
  2000 
 
Table 7: Antifungal IC80/IC50 (µM) values for MacMillan imidazolidinones (19, 109 and 
110) 
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% Biodegradation Compound 
6 d 14 d 21 d 28 d 
SDS 
 
26b 
 
41a 
 
45a 
 
45b 
 
48a 
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50a 
 
50b 
 
92 
 
97 
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102 
 
105a 
 
105b 
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Table 8: Biodegradation results for organocatalysts (26b, 41a, 45a, 45b, 48a, 48b, 50a, 
50b, 92, 97, 100, 101, 102, 105a and 105b)  
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Fig 1 Biodegradation curves for organocatalysts (26b, 41a, 45a, 45b, 48a, 48b, 50a, 50b, 
92, 97, 100, 101, 102, 105a and 105b)  
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Compound Concentration 
(mgC/L) 
Molar 
concentration of 
test sample 
Inhibition (%) 
26b + SDS 20 + 20 83 µM 0 
    
41a + SDS 20 + 20  98 µM 0 
 
   
45a + SDS 20 + 20 83 µM 2 
 
   
45b + SDS 20 + 20  83 µM 0 
    
48a + SDS 20 + 20 83 µM 4 
    
48b + SDS 20 + 20 83 µM 0 
    
50a + SDS 20 + 20 83 µM 18 
 
   
50b + SDS 20 + 20 83 µM 4 
    
92 + SDS 20 + 20 333 µM 0 
 
   
97 + SDS 20 + 20 79 µM 0 
 
   
100 + SDS 20 + 20 54 µM 0 
 
   
101 + SDS 20 + 20 79 µM 0 
 
   
102 + SDS 20 + 20 76 µM 9 
 
   
105a + SDS 20 + 20 83 µM 0 
 
   
105b + SDS 20 + 20 83 µM 6 
Table 9: Inhibition of SDS biodegradation by organocatalysts (26b, 41a, 45a, 45b, 48a, 
48b, 50a, 50b, 92, 97, 100, 101, 102, 105a and 105b)  
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NMR studies of polysubstituted BINOLs 
 
All NMR experiments were carried out in deuterated solvents such as CDCl3, d6-DMSO, 
d6-acetone and d4-methanol depending on chemical solubility and signal resolution. 
Solvent effects will be discussed for relevant spectra.  
The molecular structures of polysubstituted BINOLs contain a C2 symmetric axis, which 
results in the two substituted naphthol units being chemically and magnetically equivalent 
when the substituents are the same for each unit (Figure 2). 
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Fig 2 General structure of polysubstituted BINOL with numbering 
 
Each substituted naphthol unit is composed of benzene and a phenol fused together, with 
the carbon atom at C1 position linking to another substituted naphthol unit, at C3 a 
phenyl ring is positioned and at C6 various substituents are placed such as bromo, 
methoxy, n-butyl and a carboxylic acid. Substituents at C6 contribute different electronic 
effects to the naphthol ring which results in different chemical shifts for some protons in 
the naphthol unit. 
 
Within each substituted naphthol unit the proton and carbon atoms at 12 and 16 are 
chemically equivalent to each other. Also atoms at 13 and 15 are chemically equivalent to 
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each other. All other proton and carbon atoms within the substituted naphthol unit are not 
chemically and magnetically equivalent to each other. 
 
 
1H NMR studies of polysubstituted BINOLs 
 
In this section the NMR spectra of the racemic BINOL target molecules is discussed. 
Identical spectra were recorded for the single enantiomers.  
 
 
1H NMR study of (+/−)-6,6’-dibromo-3,3’-diphenyl-2,2’-dihydroxy-1,1’-binaphthyl 
(123) 
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For the 1H NMR spectrum of (+/−)-6,6’-dibromo-3,3’-diphenyl-2,2’-dihydroxy-1,1’-
binaphthyl (123), six spin coupled aromatic proton signals, one non-spin coupled 
aromatic proton and a non-spin coupled hydroxyl signal are present (Figure 3). 
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Fig 3 1H NMR spectrum for (+/−)-6,6’-dibromo-3,3’-diphenyl-2,2’-dihydroxy-1,1’-
binaphthyl (123) 
 
 
A doublet at 8.07 ppm and a singlet at 7.91 ppm are distinctly observed. The doublet with 
a coupling constant of 2.0 Hz correlates with H5 H5’ and the singlet correlates with H4 
H4’. Between 7.69-7.44 ppm the protons of the phenyl ring at position 3 reside. These 
protons give rise to a complicated splitting pattern. The downfield signal at 7.69 ppm is 
correlating with H12 H12’ H16 H16’ showing a doublet of doublets. This proton is split 
as it is coupling with protons that are ortho and meta to its position. Protons for H13 H13’ 
H15 H15’ appear as a doublet of doublets at 7.51 ppm with a coupling constant of 7.6 Hz 
and 1.2 Hz. The more shielded para proton H14 H14’ gives a triplet of triplets at 7.44 
ppm. Remaining aromatic protons are a doublet of doublets at 7.38 ppm and a doublet at 
7.06 ppm. The doublet of doublets is assigned to H7 H7’ with coupling constants of 2.0 
Hz and 9.0 Hz as it couples with H5 H5’ (meta coupling) and H8 H8’ (ortho coupling) 
protons. While the doublet which represents H8 H8’ has a coupling constant of 9.0 Hz as 
it couples with H7 H7’. The hydroxyl signal appears at 5.39 ppm as a singlet.  
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1H NMR study of (+/−)-6,6-dimethoxy-3,3’-diphenyl-2,2’-dihydroxy-1,1-binaphthyl 
(111) 
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In the proton NMR spectrum of (+/−)-6,6-dimethoxy-3,3’-diphenyl-2,2’-dihydroxy-1,1-
binaphthyl (111) (Figure 4) there is a marked difference in the chemical shift for protons 
at  H5 H5’ and H7 H7’ when compared to the 1H spectrum for (123). These protons are 
shifted more upfield (shielded) due to the electron donating methoxy group. H7 H7’ is the 
most shielded aromatic proton, observed as a doublet of doublets at 7.04 ppm with 
coupling constants of 9.0 Hz and 2.8 Hz. The signal for H5 H5’ appears as its usual 
doublet at 7.28 ppm with a coupling constant of 2.8 Hz. A slight downfield shift at 7.19 
ppm is noted for H8 H8’. All other aromatic protons stay relatively the same compared to 
the 1H NMR spectrum for (123). The methyl signal comes at 3.94 ppm as a singlet with 
an integration of 6 and the hydroxyl signal resides at 5.31 ppm as a singlet.  
249 
3.54.04.55.05.56.06.57.07.58.08.5 ppm
3.
94
1
5.
30
8
7.
02
7
7.
03
4
7.
05
0
7.
05
6
7.
17
9
7.
20
2
7.
27
6
7.
28
3
7.
42
8
7.
43
1
7.
43
4
7.
44
4
7.
44
9
7.
45
4
7.
46
5
7.
46
8
7.
47
1
7.
51
6
7.
53
5
7.
54
9
7.
55
3
7.
77
4
7.
79
2
7.
79
5
7.
96
1
6.
04
1.
99
1.
97
1.
97
2.
14
2.
05
4.
02
3.
91
2.
00
7.57.67.77.8 ppm
7.
43
1
7.
43
4
7.
44
4
7.
44
9
7.
45
4
7.
46
5
7.
46
8
7.
47
1
7.
51
6
7.
53
5
7.
54
9
7.
55
3
7.
77
4
7.
79
2
7.
79
5
 
 
Fig 4 1H NMR spectrum of (+/−)-6,6-dimethoxy-3,3’-diphenyl-2,2’-dihydroxy-1,1-
binaphthyl (111) 
 
1H NMR study of (+/−)-6,6’-dipentan-1-one-3,3’-diphenyl-2,2’-dihydroxy-1,1’-
binaphthyl (118) 
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Compound 118 has an electron-withdrawing ketone substituent at the 6 6’ position and 
this results in a downfield shift for some protons, especially for protons that are ortho to 
its position on the aromatic ring. A doublet at 8.51 ppm with a coupling constant of 1.6 
Hz is assigned to H5 H5’. Proton signal for H7 H7’ appears at 7.82 ppm as a doublet of 
doublets. Both protons are ortho to the ketone substituent at position 6 6’ and there 
chemical shifts are more downfield when compared to there respective signals in the 1H 
spectrum for compound 123. The downfield shift for these protons is due to the 
deshielding effect contributed by the electron withdrawing ketone substituent. This is not 
surprising, as electron withdrawing substituents on aromatic compounds are meta 
directing while the ortho and para positions are deshielded.  
 
 
The singlet at 8.12 ppm correlates with H4 H4’. Proton signals for the phenyl substituent 
reside between 7.73 ppm and 7.44 ppm. A downfield shift is noted for the hydroxyl signal 
at 5.84 ppm. Proton signals for the butyl chain appear in the aliphatic region of the 1H 
NMR spectrum. A triplet at 3.01 ppm with a coupling constant of 7.4 Hz is the most 
downfield signal in the aliphatic region and corresponds with H18 H18’. At 1.72 ppm a 
triplet of triplets is observed for H19 H19’. The proton signal for H20 H20’ comes at 1.41 
ppm as a quartet of triplets. Remaining triplet at 0.95 ppm with a coupling constant of 7.4 
Hz is the most upfield signal for this 1H spectrum and belongs to the methyl protons H21 
H21’.  
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Fig 5 1H NMR spectrum of (+/−)-6,6-dipentan-1-one-3,3’-diphenyl-2,2’-dihydroxy-1,1-
binaphthyl (118) 
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Fig 6 Enlarged proton aromatic spectrum of (+/−)-6,6-dipentan-1-one-3,3’-diphenyl-2,2’-
dihydroxy-1,1-binaphthyl (118) 
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Electronic effects contributing to different proton chemical shift 
 
From the proton NMR discussion of compounds 111, 118 and 123 the effect of electron 
donating and withdrawing substituents on binaphthyl protons is notable (Table 10).  
Protons H5 H5’ and H7 H7’ are shifted more upfield when an electron donating 
substituent is present at the 6 6’ position and are shifted downfield when an electron 
withdrawing substituent is present. For instance, methoxy has an electron donating effect 
on H5 H5’ and H7 H7’ while the pentan-1-one (alkylcarbonyl) substituent deshields these 
proton signals. As well, the differences for proton chemical shifts were noted for other 
substituents like ethoxy, n-butyl and pentynyl. (Table 10) when compared to the bromo 
substituent. 
 
 
 
Compound R H4, H4’ H5, H5’ H7, H7’ H8, H8’ OH 
       
111 OMe 7.96  7.28  7.04  7.19  5.31  
 
112 OEt 7.90  7.23  7.00  7.14  5.23  
 
114 n-Butyl 7.98  7.71  7.20*  7.20*  5.32 
  
117 Pentynyl 7.95  7.99  7.32  7.13  5.40  
 
118 Pentan-1-one 8.12  8.51  7.82  7.21  5.84  
 
123 Br 7.91 8.07 7.38 7.06 5.39 
 
*protons overlap 
 Table 10: Selected 1H NMR spectral data for compounds (111, 112, 114, 117, 118 and 
123) 
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13C NMR study of polysubstituted BINOLs 
 
From the general structure of a polysubstituted BINOL (Figure 2), seven tertiary and 
seven quaternary carbon signals would be expected to be seen in the 13C NMR spectrum 
plus the additional carbon signals contributed by the variable substituent.   
 
 
13C NMR and DEPT 135 spectroscopic study of (+/−)-6,6-dimethoxy-3,3’-diphenyl-
2,2’-dihydroxy-1,1-binaphthyl (111) 
 
A total of fifteen carbon signals are observable in the 13C spectrum of (+/−)-6,6-
dimethoxy-3,3’-diphenyl-2,2’-dihydroxy-1,1-binaphthyl (111). In the upfield region at 
55.44 ppm the methyl signal is clearly evident (Figure 7). All the remaining aromatic 
carbon signals reside between 156.59 ppm and 106.72 ppm. From the DEPT 135 it is 
possible to distinguish the tertiary and quaternary carbon signals. All seven quaternary 
carbon signals are not present in the DEPT 135 while the seven tertiary carbon signals 
and the methyl carbon signal are present (Figure 8). 
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Fig 7 13C NMR spectrum of (+/−)-6,6-dimethoxy-3,3’-diphenyl-2,2’-dihydroxy-1,1-
binaphthyl (111) 
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Fig 8 DEPT 135 spectrum of (+/−)-6,6-dimethoxy-3,3’-diphenyl-2,2’-dihydroxy-1,1-
binaphthyl (111) 
  
  
 
 
 
Electronic effects on carbon signals 
 
A selection of carbon signals for the polysubstituted BINOLs are presented in Table 11. 
The effects of electron donating and withdrawing substituents is notable for carbon 
signals at C5 C5’ and C7 C7’. The methoxy substituent shields C5 C5’ and C7 C7’ while 
the electron withdrawing bromo and pentan-1-one substituents deshield these positions as 
can be seen in Table 11.  
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Compound R C4, C4’ C5, C5’ C7, C7’ C8, C8’ C2, C2’ 
111 OMe 130.12  106.72  119.88  125.98  148.38  
 
112 OEt 130.05  107.50  120.14  125.92  148.28  
 
114 n-Butyl 130.90  126.93  128.99*  
124.27* 
128.99*  
124.27* 
149.52 
  
117 Pentynyl 131.05 131.18  130.33 124.26  150.45  
 
118 Pentan-1-one 132.97 130.24 125.64  124.60  152.20  
 
123 Br 130.41* 
130.37* 
130.41* 
130.37* 
130.64 126.08 150.26 
* indistinguishable carbons in hmqc  
 Table 11: Selection of 13C NMR spectral data for compounds 111, 112, 114, 117, 118 and 
123 
 
Solvent effects in 1H and 13C spectra for polysubstituted BINOLs 
 
1H NMR spectrum of (+/−)-6,6’-dicarboxyl-3,3’-diphenyl-2,2’-dihydroxy-1,1’-
binaphthyl (115) 
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(115) 
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The proton NMR spectrum for (+/−)-6,6’-dicarboxyl-3,3’-diphenyl-2,2’-dihydroxy-1,1’-
binaphthyl (115) was carried out in d6-DMSO (Figure 9) and d4-methanol (Figure 11). It 
was not possible to run the proton NMR spectrum in deuterated chloroform as the 
compound was insoluble for this solvent. In d6-DMSO all expected proton signals are 
present, the carboxylic acid proton is observed as a broad singlet at 12.84 ppm. 
Carboxylic acid protons usually appear this downfield due to the anisotropic field and the 
nearby electronegative oxygen atom.1 The hydroxyl on the naphthyl ring resides at 8.85 
ppm. This signal is shifted more downfield in d6-DMSO than previously seen for 
compounds 111, 118 and 123 in deuterated chloroform. Deuterated DMSO is a hydrogen 
bonding solvent and hydroxyl signals appear more downfield for this solvent when 
compared to non-hydrogen bonding solvents like deuterated chloroform.1 Due to the 
electron withdrawing nature of the carboxylic acid, protons H5 H5’ and H7 H7’ appear 
downfield at 8.65 ppm and 7.73 ppm respectively. The proton signal for H7 H7’ is 
overlapping with the ortho phenyl protons H12 H12’ H16 H16’ and can not be seen 
directly. Remaining phenyl protons reside between 7.50 ppm and 7.40 ppm. A singlet at 
8.18 ppm is observed for H4 H4’ and a doublet at 6.98 ppm is correlating with H8 H8’. 
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Fig 9 1H NMR spectrum of (+/−)-6,6’-dicarboxyl-3,3’-diphenyl-2,2’-dihydroxy-1,1’-
binaphthyl (115) in d6-DMSO 
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A D2O shake was performed to verify the carboxylic acid and hydroxyl signals at 12.84 
ppm and 8.85 ppm, respectively. After the D2O shake, the hydroxyl and carboxylic acid 
signals are not observed in the proton spectrum as they have exchanged with the 
deuterium in D2O (Figure 10). 
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Fig 10 1H NMR spectrum of (+/−)-6,6’-dicarboxyl-3,3’-diphenyl-2,2’-dihydroxy-1,1’-
binaphthyl (115) after D2O shake in d6-DMSO 
 
For the 1H NMR spectrum of 115 in deuterated methanol the aromatic proton signals are 
clearly resolved. The overlap between H7 H7’ and H12 H12’ H16 H16’ is not observed 
as both signals come at separate chemical shifts. Proton signal for H7 H7’ appears at 7.83 
ppm as a doublet of doublets with coupling constants 1.6 Hz and 8.8 Hz. Between 7.78 
and 7.40 ppm the phenyl proton signals reside. A doublet at 8.69 ppm is observed for H5 
H5’ and the singlet at 8.11 ppm represents H4 H4’. Both hydroxyl and carboxylic acid 
signals are not observed in the proton spectrum, probably as they have exchanged with 
deuterium from the deuterated methanol. 
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Fig 11 1H NMR spectrum of (+/−)-6,6’-dicarboxyl-3,3’-diphenyl-2,2’-dihydroxy-1,1’-
binaphthyl (115) in d4-methanol 
 
 
13C NMR spectra for (+/−)-6,6’-dibromo-3,3’-diphenyl-2,2’-bis(methoxymethoxy)-
1,1’-binaphthyl (125) 
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In the 13C NMR spectrum for (+/−)-6,6’-dibromo-3,3’-diphenyl-2,2’-
bis(methoxymethoxy)-1,1’-binaphthyl (125) a difference is noted for the number of 
carbon signals observable in CDCl3 and d6-acetone. A total of sixteen carbon signals 
should be seen for this compound. However, when the spectrum was carried out in CDCl3 
a total of fourteen carbons were noted (Figure 12). The missing 2 carbon signals are 
overlapping with other carbon signals. While in d6-acetone the expected 16 carbon 
signals were present and clearly resolved (Figure 13).  
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Fig 12 13C NMR spectrum of (+/−)-6,6’-dibromo-3,3’-diphenyl-2,2’-
bis(methoxymethoxy)-1,1’-binaphthyl (125) in CDCl3 
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 Fig 13 13C NMR spectrum of (+/−)-6,6’-dibromo-3,3’-diphenyl-2,2’-
bis(methoxymethoxy)-1,1’-binaphthyl (125) in d6-acetone 
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NMR studies of biquinoline derivatives 
 
The molecular structures of biquinoline derivatives contain a C2 symmetric axis, which 
results in the two quinoline units being chemically and magnetically equivalent when the 
substituents are the same for each unit.  
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Fig 14 General structure of biquinoline with numbering 
 
Each quinoline unit is composed of pyridine and a phenol fused together, with the carbon 
atom at C5 position linking to another quinoline unit. Modification of the nitrogen 
position is possible with various alkylating agents resulting in the generation of N-
alkylated biquinoline salts. 
Proton and carbon atoms within the quinoline unit are not chemically and magnetically 
equivalent to each other. In the 1H NMR spectrum for biquinoline, 5 spin coupled proton 
signals and a non-spin coupled hydroxyl signal are expected plus additional signals 
contributed by the substituents. 
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1H NMR study of quinoline and biquinoline derivatives 
 
1H NMR study for (+/−)-1,1’-ethoxycarbonylmethyl-6,6’-dihydroxy-5,5’-biquinoline 
(135) 
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(135) 
 
For the 1H NMR spectrum of (+/−)-1,1’-ethoxycarbonylmethyl-6,6’-dihydroxy-5,5’-
biquinoline (135) in d6-DMSO , five spin coupled aromatic proton signals, two spin 
coupled aliphatic proton signals, one non-spin coupled aliphatic proton and a non-spin 
coupled hydroxyl signal are present (Figure 15). The singlet at 11.31 ppm is 
corresponding with the hydroxyl group and is the most downfield signal for this 
spectrum. A doublet of doublets at 8.06 ppm with coupling constants 8.4 Hz and 5.2 Hz 
can be seen for H3 H3’. This proton signal appears as a doublet of doublets as it is 
coupling with H2 H2’ and H4 H4’. The doublet at 8.40 ppm with a coupling constant of 
8.4 Hz correlates with H4 H4’ and the doublet at 9.45 ppm with a coupling constant of 
5.2 Hz belongs to H2 H2’.  Remaining doublets at 8.56 ppm and 8.14 ppm with coupling 
constants of 9.6 Hz are corresponding to H8 H8’ and H7 H7’ respectively. Within the 
aliphatic region of the spectrum a downfield singlet at 6.28 ppm is noted for H11 H11’. A 
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quartet at 4.30 ppm with a coupling constant of 6.8 Hz is observed for H13 H13’.  Proton 
signal for H14 H14’ appears at 1.31 ppm as a triplet with a coupling constant of 6.8 Hz. 
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Fig 15 1H NMR spectrum of (+/−)-1,1’-ethoxycarbonylmethyl-6,6’-dihydroxy-5,5’-
biquinoline (135) 
 
Effect of n-alkyl substituents on aromatic proton signals for biquinoline compounds 
 
Following the n-alkylation of the biquinoline scaffold a significant change in chemical 
shifts can be seen for the 1H NMR spectrum of 134, 135 and 136 when compared to the 
1H NMR spectrum of 130 (Table 12). All aromatic protons are shifted downfield as a 
result of the electron withdrawing quaternary nitrogen. The greatest downfield shift for 
proton signals is observable for the ethoxy compound (135) as can be seen in Table 12. 
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Compound R H2, 
H2’ 
H3, 
H3’ 
H4, 
H4’ 
H7, 
H7’ 
H8, 
H8’ 
OH 
        
130 Unsubstituted 8.66 7.25 7.35 7.60 8.01 8.90 
 
       
134 n-butyl 9.39 7.92 8.25 8.08 8.73 11.15 
 
       
135 Ethoxycarbonyl 
methyl 
9.45 8.06 8.40 8.14 8.56 11.31 
 
       
136 methyl 9.31 7.92 8.21 8.03 8.62 11.19 
 
Table 12: Selected proton signals for biquinoline compounds 130, 134, 135 and 136 
 
 
 
 
 
 
1H NMR study of 6-hydroxy-quinoline-3-carboxylic acid methyl ester (142) 
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142 
 
For 142, the hydroxyl proton signal can be seen at 10.32 ppm as a broad singlet in the 1H 
NMR spectrum in d6-DMSO (Figure 16). Proton H2 is observed as a doublet with a 
coupling constant of 2.0 Hz at a downfield shift of 9.06 ppm. The doublet for H4 with a 
coupling constant of 2.0 Hz is evident at 8.76 ppm. A proton signal for H7 at 7.46 ppm is 
coupling with H8 and H5, resulting in a doublet of doublets with coupling constants 9.2 
Hz and 2.6 Hz. The adjacent H8 resides at 7.95 ppm as a doublet and the doublet at 7.35 
ppm is noted for H5. Methyl signal can be seen at 3.92 ppm with an integration of 6 
protons. 
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Fig 16 1H NMR spectrum of 6-hydroxy-quinoline-3-carboxylic acid methyl ester (142)  
 
 
1H NMR study of 6,6’-dihydroxy-5,5’-biquinoline-3,3’-dicarboxylic acid dimethyl 
ester (137a) 
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In the 1H NMR spectrum of 6,6’-dihydroxy-5,5’-biquinoline-3,3’-dicarboxylic acid 
dimethyl ester (137a) in d6-DMSO, a broad downfield singlet at 10.22 ppm is evident for 
the hydroxyl group (Figure 17). Both H8 H8’ and H7 H7’ are coupling with each other at 
8.16 ppm and 7.77 ppm, respectively, with a coupling constant of 8.6 Hz. A singlet at 
9.13 ppm is corresponding with H2 H2’ and the singlet at 7.98 is correlating with H4 
H4’. Coupling is not evident between H2 H2’ and H4 H4’ possibly due to line 
broadening. In the upfield region of the spectrum the methyl signal can be seen at 3.77 
ppm as a singlet.  
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Fig 17 1H NMR spectrum of 6,6’-dihydroxy-5,5’-biquinoline-3,3’-dicarboxylic acid 
dimethyl ester (137a)  
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13C and DEPT 135 studies of quinoline and biquinoline derivatives 
 
13C and DEPT 135 NMR study of 6-hydroxy-quinoline-3-carboxylic acid methyl 
ester (142) 
 
In the 13C spectrum of 142 in d6-DMSO, a total of 11 carbon signals can be seen (Figure 
18). A downfield chemical shift at 165.44 ppm is noted for the carbonyl group and in the 
DEPT 135 NMR spectrum (Figure 19) this peak is not observed. In the upfield region of 
the spectrum a signal for the methyl ester is evident at 52.30 ppm. All remaining carbon 
signals belong to the aromatic carbon atoms within the quinoline unit. 
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Fig 18 13C NMR spectrum of 6-hydroxy-quinoline-3-carboxylic acid methyl ester (142) 
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Fig 19 DEPT 135 spectrum of 6-hydroxy-quinoline-3-carboxylic acid methyl ester (142) 
 
13C and DEPT 135 NMR study of 6,6’-dihydroxy-5,5’-biquinoline-3,3’-dicarboxylic 
acid dimethyl ester (137a) 
 
 
A total of 11 carbon signals can be seen in the 13C NMR spectrum of 6,6’-dihydroxy-5,5-
biquinoline-3,3’-dicarboxylic acid dimethyl ester (137a) in d6-DMSO (Figure 20). The 
carbonyl signal is evident at 165.28 ppm and is not observed in the DEPT 135 (Figure 
21). The upfield signal at 52.35 ppm is corresponding with the methyl ester group. All 
remaining aromatic carbon signals reside between 154.24 ppm and 114.55 ppm. In the 
DEPT 135 spectrum, four tertiary carbon signals and a methyl signal can be seen. 
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Fig 20 13C NMR spectrum of 6,6’-dihydroxy-5,5’-biquinoline-3,3’-dicarboxylic acid 
dimethyl ester (137a)  
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Fig 21 DEPT 135 NMR spectrum of 6,6’-dihydroxy-5,5’-biquinoline-3,3’-dicarboxylic 
acid dimethyl ester (137a) 
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Difference between 137a and 142 proton and carbon spectra 
 
 
The difference between the proton and carbon spectra for 137a and 142 further verifies 
proof of structure for 137a (Table 13 and 14). 
 
A total of 6 proton signals are present for 142 in 1H NMR spectrum while for 137a a total 
of 5 proton signals are present. The proton signal at H5 is present in the proton spectrum 
of 142 while absent in the spectrum of 137a which suggests that dimerisation has 
occurred in this position. As well H7 appears as a doublet of doublets in the 1H spectrum 
of 142 but is a doublet in the spectrum of 137a, this suggest that the meta coupling for H7 
apparent in 142 is absent in 137a as this compound has dimerised at C5.  
 
 
Proton 142 137a 
OH 10.32 (s) 10.22 (s) 
H2 9.06 (d) 9.13 (s) 
H4 8.76 (d) 7.98 (s) 
H5 7.35 (d) - 
H7 7.46 (dd) 7.77 (d) 
H8 7.95 (d) 8.16 (d) 
H12 3.92 (s) 3.77 (s) 
 
Table 13: Proton data for 137a and 142 
 
Both 137a and 142 have a total of 11 carbon signals present for each 13C NMR spectrum. 
142 includes 5 tertiary, 5 quaternary and a primary carbon signal for its spectrum while 
137a includes 4 tertiary, 6 quaternary and a primary carbon signal. The absence of a 
tertiary carbon signal and the extra quaternary carbon signal for the spectrum of 137a 
compared to 142 further supports the dimerised molecule.    
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142 137a 
165.44 (CO) 165.28 (CO) 
156.26 (C) 154.24 (C) 
145.88 (CH) 145.85 (CH) 
144.45 (C) 144.87 (C) 
136.55 (CH) 134.25 (CH) 
130.27 (CH) 130.57 (CH) 
127.95 (C) 127.43 (C) 
124.60 (CH) 124.49 (CH) 
122.46 (C) 122.63 (C) 
109.61 (CH) 114.55 (C) 
52.30 (CH3) 52.35 (CH3) 
 
Table 14: 13C data for 137a and 142 
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